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ABSTRACT
Quality of life (QoL) in cancer survivors is an important area of research. While data are
available about QoL and breast cancer, there is a paucity of research regarding older breast
cancer survivors. The purpose of this research was to examine QoL in older women with early
stage breast cancer, within the first year of post-treatment survivorship. The specific aims of this
study were to: 1) Describe the changes in overall QoL and the four QoL domains of Physical,
Psychological, Social, and Spiritual well-being; 2) Examine the effects of a psychoeducational
support intervention on QoL outcomes in older women; and 3) Describe nurses‘ perceptions of
their interactions with older breast cancer survivors.
A descriptive, longitudinal design was used to answer the research questions. Data for
this study were drawn from the Breast Cancer Education Intervention (BCEI), a longitudinal
psychoeducational support intervention for women with early stage breast cancer. Fifty women
from the BCEI who were 65 years of age and older were included in this sample, of whom 24
were assigned to the Experimental (EX) Group and 26 were assigned to the Wait Control (WC)
Group. Data were collected at three time points: baseline, three months, and six months after
study entry. Measurement tools included the BCEI Demographics Form, the Quality of LifeBreast Cancer Survey (QoL-BC), and field notes of the BCEI Research Nurses. The QoL-BC
survey is a 50-item scale that measures QoL in women with breast cancer. Descriptive statistics,
Generalized Estimating Equation (GEE) methods and t-tests were used to answer research
questions #1 and #2. Content analysis was used to answer research question #3.
Subjects reported good overall QoL at baseline, but QoL declined over six months.
Physical and Psychological well-being declined from baseline to six months later. Social well-
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being initially improved from baseline to three months but declined at six months. Spiritual wellbeing initially declined at three months and improved at six months. There was insufficient
power to detect a difference in the effects of the BCEI Intervention between the two groups.
However, the decline in overall QoL was less in the EX Group. Field notes focusing on nurses‘
perception of their interactions with older women revealed four themes. These themes include:
continuing breast-related health, personal health issues, family health issues, and potential
stressors.
Results from this study suggest that: 1) changes in overall QoL and within the four QoL
domains occur over time; 2) decline in overall QoL was lessened by the BCEI Intervention; and
3) concerns after treatment are both breast cancer and non-breast cancer related. Study findings
can direct future research in the following areas: 1) identification of specific concerns within
each QoL domain that could lead to an increase or decrease in well-being in older breast cancer
survivors; 2) interventions tailored to the needs of older breast cancer survivors to maintain,
improve, or lessen decline in QoL after treatment; and 3) reconceptualizing QoL in older breast
cancer survivors to include non-cancer related factors.
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CHAPTER 1: INTRODUCTION
Breast cancer is the most common cancer diagnosed in women in the United States. The
mean age of women diagnosed with breast cancer is 61 with women age 75 to 79 having the
highest incidence. Today, there are more than 2.3 million women surviving with breast cancer.
As the Baby Boomer generation ages and their life expectancy increases, the number of older
women diagnosed and surviving with breast cancer is also expected to increase. Throughout this
dissertation, ―older‖ represents women age 65 and older.
Evidence suggests that women with breast cancer experience adverse effects related to
their cancer that can affect quality of life (QoL) after treatment. Data also suggest that QoL after
treatment may be influenced by non-cancer related stressors that occur before a diagnosis of
breast cancer. The majority of research regarding QoL in women with breast cancer focused on
women with an average age of 50 years. Despite the increased risk for breast cancer in aging
women, less research attention has been paid to women age 65 and older. The overall purpose of
this research was to examine QoL in women with early stage breast cancer who are age 65 and
older and are within the first year of post-treatment survivorship.
The goal of this research was to add to the body of knowledge concerning QoL in older
women after treatment for early stage breast cancer. The research proposal in Appendix C
includes extensive details of the study‘s overall purpose, specific aims, research design, methods
and analysis. This dissertation used a secondary analysis based on data drawn from the Breast
Cancer Education Intervention (BCEI), a longitudinal psychoeducational support intervention
trial. A descriptive, longitudinal design using mixed methods was used to examine QoL in older
women with breast cancer and to answer the research questions.
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This dissertation followed the University of Central Florida alternate model and is
comprised of three manuscripts that focus on older, early stage breast cancer survivors after
treatment. Consistent with the background and literature review, the first manuscript, entitled
Quality of life in women age 65 and older surviving early stage breast cancer: A review of the
literature, focuses on the state of the science related to women, age 65 and older, with early stage
breast cancer after treatment. The second manuscript, entitled A longitudinal study of quality of
life in older women with early stage breast cancer in the first year of post-treatment
survivorship, describes the Overall QoL and QoL within the domains of Physical, Psychological,
Social, and Spiritual well-being in women age 65 and older with early stage breast cancer who
are within the first year post-treatment. This manuscript also describes the effect of the BCEI
psychoeducational support intervention in these women. The third manuscript, entitled Nurses
perceptions of their interactions with older women with early stage breast cancer within the first
year of post-treatment survivorship, explores nurses‘ perceptions of their interactions with
women, age 65 and older, with early stage breast cancer.
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CHAPTER 2: QUALITY OF LIFE IN WOMEN AGE 65 AND OLDER
SURVIVING EARLY STAGE BREAST CANCER: A REVIEW OF THE LITERATURE
Introduction
Quality of life (QoL) is recognized as a multidimensional concept with perception based
on the subjective experiences of the individual assessing it.1-5 For the purposes of this literature
review, QoL is defined as a personal sense of well-being that encompasses physical,
psychological, social and spiritual dimensions.6-8 Other dimensions have also been identified and
include health and functioning, socioeconomic,9 functional ability, family well-being, emotional
well-being, treatment satisfaction,2 and physical functioning.1 For persons surviving cancer, the
period after treatment can be a complex time in which survivors experience physical and
psychosocial effects,10-14 which in turn, may affect QoL.
Quality of life is recognized as an important outcome of cancer treatment. Improving
quality of care and QoL in those affected by cancer are goals set forth by the National Cancer
Institute‘s (NCI) Strategic Plan for Leading the Nation to Eliminate the Suffering and Death Due
to Cancer.15 The National Institutes of Health (NIH) encourages using QoL endpoints in NIHfunded clinical trials. In addition, the National Institute of Aging‘s (NIA) Action Plan for Aging
Research: Strategic Plan for Fiscal Years 2001-200516 recognizes the need to address
knowledge deficits regarding the elderly, disease and aging. One of the primary goals of its
strategic plan is to improve health and QoL in older people. Older people with cancer have been
identified as an unexplored population.17-19 In this paper, ―older‖ is defined as age 65 or older.
Combined, these organizations outline a need for more research regarding QoL after cancer
treatment.
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The aging of Baby Boomer generation makes QoL research in older populations with
cancer particularly salient. Because of the growth expected in the 65 and older age group and
because the incidence of cancer increases with age, the number of all cancers diagnosed annually
is expected to double from the current rate of 1.3 million to 2.6 million by 2050.17 Currently,
57% of all new cancer diagnoses and 71% of cancer-related deaths occur in people age 65 and
older.19 In women, breast cancer is the most common cancer.20 The mean age of all women
diagnosed with breast cancer is 61, while women ages 75 to 79 have the highest incidence rate.21
In brief, there are many older women living with breast cancer, and in the future, there will be
many more. These figures make older women with early stage breast cancer a particularly
important population to study.
Today, there are more than 2.3 million women surviving with breast cancer.21 Since
more than 90% of all breast cancers are diagnosed in early stages, prior to metastasis,22 more
older women will become cancer survivors in the near future. After treatment, women are at risk
for physical and psychosocial consequences that can affect QoL. Physical effects include
fatigue,23 pain, cognitive changes,23 lymphedema, sexual effects, pulmonary, neurologic,
gastrointestinal,12 and cardiac effects.12, 24, 25 Psychosocial effects include fear of recurrence,
depression, uncertainty in illness, and finding meaning in illness.10 The majority of research on
QoL in breast cancer survivors has been conducted in samples of women with an average age
near 50 years. 6, 26-34 Less research attention has been given to women over the age of 65 years.
Since the number of older women who will receive a diagnosis of breast cancer is large
and will increase, it is important to better understand the needs of this population. Thus, the goal
of this paper is to: 1) review the literature review concerning quality of life in women, age 65
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and older, surviving with early stage breast cancer after treatment; 2) describe implications for
future research; and 3) describe implications for nursing practice.
Methods
A review of literature was conducted using Medline, CINAHL, PsychInfo and Ageline
databases. The literature search was conducted in several phases. First, the search began by
using the keywords: quality of life, breast cancer and older women. No date limitations were
used. This search yielded fifty-four articles in CINAHL/PsychInfo, 127 articles in Medline and
nine articles in Ageline, totaling 190 articles. Several articles were duplicated between the
databases. The title and abstract of each article were reviewed to determine if the articles met
inclusion criteria. Articles were included if they: 1) were published in a peer-reviewed journal; 2)
included an age group of 65 and older as either the only population or a specific comparative
group; 3) focused on the post-treatment phase of breast cancer; 4) focused on women with early
stage disease and; 5) were published in the English language. Dissertations, editorials, and
articles that focused on breast cancer in men were excluded. Six articles met the inclusion
criteria.
Second, the search was expanded since so few articles were found. The key words of
breast cancer and older women were retained, and new keywords were added that related to
aspects of QoL that had been previously reported in breast cancer survivors.6, 30 These additional
keywords included: physical well-being, psychological well-being, social well-being, spiritual
well-being, survivorship, coping, adaptation, fatigue, pain, lymphedema, sleep disturbances,
insomnia, weight gain, menopause/menopausal symptoms, sexual functioning, cognitive
functioning, social support, fear of recurrence, depression, relationships, employment, body
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image, meaning in illness, religion, spirituality, hope, and uncertainty. Each of these keywords
was added to the previously used keywords, breast cancer and older women. This search yielded
an additional 408 articles in CINAHL/PsychInfo and 682 articles in Medline. Duplicate articles
were noted throughout the searches. The new articles from this expanded search were reviewed
according to the same inclusion criteria used in the first phase of the search. Five new articles
were identified bringing the total number of articles retrieved to eleven.
Third, the reference lists of the eleven included articles were hand searched and evaluated
for relevance. Two more articles were identified bringing the total number of articles to thirteen.
Fourth, this author also reviewed articles in her possession from previous work and identified
one additional article that met the inclusion criteria for this review bringing the total number of
articles to fourteen. This literature review will present the available knowledge concerning QoL
of older women, age 65 and older, with early stage breast cancer after treatment.
Findings
Fourteen studies met inclusion criteria and are included in this discussion. Seven studies
focused exclusively on women with breast cancer age 65 and older. Four studies compared
women with breast cancer age 65 and older to age-based controls. Three studies were conducted
that compared women, age 65 or older, to younger women with breast cancer.
Women age 65 and older
Seven studies examined QoL specifically in women with early stage breast cancer age 65
and older. These studies have focused on QoL outcomes in older women after surgery and the
ability of older women to find meaning in illness. See Table 1 for a summary.
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Effect of surgery on QoL outcomes
Four studies looked at the effects of treatment on outcomes of QoL. De Haes and
colleagues35 compared QoL in women with breast cancer age 70 and older (N=136) who had
received lumpectomy plus tamoxifen or mastectomy as primary treatment. This was a
randomized clinical trial. QoL was measured using an unspecified QoL questionnaire that
evaluated 9 domains. Women completed this survey between two and twelve months after
surgery. Data were analyzed using Wilcoxon signed ranks test. Results showed that regardless
of treatment, women experienced similar levels of fatigue, physical and emotional functioning,
fear of recurrence, social support, and leisure-time activities. Women with mastectomy reported
significantly more arm problems (p=.004), and women who received breast-conserving treatment
had better body images (p=.006). This study concluded that older women who had conservative
treatment had better QoL than women who had more extensive surgeries.
Using longitudinal design, Mandelblatt and colleagues36 examined the impact of axillary
dissection (AD) in women, age 67 and older, who had early stage breast cancer (N=571). Posttreatment QoL was a primary outcome of the study. The Medical Outcomes Study-Short Form
(SF-12) measured physical and mental functioning, while fear of recurrence was measured using
two items from the Cancer Rehabilitation Evaluation Survey-Short Form (CARES-SF). The
study included an additional question involving the impact of breast cancer on life. Subjects
completed surveys at one and two years after surgery. Data were analyzed using analysis of
variance (ANOVA) and chi square distribution statistics. Longitudinal data were measured
using Generalized Estimating Equation (GEE) methods. Results indicate that 60% of the sample
reported arm problems (i.e. swelling, loss of arm movement, and limitations of use) at some time
during the study, and 83% of women who received AD reported arm problems. In addition,
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women with arthritis were more likely to report arm problems 2 years after surgery. Women
who received AD and reported arm problems reported lower physical (p=0.0001) and mental
functioning (p=0.04) at both points of the study. Finally, women who experienced arm problems
indicated that the breast cancer had a more severe impact on their lives than women who did not
have arm problems (p= 0.0006). This study concluded that AD increased the risk of developing
arm problems within two years and had negative effects on QoL.
In another study, Mandelblatt and colleagues37 used a randomized cross-sectional design
to describe the long-term impact of primary therapy on QoL and satisfaction in early stage breast
cancer survivors age 67 and older (N=1,812). Women who were three to five years posttreatment and received either breast conservation treatment (BCT) or mastectomy were included
in this sample. Physical functioning was examined using the SF-12. Social and role function,
vitality, and general health were examined using scales from the Medical Outcomes Survey
Short Form-36 (SF-36). Data were analyzed using chi square distribution, t tests, and logistic
regression. Results indicate that regardless of the treatment group, women did not differ
significantly in any of the scales. Having a co-morbid illness prior to treatment affected physical
outcomes (p=<.001). Women with axillary dissection reported more arm problems, which
negatively impacted all other outcomes (p=<.001). In addition, older women who felt they were
not given a choice about treatment reported more pain, poorer mental health, and less satisfaction
(p=.0001). The study concluded that processes of care, not treatment, were important predictors
of long-term QoL in these older women.
In a longitudinal clinical trial, Figueiredo and colleagues 38 examined the effect of
surgery preference and surgery received on body image and mental health in women age 67 and
older (N=563). Data were collected using the SF-36, CARES-SF, and two investigator-
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developed questions. Data were analyzed using chi square distribution, t tests, ANOVA, Pearson
and Spearman rank correlation, path analysis and GEE methods. Results indicated that physical
appearance was important for 31% of the sample when making treatment decisions. In addition,
younger women and those with fewer co-morbid illnesses were more likely to be concerned
about appearance. At one and two year follow-ups, women who received mastectomy had more
concerns about body image (p<.0001) and worse mental health (p<.05) than women who
received BCT. Generally, if subjects did not receive the type of treatment preferred, they
reported greater concern for body image and poorer outcomes related to mental health. This
study concluded that body image is important to older women, and receiving treatments
according to preference about appearance was an important factor for positive mental health
outcomes.
In summary, four studies focused on QoL outcomes after primary treatment and
suggested that conservative treatment leads to better QoL. Women who receive more aggressive
treatments such as mastectomy experience more arm problems, concerns with body image, and
poor mental health. Women who received axillary node dissection also report more arm
problems, and this had a negative impact on QoL. In addition, if older women felt involved in
treatment decisions, they reported better mental health and satisfaction.
Meaning in Illness
Three qualitative studies explored meaning in illness after breast cancer. In the first, Feher
and Maly 39 used structured interviews and open-ended questions to examine religious and
spiritual coping strategies in women age 65 and older (N=33) who were recently diagnosed with
breast cancer. Content analysis was used to analyze data. All of the subjects in this study
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indicated that their faith had been maintained or strengthened during illness. Three themes
emerged during analysis. First, women felt that their religious and spiritual faith helped give
them the emotional support needed in order to cope with breast cancer and make meaning in
their lives during illness. Faith gave women a sense of companionship and being taken care of.
Faith also provided emotional support and helped women control their fears, take comfort, and
have a sense of well-being. Second, older women used their associations with the church to
maintain social connections with others. Being associated with a church or religious community
allowed women to keep in touch with others through volunteer work and their relationship with
the leader of their church. In addition, women liked being prayed for by others. Women felt
protected, loved, and unafraid due to the presence of God in their lives. Third, women were able
to make meaning in their lives through their faith. They felt that faith acted as a moral compass
and gave them identity. In addition, some women felt that their illness was in God‘s hands and
out of their control. They believed their illness was for a greater purpose. Overall, women used
religion and faith to cope with their illness.
Utley 40 sought to discover the meaning of cancer in older, long-term breast cancer
survivors using qualitative analysis. Twenty women, age 65 and older who were five to twentynine years past diagnosis, participated in three life history interviews. Results showed that
women experience three distinct and progressive phases of finding meaning in their illness. The
first phase viewed cancer as sickness and then death. Women talked about expecting to feel sick
if they had cancer and how their expectation did not correlate with how they really felt. The
second phase viewed cancer as an obstacle and something to overcome. Women realized cancer
was something they could live with. In the third phase, cancer was viewed as transforming.
Women realized that their lives changed and could see how cancer benefited them and their
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lives. The meaning of cancer evolved over time, and most women experienced a positive effect
from having cancer.
Through methods informed by grounded theory, Crooks 41 developed the theoretical
model of Living Day by Day in which older women went through several phases before coming
to terms with and finding meaning in their disease. Twenty women, age 66 to 94 with early
stage breast cancer, participated in this study. Initially, women ―faced the music‖ by finding out
about their diagnosis and taking action against it through treatment. ―Getting back to normal‖
after treatment was a considerable task for older women. In this phase, women acknowledged
the physical changes that they experienced, such as pain or the loss of a breast, and strategized to
assimilate these changes into their lives. In addition, older women were able to realize that
having cancer changed how other people viewed them as individuals. As a result, older women
protected family members by downplaying their own fears and concerns and sharing information
about themselves with others in similar situations or with those who cared about their situation.
―Getting perspective‖ is the third phase in which older women sought perspective on their
disease and life expectancy. Women made decisions for themselves based on their comparison
of themselves to other women in similar situations and those with different illnesses to
determine if their problems were more or less significant. Older women used this strategy to
affirm previous decisions and to determine how much effort should be given to concerns about
the diagnosis and fears of recurrence. Finally, ―being different than before‖ was the last phase
identified by older women. Women became aware of the isolation caused by the diagnosis and
the need for time to make sense of the changes. Older women examined their belief systems and
focused on the important things in their life. Ultimately, this process of finding meaning in
illness allowed women to live each day to the fullest.
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In summary, three qualitative research studies discussed meaning in illness in older early
stage breast cancer survivors. The next section of the review will focus on studies that compare
women, age 65 and older, surviving with early stage breast cancer to age-based controls without
cancer.
Women age 65 and older and age-based controls
Women age 65 years and older with early stage breast cancer were compared to women
with and without cancer. Two studies compared older women with breast cancer with age-based
controls without cancer, and two studies compared older women to both age-based controls
without cancer and younger women with and without cancer. These studies focused on symptom
distress, physical functioning, and psychological well-being, which will be discussed in the next
section. See Table 2 for a summary.
Symptom distress
Using descriptive, correlational design, Heidrich and colleagues42 examined symptoms,
symptom belief, and QoL in older women (age 65 or older) with chronic illnesses with (n=18)
and without (n=24) breast cancer. Symptom distress was measured by the Heidrich Symptom
Bother Scale-Revised (SB-R); symptom belief was evaluated by asking women the origin of
their symptoms; QoL was measured using the SF-36; and the Purpose in Life Scale was used to
measure existential QoL. The Center for Epidemiologic Studies Depression Scale (CES-D),
State-Trait Anxiety Inventory, and Older Americans Resources Service Schedule of Illnesses
(OARS) were also used. Data were analyzed using Wilcoxon-Mann-Whitney U test and chisquare distribution tests.
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Results showed that both groups of women reported multiple symptoms and low levels of
symptom distress. Symptoms reported included pain, fatigue, aching, joint pain, dry mouth,
weight gain, lack of concentration, weakness, constipation, and hot flashes. Aching was the only
symptom reported more often by women with breast cancer (p< 0.05). Women in both groups
attributed their symptoms to aging, chronic conditions, or unknown causes. Women in the breast
cancer group rarely associated their symptoms with breast cancer. When older women were able
to attribute symptoms to a cause, they found them less distressing than women who were not
able to identify a cause for their symptoms. In summary, symptom experience and symptom
attribution were similar in both groups. Although women with breast cancer reported
experiencing symptoms, they reported low levels of distress. In addition, they rarely associated
their symptoms with breast cancer, instead attributing symptoms to aging and other chronic
conditions.
Physical functioning
Satariano and colleagues43 conducted a longitudinal study to examine instrumental
functioning in women with breast cancer (n=422) compared to non-cancer peers (n=478).
Women were divided into three age groups: age 55 to 64, 65 to 74 and 75 to 84 and were
compared to non-cancer peers within their age group. Instrumental daily living was measured
using the Instrumental Activities of Daily Living (IADL) survey at three and twelve months after
diagnosis. Data were analyzed using Ridit analysis. Results showed that at three months postdiagnosis, women with cancer, ages 55 to 64 and 65 to 74 reported more instrumental
functioning problems (e.g. housekeeping, preparing meals, shopping) compared to controls
within their age group. Women ages 75 and older reported the fewest instrumental functional
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problems compared to similar-aged controls: these women named transportation as the most
problematic issue. At twelve months, women ages 55 to 64 were more similar to their control
group, but women ages 65 to 74 continued to report less independence than their control group.
Women with cancer, ages 75 to 84 were again not significantly different from their control group
in respect to instrumental functioning or independence at the twelve month time point.
Kroenke and colleagues44 (2004) examined physical and psychosocial changes due to
breast cancer using non-cancer comparison groups of women of different ages. The total sample
was obtained from the Nurses‘ Health Study and the Nurses‘ Health Study II and consisted of
122,969 women, of which 1,082 had breast cancer. Comparative groups for this prospective,
longitudinal study included younger (ages 40 and younger), middle-aged (41 to 64 years), and
older women (ages 65 and older). Measurement tools included the SF-36 and the CARES-SF.
Data were analyzed using linear regression methods. Results indicated that the youngest women
with breast cancer experienced the most significant declines in physical roles, social functioning,
bodily pain and mental health compared to their non-cancer peers (p< 0.05). Both groups of
older women experienced statistically significant declines in physical functioning, role
limitations due to both physical and emotional problems, and bodily pain (p< 0.05). However,
older women without breast cancer showed about half the decline as their peers with breast
cancer. Physical declines in the oldest groups were similar regardless of disease state. These
researchers suggest that the declines were related to age instead of treatment or the disease itself.
This study concluded that older women fare better than younger women in physical and
psychosocial domains after diagnosis.
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Psychological well-being
Using a 2x2 cross-sectional design, Heidrich 45 examined the influence of age and type
of illness on health and functioning, self-interpretive mechanisms, and psychological well-being.
Women with breast cancer (n=86) and osteoarthritis (n=102) were divided into two age groups
for comparison: young-old (ages 60 to 74) and old-old (ages 75 and older). Multiple instruments
were used in this study and included the OARS ADL measure for functional health status;
Heidrich‘s Symptom Bother Scale; a social comparison scale; a social network index to assess
social integration; single-item questionnaires to assess illness perceptions; the CES-D;
Rosenberg‘s Self- Esteem Scale; and Ryff‘s scales of psychological well-being. Data were
analyzed using analysis of co-variance (ANCOVA) and multivariate analysis of covariance
(MANCOVA).
Results indicated that age did not influence outcomes such as health, functioning and
psychological well-being. However, type of illness did influence these outcomes. Compared to
women with breast cancer, women with arthritis reported more symptom bother and problems
with activities of living (p= 0.0001). Women with arthritis also reported their illness as less
controllable and more severe and chronic (p< 0.001) than women with breast cancer. Women in
both groups compared themselves with other women they knew, making upward and downward
comparisons to help discern their own appraisal of psychological well-being. These appraisals
influenced psychological outcomes. Women who made upward comparisons had better
psychological well-being. This study indicates that older women with arthritis reported more
symptom bother than women with breast cancer. In addition, positive appraisal or comparisons
influenced psychological outcomes.
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In summary, studies that compared older women with breast cancer to non-cancer agebased controls suggest the following: 1) older women believe that the symptoms they experience
after breast cancer are related to age or chronic illness, not breast cancer; 2) older women
experience changes in functioning, but so do their non-cancer peers, suggesting that declines in
physical functioning may be attributable to age, not treatment; 3) older women with arthritis
report more symptom bother than women with breast cancer. The next section of the review will
focus on differences between older and younger women with breast cancer.
Older women compared to younger age groups
Three studies compared older and younger women with breast cancer. These studies
examined functional status, cognitive functioning, and overall QoL. Please see Table 3 for a
summary.
Functional status
Fehlaur, Tribius, Mehnert, and Rades (2005) compared functional status based on age at
diagnosis in long-term breast cancer survivors. The effects of adjuvant treatment on healthrelated QoL (HR-QoL) were also examined. The sample consisted of 370 women treated with
lumpectomy, axillary node dissection, and radiation. Women were grouped according to time of
follow-up (either seven or twelve years), age at time of therapy (<50 years, 50-65 years, and >65
years), and type of treatment. Measurements included the European Organisation for Research
and Treatment of Cancer‘s (EORTC) Quality of Life Questionnaire (QLQ-C30) and the EORTC
Breast Cancer Module (QLQ-BR23). Data were analyzed using two-way multivariate analysis
of variance (MANOVA) and post-hoc Scheffe tests.
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Results indicated that at seven and twelve years from treatment, the oldest women at the
time of treatment reported worse physical functioning (p<0.001) and more body pain (p<0.01)
compared to younger women. Older women had significantly more arm symptoms (p=0.005) at
twelve years, and their illness had less financial impact (p=0.006) compared to younger women.
Global HR-QoL scores improved significantly for older women at the twelve year follow-up
(p=0.006) despite these concerns. The type of treatment did not have an impact on HR-QoL in
this study. This study concluded that age at time of therapy is related to differential disturbances
in HR-QoL.
Cognitive functioning
Cognitive functioning in older women after treatment for early stage breast cancer has
been examined in the literature. Cimprich46 examined the effect of age and type of surgery on
attentional fatigue in women (N=74) with early stage breast cancer. This study had three groups:
younger (ages 25 to 45), middle-aged (ages 46 to 64) and older (ages 65 to 74) women. The
capacity to directed attention (CDA) was measured before and after surgery (lumpectomy or
mastectomy). Four measures of CDA were used, which tested the subjects ability to block a
competing stimulus when they focused on a task. Data were analyzed using ANOVA, t tests,
and multiple regression.
Results indicate that older women had significantly lower total attention scores than
younger women at baseline (p< 0.05). Older women also experienced significant losses in
overall attention performance (p= 0.04) and total attention scores (p<.05) over time compared to
younger women. Within the older group, women who received mastectomy also showed
significantly greater loss in total attention scores compared to women of the same age who
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received breast conservation treatments (p= 0.05). More extensive surgeries led to more attention
deficits. This study concluded that age and type of surgery affected the capacity to direct
attention in older women with early stage breast cancer.
Overall quality of life
Using a cross-sectional design, Cimprich and colleagues 47 examined the relationship
between age at diagnosis and QoL in long-term breast cancer survivors (N=105). Women were
divided into groups that represented life stages: younger women (ages 45 and younger), middle
age (ages 46 to 65) and older (ages 66 and older). Quality of life outcomes were measured by
using the Quality of Life-Cancer Survivors (QoL-CS) instrument, which focuses on physical,
psychological, social, and spiritual well-being. Data were analyzed using ANOVA and multiple
regression.
Results indicate that that older women have significantly worse physical well-being
scores (p= 0.008) than middle-aged women but significantly better social well-being scores (p=
0.025) than the youngest women. Within the physical domain, older women reported
significantly (p< 0.05) more problems with fatigue, pain, constipation, and sleep changes
compared to younger women. Within the psychological domain, older women reported
significantly less (p< 0.05) distress at diagnosis and treatment but better outcomes related to
changes in appearance than younger women. Within the social domain, older women reported
significantly lower impact (p< 0.05) on sexuality, employment, and family distress than younger
women. In the spiritual domain, older women also reported significantly fewer (p<.05) positive
changes as a result of breast cancer than younger women and more uncertainty for the future

18

compared to middle-aged women. This study concluded that life stage at the time of diagnosis
had a significant impact on long-term QoL in breast cancer survivors.
In summary, studies that examined age-related differences in women with breast cancer
showed the following. Compared to younger women, older women reported: 1) worse physical
well-being and functioning; 2) less distress from diagnosis; 3) better outcomes for appearance; 4)
less distress related to sexuality; 5) less distress related to employment; 6) less family distress; 7)
more decline in cognitive functioning; and 8) fewer positive changes from breast cancer.
Discussion
It is surprising that the literature review yielded so few articles that specifically focused
on women, age 65 and older with early stage breast cancer. However, these fourteen articles
provide a beginning foundation for knowledge concerning this population in five areas. First,
studies have shown the benefits of conservative surgical treatment for breast cancer and keeping
older women involved in their treatment choices. Overall, older women who receive breast
conservation treatments report fewer QoL concerns than women who received mastectomy and
axillary dissection. Older women who were treated conservatively report fewer arm problems35
and better physical functioning37 than older women who received mastectomy. The experience
of having arm problems negatively affected other QoL outcomes.36, 37 In addition, older women
consider their physical appearance when making treatment decisions,38 leading to better
outcomes. Women who felt that they had treatment options reported better mental health and
satisfaction compared to women who felt that they were not involved in decisions related to their
treatment.37
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Second, studies have examined physical symptoms, physical functioning, and physical
well-being in older women after treatment for early stage breast cancer. While older women
reported more physical symptoms compared to younger women,47 they report a similar number
of symptoms compared to women of the same age with other chronic illnesses.42 In addition,
older women with breast cancer report less symptom bother than older women with arthritis.45
Older women with breast cancer rarely attribute their symptoms to breast cancer but instead
attribute symptoms to aging and other chronic illnesses.42 Older women also report worse
physical well-being47 and worse physical functioning48 compared to younger women. However,
in studies that used age-based controls without cancer, these declines were also noted in older
women of the same age without cancer. 43, 44 These findings suggest that older women naturally
experience declines in physical functioning. Breast cancer is not necessarily the cause of these
declines.
Third, it has been reported that older women with early stage breast cancer report fewer
psychological effects compared to younger women. Older women report being less distressed at
diagnosis and through treatment and report fewer concerns with changes in their appearance
compared to younger women.47
Fourth, several social differences have been noted between older and younger women
with early stage breast cancer. Compared to younger women, older women report that breast
cancer has less of an impact on sexuality, employment, family distress,47 and finances.48 In
addition, older women experience greater cognitive losses and a reduced attention span
compared to younger women with breast cancer.49
Finally, spirituality in older women with early stage breast cancer has been explored.
Older women report that faith assists with coping and emotional support and allows them to
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maintain a social connection with others.39 Through faith, older women are able to find meaning
in having breast cancer,39-41 which allows older women to live each day to the fullest.41
Conflicting information is presented related to the ability of older women with breast cancer to
note the positive effects having cancer has had on their lives. While, qualitative studies have
reported that older women experienced positive effects from having breast cancer,40 quantitative
studies report that older women experience fewer positive changes compared to younger women
with breast cancer.47

Implications for Research
Despite current findings, several areas were identified for future research. Given the
limited research concerning older women, it is possible that there are factors within this older
population that have not yet been identified that may have an impact of QoL. More research will
help eliminate knowledge gaps and identify these factors in older women.
First, while we do know that older women experience side effects and symptoms, the
extent of the symptom experience is unknown. How specific symptoms affect aspects of
everyday life or how older women manage side effects is also unknown. Problems such as
fatigue, pain, lymphedema, functional limitations, and fear of recurrence need to be further
explored so that healthcare providers can assist older women in managing their concerns to
improve or maintain QoL.
Second, the impact of co-morbid illnesses in older women after treatment for breast
cancer is unknown. Research demonstrates that the presence of co-morbidity affects screening 50
and treatment 51, 52 of breast cancer, but it is not known how co-morbidities influence QoL in
older women after treatment for breast cancer. Only three studies in this review addressed co-
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morbid illnesses. Women with arthritis were more likely to report arm problems after surgery;36
having a co-morbid illness prior to treatment negatively affected physical outcomes;37 and
women with fewer co-morbid illnesses were more likely to be concerned about their appearance
after surgical treatment for breast cancer. It is likely that older women will have at least one comorbid illness by the time they are diagnosed with breast cancer,19 and knowing how to manage
the effects of treatment within the context of other illnesses will be crucial to improving QoL in
these women.
Third, appropriate interventions for older women with breast cancer have not been
explored. This information is important because older women may have different educational
needs and learning styles than younger women. Crooks41 stated that the older women in her
study rejected the written materials offered by health care providers. Older women felt that
providers were not interested in them as people when they were given written material without a
verbal explanation. The current method of giving patients copious amounts of reading material
about managing their symptoms may be ineffective in older populations.
Finally, the use of various standardized measurement tools, each of which examine and
measure different dimensions of QoL in older women, makes comparison of these studies
difficult. Opportunity exists to duplicate or confirm the results of these studies using
measurement tools that have been previously used in this population. This may help support
results of prior studies.
Implications for Nursing Practice
Through this research, several implications for nursing practice can be offered. First,
older women who receive more conservative surgical treatments, such as lumpectomy
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experience fewer side effects and better outcomes than women who receive mastectomy. Since
women over the age of 55 are more likely to receive mastectomy,53 nurses may use this
information to identify older women at risk for side effects caused by the treatment. Once
identified, educational programs or guidelines can be developed to assist these women in
reducing or managing their symptoms and improving QoL.
Second, older women want to be involved in treatment decisions, especially those that
impact their appearance. In nursing and the health professions, there may be a misperception
that older women are not concerned about their appearance or body image, which may lead to a
lack of patient involvement in treatment decisions. Nurses should consider that many older
women are interested in preserving their appearance and may want to know all of the treatment
options available to them. In addition, education may need to be provided on the use of
prosthetics and reconstructive surgery in order to help older women preserve their appearance.
Third, while it has been reported that older women experience more physical symptoms
compared to younger women with breast cancer, it has also been reported that older women
experience similar symptoms to older women without breast cancer but with other chronic
illnesses. In addition, older women may not demonstrate the level of distress regarding their
symptoms that nurses expect. During follow-up visits after treatment, nurses may need to
explore the symptoms of older women in order to help them manage their concerns. Education
regarding symptom management should be specifically tailored to help older women maintain or
improve their physical functioning and QoL. However, tailoring interventions to older women
may also be challenging when basing the intervention on research that has dealt with younger
populations, which highlights the need for research based on older women.
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Fourth, psychosocial findings related to older women with breast cancer suggest that
older women experience fewer effects compared to younger women. Despite these findings,
nurses should still consider the individuality of the experience of having breast cancer and
explore the psychosocial impact of diagnosis and treatment in all women with breast cancer in
order to provide appropriate counseling and interventions.
Fifth, faith is important to many older women with breast cancer. It should be recognized
that some older women draw upon their faith for support and coping. Nurses may want to
incorporate faith into their assessment of patient coping methods. In addition, nurses may
consider discussing the positive changes that breast cancer may have brought to the patients‘
lives.
Conclusions
This review of the literature has summarized what is currently known about QoL in older
women, ages 65 and older, with early stage breast cancer. Currently, the literature suggests that
older women: 1) have better QoL outcomes when they receive conservative surgical treatments
such as lumpectomy; 2) want to be involved in decisions concerning their treatment; 3)
experience more physical symptoms and declines in functioning compared to younger women,
but experience similar symptoms and functioning compared to women of the same age with
other chronic illnesses; 4) have fewer psychosocial concerns compared to younger women; and
5) use faith to cope and find meaning in their illness.
Despite current research, areas for future research exist related to older women with early
stage breast cancer after treatment. More research is needed to determine the extent of

24

symptoms in this population, the effect of co-morbid illnesses after treatment for breast cancer,
and appropriate interventions to help older women improve their QoL.
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CHAPTER 3: A LONGITUDINAL STUDY OF QUALITY OF LIFE IN OLDER
WOMEN WITH EARLY STAGE BREAST CANCER IN THE FIRST YEAR OF
POST-TREATMENT SURVIVORSHIP
Introduction
Breast cancer is the most common cancer among women in the United States.1 Today,
there are more than 2.3 million women alive who have survived breast cancer.2 The mean age of
all women diagnosed with breast cancer is 61, and women between the ages of 75 to 79 have the
highest incidence of the disease.2 As the Baby Boomer generation advances toward older age
with increased life expectancy, the number of older women diagnosed with breast cancer is also
expected to increase.3
This paper defines ―older‖ as age 65 and older. Older women with breast cancer receive
standard treatments such as mastectomy, lumpectomy, radiation, chemotherapy, and/or hormonal
therapy.4-7 Older breast cancer survivors are at risk for adverse effects after treatment that may
have an impact on quality of life (QoL).8-14 At diagnosis, older women may also experience
other chronic illnesses in addition to breast cancer which may have further impact on QoL.15
Research demonstrates that women of different ages diagnosed with breast cancer have
different concerns and needs.16, 17 However, current research has recently begun to explore these
needs in women with breast cancer who are age 65 and older and in the first year of survivorship.
The purpose of this paper is to report the results of a study of QoL in older, early stage breast
cancer survivors in the first year of post-treatment survivorship. The specific aims were to: 1)
Describe changes that occur over time in overall QoL and the QoL domains of Physical,
Psychological, Social and Spiritual well-being for women with breast cancer aged 65 and older
in the first year of post-treatment survivorship; 2) Examine the effects of the BCEI
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psychoeducational support interventions on QoL outcomes among older women with breast
cancer.
Literature Review
Data show that cancer and its treatment affect QoL in breast cancer survivors; however,
the effect on QoL in older women is unclear. Many studies that examine QoL report the
average age of the participants as 50 years.18-27 Such data can not be generalized to an older
sample. Exclusion or lack of participation of older women in clinical trials has led to a
knowledge deficit in many areas regarding older women with breast cancer. This literature
review is limited to research that specifically included women age 65 and older in their samples.
Several studies have focused on QoL outcomes in older women after surgical treatment
for early stage breast cancer. These studies indicate that older women who receive conservative
treatments such as lumpectomy experience fewer arm problems,28-30 fewer concerns with body
image,28, 31 and better mental health28 compared to women who receive mastectomy and axillary
lymph node dissection. In addition, older women reported better mental health when they felt
involved in making their treatment decisions.30
Other studies have focused on physical outcomes in older women after treatment for
early stage breast cancer. Physical effects, such as fatigue,28, 32 arm problems related to axillary
dissection, such as lymphedema, swelling and numbness,30 pain,33 concerns with physical
functioning,34 weight gain, constipation,32 dry mouth, weakness, and hot flashes,32 have been
reported by older women. Compared to younger women, older women report more physical
symptoms.35 However, compared to women their own age with chronic illnesses other than
breast cancer, older women with breast cancer report similar symptoms.32 In addition, older
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women with breast cancer report being less bothered by symptoms than women with other
chronic illnesses such as arthritis.33
Declines in physical well-being and functioning have also been reported by older women.
Compared to younger women, these declines in well-being and functioning are more severe in
older women35, 36 but similar to declines experienced by older women without a history of breast
cancer.34, 37
Psychological effects reported by older women include concerns with emotional
functioning,34 fear of recurrence, lack of social support,28 body image concerns,28, 31 and
cognitive changes.32, 38 All of these effects may have an impact on QoL outcomes in older
women with early stage breast cancer. Older women have reported experiencing less distress at
diagnosis and during treatment compared to younger women with breast cancer.35
Socially, compared to younger women, older women report fewer concerns with
sexuality, employment, family distress,35 and finances.36 In contrast, cognitive changes and
deficits in concentration are more prominent in older women compared to younger women.39
Spiritually, while the importance of faith and religion has been noted in many women
with breast cancer, benefits related to religion and spirituality have been reported in older women
with breast cancer. Religion and faith give older women support, comfort, and a feeling of
connectedness.40 Faith also helps older women cope and make meaning in their illness.40
Conflicting information exists concerning the ability of older women to note positive changes in
their lives after breast cancer. Utley 41 reports that older women are able to see the benefits from
cancer; however, Cimprich 38 reports that older women note fewer positive changes from their
breast cancer diagnoses than younger women.
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In summary, this literature review showed that older women experience multiple side
effects and concerns after treatment for breast cancer. Compared to younger women, older
women report declines in their physical functioning; however, their non-cancer peers also
experience physical decline. Psychologically, older women report less distress at diagnosis
compared to younger women. Socially, older women face fewer financial concerns compared to
younger women. Older women also report more cognitive changes compared to younger women.
Spiritually, faith and religion are also important to older women and helps them to cope and
make meaning of their illness.
Theoretical Framework
The Conceptual Model of Quality of Life in Aging Breast Cancer Survivors (QoLABCS) was used to frame the present study. The Model is shown in Figure 1. The QoL-ABCS
uses the domains of Physical, Psychological, Social, and Spiritual well-being from the Quality of
Life for Breast Cancer Survivors conceptual framework.22, 42, 43 The model uses the WHO
(World Health Organization) definition of QoL as ―an individual‘s perception of their position in
life in the context of the culture and value system in which they live and in relation to their goals,
standards, and concerns.‖ 44
The QoL-ABCS acknowledges that QoL is influenced by more than health-related
factors. Aging may also influence QoL in older women. The QoL-ABCS accounts for both of
these factors by demonstrating the influence of well-being and age on QoL. This model
maintains: 1) QoL is multi-dimensional, subjective and dynamic; 2) the domains of QoL are
interactive with each other and one concept within a domain often influences another domain; 3)
aging influences perception of QoL in survivorship; 4) perception of Physical, Psychological,
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Social, and Spiritual well-being influences QoL in survivorship; 5) perception of QoL influences
well-being in survivorship.
Methods
Research Design
This study used a longitudinal repeated measures approach to examine QoL in older
women with early stage breast cancer in the first year of post-treatment survivorship. Data were
drawn from a larger study, the Breast Cancer Education Intervention Study (BCEI). The BCEI
was a longitudinal intervention trial that examined the effect of a psychoeducational support
intervention for early stage breast cancer survivors. Details of this study are described
elsewhere.45-47
Sample
Subjects for this study included 50 women, age 65 and older from the BCEI. Inclusion
criteria included: 1) female; 2) histologically confirmed early stage breast cancer [Stage 0-II]; 3)
completion of treatment; 4) within the first year post-treatment; and 5) able to communicate in
English. Subjects may have been on hormonal or anti-HER2 therapy at the time of study entry.
Women with advanced or metastatic disease at the time of diagnosis were excluded from the
study. All subjects were community dwelling. In this convenience sample, there were 24 older
women assigned to the Experimental (EX) Group and 26 women assigned to the Wait Control
(WC) Group.
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Measurement Tools
Demographics were obtained using the BCEI Demographic Tool. This 32-item tool
includes items concerning sociodemographic characteristics (e.g., age, ethnicity, primary
language, income, occupational status, religious affiliation) and treatment variables.45
Quality of life was measured using the Quality of Life Instrument- Breast Cancer (QoLBC). The QoL-BC scale is a 50-item scale that specifically measures QoL in women with breast
cancer. The QoL-BC was adapted from the QoL-Cancer Survivors Scale (QoL-CS).18, 23 The
QoL-BC uses a 10-point rating scale used to describe QoL problems or concerns within four
identified QoL domains-Physical, Psychological, Social and Spiritual well-being.23 Scoring is
based on a scale of 0 = best outcomes to 10 = worst outcomes. Thus, the lower the total score,
the better the QoL. Reliability for the QoL-BC was established using the QoL-CS, which
indicated a test-retest reliability of 0.89 and a Cronbach‘s alpha of 0.93.
In the BCEI, alpha coefficients for the total QoL and subscales were as follows:
Overall QoL = 0.91; Physical well-being = 0.99; Psychological well-being = 0.96; Social wellbeing = 0.84; and Spiritual well-being = 0.85.45 In the current study, the alpha coefficients for
total QoL and each QoL subscale were: Overall QoL = 0.80; Physical well-being = 0.66;
Psychological well-being = 0.93, Social well-being = 0.81; and Spiritual well-being = 0.78.
Procedures
Several steps were followed to obtain, clean, and analyze the data for this secondary
analysis. First, the investigator obtained written permission from the principal investigator of the
BCEI Research Study (See Appendix D). Second, Institutional Review Board (IRB) approval
was obtained from the University of Central Florida‘s Office of Research and Commercialization
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(See Appendix E). Third, this investigator received eight de-identified data files in SPSS-v1348
for subjects age 65 and older. These files contained data collected at baseline (Time 1), month 3
(Time 2), and month 6 (Time 3). Fourth, Dr. Xiaogang Su, a biostatistician, was asked to provide
a statistical consultation for the Generalized Estimating Equation (GEE) portion of the analysis
(See Appendix G).
Finally, data files were examined for accuracy, missing data, and outliers prior to analysis
using descriptive statistics.49 Frequencies were run on all variables to evaluate completeness of
the data. No unexpected missing data were noted. However, two subjects who were age 65 and
older did not complete the study. One subject withdrew from the study prior to data collection at
Time 2. Another subject died prior to the final data collection (month 6) due to causes unrelated
to breast cancer or participation in the study. This resulted in complete data for forty-nine
subjects at month 3 and forty-eight subjects at Time 3.
Data Analysis
Descriptive statistics including frequencies, means, and standard deviations (SD) were
used to describe overall QoL and the four QoL domains. Generalized Estimating Equation
methods,50, 51 which are useful in analyzing correlated longitudinal data, were used to evaluate
the overall effect of the BCEI intervention. Two-sample and paired t tests were used to further
analyze between group differences and within group longitudinal changes. Bonferroni type
adjustments were also made. In the t tests, three inferences were made for each variable, bringing
the significance level to .017 (.05/3). Descriptive statistics and t tests were run by the
investigator using SPSS-v1348 software. GEE analysis was run using software developed in
R 52 by Dr. Xiaogang Su, the biostatistician consultant.
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Research Question # 1 describes the changes that occurred over time in overall QoL and
the QoL domains of Physical, Psychological, Social, and Spiritual well-being for older breast
cancer survivors in the first year of post-treatment survivorship. Descriptive statistics, including
means and standard deviations, were used to answer this research question. Overall QoL for the
entire sample was determined by using the overall mean score of the combined subscales (i.e.,
Physical, Psychological, Social, and Spiritual well-being) from the QoL-BC scale. Subscale
scores were determined by using the combined mean scores for all items within each subscale.
Research Question # 2 used GEE analysis to examine the effects of the BCEI
psychoeducational support interventions on QoL outcomes among older breast cancer survivors
in the first year of post-treatment survivorship. Without adjusting for covariates, GEE methods
were used to examine the effects of the BCEI intervention using the outcome variables of overall
QoL and the four QoL subscales. Two-sample and paired t tests were also used to make detailed
between and within group comparisons for overall QoL and subscale scores for the EX and WC
Groups.
Results
The results section will first describe the baseline characteristics of the sample. The
answers to each specific research question follow.
Characteristics of the Sample
Demographic characteristic of this sample consisted of 50 older breast cancer survivors in
the first year of post-treatment survivorship. The mean age of this sample was 72.1 years (SD:
5.12) with a range of 65 to 83 years. The majority of the sample was Caucasian (82%) and
reported English (92%) as their primary language. Slightly less than half of the sample reported
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an educational level of college or better (44%). The majority of the sample reported being
Christian of varying denominations (98%). More than half the sample was married (56%). Most
subjects (80%) were not employed; 8% worked full-time and 12% worked on a part-time basis.
Approximately half the sample (44%) had an annual family income of $30,001 or more, and
42% had an annual family income of $30,000 or less.
Disease- and treatment-related demographics indicated that 70% of the sample was
diagnosed with Stage I breast cancer, and 30% was diagnosed with Stage II. Women were
treated with lumpectomy (72%), mastectomy (24%), or bilateral mastectomy (2%). Other
treatment included chemotherapy (18%), radiation therapy (78%), and hormonal therapy (84%).
Table 4 lists a complete summary of demographic statistics.
Baseline demographic and cancer treatment characteristics were compared to determine
whether there were any significant differences between the EX and WC groups. No statistically
significant demographic differences were noted between the two groups. Table 5 lists a
complete summary of the demographic characteristics of each group.
Quality of Life in Older Breast Cancer Survivors
Research Question # 1 described the changes that occur over time in overall QoL and the QoL
domains of Physical, Psychological, Social, and Spiritual well-being for older breast cancer
survivors in the first year of post-treatment survivorship.
At baseline, mean overall QoL was 2.38 (SD = 0.1.02). At Time 2, it was 2.48 (SD=
1.20), and at Time 3, 2.58 (SD = 1.33). Overall QoL worsened at Time 2 and continued to
worsen at Time 3. Table 6 presents the mean QoL scores and standard deviations. Figure 2 plots
the mean overall QoL scores over time.
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Changes in the QoL subscale scores were noted for the entire sample. Table 6 presents
the mean subscale scores and standard deviations. Physical well-being declined from baseline to
Time 2 and Time 3. Psychological well-being declined from baseline to Time 2 and Time 3.
Social well-being improved at Time 2 but declined at Time 3. Spiritual well-being declined at
Time 2, then improved at Time 3. Figure 3 plots the mean QoL subscale scores over time.
Research Question # 2 examined the effects of the BCEI psychoeducational support intervention
on QoL outcomes among women with breast cancer aged 65 and older in the first year of posttreatment survivorship.
At baseline, there were no significant differences in the mean scores for overall QoL
between the EX and WC Group. In addition, there were no significant differences for overall
QoL at any time point between the two groups. Table 7 shows the mean overall QoL scores for
each group over time and the results of independent sample t-tests for overall QoL. Figure 4
plots the changes in the mean overall QoL scores for each group over time.
At baseline, there were no significant differences in the mean scores for the four QoL
subscales (i.e., Physical, Psychological, Social, and Spiritual well-being) between the EX Group
and the WC Group. In addition, there were also no significant differences for any of the QoL
subscales at any time point between the two groups. Table 7 shows the mean QoL subscale
scores for each group. Figure 5 plots the mean changes in the four QoL subscales for both
groups at each of the three time points.
GEE analysis indicates that there was no treatment effect or intervention effect over time
between these groups of older women for overall QoL or for Physical, Psychological, Social, or
Spiritual well-being. Absolute Robust Z Scores ranged from -0.591 to 1.749 indicating no
significant difference in intervention effects between the two groups. See Table 8 for a summary.
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Within Group Differences: Overall QoL and QoL Domains
Within group differences were noted for both the EX and WC Groups. Within the EX
Group, significant changes were noted from baseline to Time 2 for Physical well-being,
indicating a worsening of physical well-being, t(22)= -2.962, p=.007. From Time 2 to Time 3,
Physical well-being scores remained stable. In addition, the following changes occurred but were
not statistically significant: 1) Overall QoL declined slightly, but steadily from baseline to Time
3; 2) Psychological well-being gradually worsened from baseline to Time 3; 3) Social well-being
improved at Time 2, then declined slightly at Time 3; 4) Spiritual well-being declined from
baseline to Time 2 and slightly improved to above baseline scores at Time 3.
Within the WC group, overall QoL steadily declined from baseline to Time 3. Physical,
Psychological, and Social well-being also declined from baseline to Time 3. Spiritual well-being
worsened from baseline to Time 2, then improved from Time 2 to Time 3. None of these
changes were statistically significant. Figures 4 and 5 also plot the mean overall QoL and QoL
subscale changes, respectively, for each group.
Discussion
Quality of Life in Older Women with Breast Cancer
When examining the entire sample, mean scores for overall QoL and the four QoL
domains reported by older breast cancer survivors within the first year post-treatment indicate
that older women reported generally good baseline overall QoL and QoL within the domains of
Physical, Psychological, Social, and Spiritual well-being. However, they reported that QoL
changes occur over time. Overall QoL slightly declined over a period of six months. In
addition, Physical and Psychological well-being declined over time. Social well-being initially
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improved and then returned to baseline. Spiritual well-being initially worsened before returning
to baseline.
Declines in Physical and Psychological well-being may possibly be related to noncancer related experiences and events. The initial improvement in Social well-being may be
related to participation in the psychoeducational support intervention study where the subjects
received individualized attention. Likewise, the subsequent decline in Social well-being may
have been related to fewer contacts with subjects at the end of the study. The initial decline in
Spiritual well-being which was followed by improvement of Spiritual well-being may be related
to the QoL-BC survey.
Effects of the BCEI on Older Women with Breast Cancer
At baseline, mean scores for overall QoL were comparable for the EX and WC Groups.
Over time, both groups reported a decline in overall QoL over time. The sample size in this
study was small; therefore, statistically significant differences between groups could not be
established. Data from the WC Group suggest that QoL in older women with breast cancer may
naturally decline in the first year of post-treatment survivorship. Data from the EX Group also
suggest that QoL in older women declines after treatment. However, this decline was noted to be
less pronounced in the EX Group compared to the WC Group. It is possible that the potential
effect of the intervention in older women with early stage breast cancer was to lessen the decline
in overall QoL.53 The possibility that an intervention may lessen the decline of QoL in older
breast cancer survivors after treatment is a new and important finding.
Within the four QoL domains, there were no significant differences between the groups at
any time point. However, some differences are worth noting. Within the Physical domain, while
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well-being declined for both groups during the six months of the study, QoL initially declined
more sharply for the EX Group compared to the WC Group. This decline may possibly be
linked to participation in the intervention, which may have alerted subjects to physical problems
related to breast cancer that they previously attributed to some other cause. This new way of
thinking about their symptoms may have prompted older women to report worsened physical
symptoms related to their cancer at Time 2. Within the Psychological domain, well-being also
declined for both groups with the decline more notable in the WC Group. Subjects within the
EX Group may have been experiencing a psychological benefit directly related to their
participation in the intervention. Within the Social domain, well-being appeared to improve for
the EX Group at Time 2, perhaps indicating that the EX Group received immediate benefits from
the personalized attention they received during the delivery of the intervention. This response
differs from the WC Group, which reported a steady decline in Social well-being over time.
Within the Spiritual domain, both the EX Group and WC Group reported initial decline in
Spiritual well-being; however, this decline was more pronounced in the WC Group.
Overall, this study demonstrated that older women reported positive baseline overall QoL
within the first year of post-treatment survivorship, but overall QoL declined slightly over time.
Physical and Psychological well-being also declined over time. Social well-being initially
improved, but, again, declined over time. Spiritual well-being initially worsened, but improved
six months later. When examining the effects of a psychoeducational support intervention, both
groups experienced a downward trend in overall QoL during the study period, with QoL in the
EX Group showing a smaller decline compared with the WC Group. The intervention appears to
have lessened the decline in overall QoL for the EX Group compared to the WC Group. At this
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time, the small sample size makes definitive statements concerning QoL in older breast cancer
survivors difficult to assert and future research is needed.
Strengths
Several study strengths are identified. First, findings from this secondary analysis
represent an important contribution to the literature and for future research since few studies
specifically focus on older women with breast cancer. While study results did not detect a
significant intervention effect between the EX and WC Groups, there was an interesting
attenuation in the decline of overall QoL reported by the EX Group. The majority of cancerrelated QoL studies aim to improve QoL. At baseline, both groups reported good overall QoL.
However, over time, QoL declined more notably in the WC group. Thus, an important
conceptual contribution exists—researchers must consider the attenuation of decline in QoL
rather than striving for significant improvement in QoL. This study sets the stage for future
research to use larger samples and observe subjects over longer periods of time in order to
examine possible statistically significant differences and intervention effects in older breast
cancer survivors.
Second, study results can serve as a pilot for development of future interventions for
older breast cancer survivors. Knowledge gained from this study may help guide researchers in
future development of age appropriate and tailored interventions that may help women maintain,
improve or lessen decline in QoL. In addition, this study provided data that can be used to
determine power in future intervention studies with older breast cancer survivors.
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Limitations
Several weaknesses are also noted. Limitations exist within the QoL-BC measurement
tool. While the QoL-BC has been applied to other groups of women with breast cancer of
varying ages, the components of each domain may not adequately represent concerns of older
breast cancer survivors during post-treatment survivorship. While the QoL-BC tool had
acceptable alpha levels in this sample, they were comparatively lower than in the parent BCEI
study. The alpha co-efficient for the Physical subscale was considerably lower than those
reported in other studies. Domains, such as physical functioning reported in other studies,34, 36, 37
are not represented in the QoL-BC tool and could not be directly measured for this sample.
Finally, concerns for fertility and menstrual changes reported in younger women18 did not apply.
Another limitation found with QoL-BC tool is that some items were non-directional. For
example, questions such as ―How much has your spiritual life changed as a result of your
diagnosis?‖ and ―Has your illness or treatment caused changes in your self concept (the way you
see yourself)?‖are non-directional and were problematic for interpretation.54 Rewording these
items in future studies of older breast cancer survivors may make responses easier to interpret.
While the QoL-BC survey has provided valuable information concerning older women with
breast cancer, it requires further use in older samples to determine reliability. In addition, the
potential to develop instruments specific to older breast cancer survivors is needed.
Implications for Research and Practice
There are few studies that specifically focus on older breast cancer survivors. Several
areas of research are warranted for the future. First, future studies could focus on determining the
extent of symptoms and their degree of distress in older breast cancer survivors. Second, future
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research studies could focus on specific concerns within each QoL domain that may further have
an impact on QoL among older breast cancer survivors. Third, future research may be developed
to better understand the experiences that may contribute to decline in QoL for older women
during their first year of post-treatment survivorship. Fourth, larger sample sizes and observing
subjects over longer periods of time may provide a more accurate account of the natural history
of QoL after treatment in older breast cancer survivors. Fifth, outcomes of such studies may lead
to the development of interventions specifically tailored to the needs of the older women
surviving with breast cancer. Finally, future research may strive to maintain QoL at higher
levels than would naturally occur in older breast cancer survivors in the first year after treatment.
In practice, nurses can use findings to further examine whether gradual declines occur
over time among their own patients. Nurses may also consider the education and support they
provide for their patients. Older breast cancer survivors may have differential educational and
support needs after treatment. Nurses may consider tailoring their teaching to the needs and
styles of older breast cancer survivors rather than providing generic information to all patients.
Conclusions
The findings of this study add to the body of knowledge concerning older breast cancer
survivors in the first year of post-treatment survivorship. It is one of the first reported studies of
post-treatment interventions that included older breast cancer survivors. A vital finding showed
that the BCEI Intervention attenuated the decline of QoL in the EX Group compared with the
WC Group. The findings of this study can serve as the basis for future intervention studies
targeting the needs of older women.
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CHAPTER 4: NURSES PERCEPTIONS OF THEIR INTERACTIONS WITH OLDER
WOMEN WITH EARLY STAGE BREAST CANCER WITHIN THE FIRST YEAR OF
POST-TREATMENT SURVIVORSHIP
Introduction
She again expressed concern about her problem not being from breast cancer, but from other
situations in her life. - Excerpt from field note

This statement and statements like it were recorded in field notes written by research
nurses involved in a large randomized clinical trial which examined the effectiveness of a
psychoeducational support intervention on quality of life (QoL) in women with early stage breast
cancer. Such statements are the written accounts of the nurse‘s, or participant observer‘s,
thoughts and perceptions at the moment of the interaction with the subject. The aim of this study
was to describe the perceptions of research nurses during interactions with women, age 65 and
older with early stage breast cancer. This study relies on the use of qualitative methods
including participant observation in and content analysis of the field notes recorded during the
psychoeducational support intervention. The purpose of this paper is to: 1) describe nurses‘
perception of their interactions with older breast cancer survivors in the first year post-treatment
and 2) discuss research and nursing implications based on the knowledge gained from analysis.
Background
Older women are at increased risk of developing breast cancer.1 For the purposes of this
study and discussion, older women will be defined as age 65 and older. Fifty percent of women
diagnosed with breast cancer are 61 years old or older2. The majority of these diagnoses will
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occur prior to metastasis, ensuring survival rates near 88%.2 The overall number of women with
breast cancer is expected to increase as the Baby Boomer generation ages, making older women
a particularly important population of study.
Frequently, research focuses on post-treatment adverse effects, which impact QoL.3-5
Little attention is given to stressors or experiences that are unrelated to breast cancer, but may
impact QoL in older women with breast cancer.6-8
Methods
Design
The present study is a qualitative, secondary analysis using data from the Breast Cancer
Education Intervention (BCEI) trial. The BCEI was a longitudinal clinical trial that examined the
effect of the BCEI psychoeducational support intervention for women with early stage breast
cancer (N= 256), the details of which are described elsewhere.9-11 All participants had early
stage breast cancer, completed treatment at least one month prior to enrolling into the BCEI, and
were within the first year of post-treatment survivorship.
In the BCEI, the Experimental group (n=129) received the intervention, which included
three face-to-face educational and support sessions and three follow-up telephone education and
support sessions during a six-month period. Sessions took place in the participant‘s home,
workplace, doctor‘s office, or another site selected by the participant.9-11
Throughout the BCEI trial and specifically during the intervention, research nurses
recorded field notes. These notes provided a record of the research nurses‘ encounters, as
participant observers, in the intervention. Research nurses also recorded details of the
participant‘s diagnosis, prior treatment, current treatment and side effects at the time of the initial
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interview. For subjects in the Experimental Group, nurses recorded participant-identified
problems discussed during the education and support sessions. Notations were also made if the
participant brought up other topics during these encounters. These field notes became the object
of interest for this research study and had not been previously analyzed.
The goal of the field note analysis was to describe the research nurse‘s perception of their
observations of older women with breast cancer within the context of their participation in the
BCEI. Field notes have been widely used in qualitative research. 12-14 However, many studies
have used field notes to supplement data obtained in structured or semi-structured interviews.12,
14

Only one study analyzed the notes as primary source of data.13 For the purpose of this study,

content analysis was used to analyze the field notes.
Sample
The sample for this study consists of the 24 women, age 65 and older who were in the
Experimental Group of the BCEI. Field notes related to interactions with participants in the Wait
Control (n=26) Group were excluded because the interaction and discussion between the nurses
and participants was purposefully limited and brief in order to avoid contamination between the
two groups.
Procedure
This secondary analysis consisted of several steps. First, this investigator obtained
written permission from the principal investigator of the BCEI Research Study (See Appendix
D). Second, Institutional Review Board approval was obtained from the University of Central
Florida‘s Office of Research and Commercialization for the current study (See Appendix E).
Third, this investigator received 50 de-identified Microsoft Word™ files for participants age 65
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and older. Each Microsoft Word™ file ranged from one to three pages in length. Each file
contained data collected during the BCEI at each point of contact between the research nurse and
the participant. These points of contact began with baseline data collection and ended
approximately six months later when participants were no longer involved in the BCEI. Fourth,
these documents were loaded into Ethnograph (Ethnograph v5.08, Qualis Research), a software
package that assists with the coding and sorting of data.
Analysis
Content analysis of the field notes was based on a systematic process15. First, all data
were read thoroughly prior to coding to gain an overview of the quality and content of the field
notes. Second, data were re-read; codes were generated using language closely reflecting the
language used by the nurses in the field notes. For example, if the research nurse observed that
the patient experienced a particular side effect or was concerned with an ill family member,
codes specifically reflected this. Third, these codes were defined and grouped according to
similarities. For example, several participants were worried about the health of family members;
hence, the overall code was called ―Family illnesses.‖ Fourth, like codes were examined and
similar codes were combined, resulting in the final coding scheme.
The following process supported evidence for confirmability. First, the investigator
asked a colleague to review five randomly selected field notes. The colleague has been a
professional nurse for more than twenty years. She is also a doctoral student with experience in
qualitative methods. Her research focuses on women with chronic illness and she has no
oncology experience. Second, the investigator explained that the aim of the study was to
describe the nurses‘ perception of their interaction with older breast cancer survivors in the first
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year post-treatment. Third, the doctoral student reviewed the field notes. She identified themes
from the interactions and highlighted the themes. Fourth, the investigator and doctoral student
compared their individual themes from the interactions. Fifth, they discussed and agreed the
codes were appropriate. For example, one participant had a daughter with breast cancer. The
investigator coded the theme as ―daughter with breast cancer‖ and the doctoral student coded the
theme as ―daughter illness.‖ These codes were thought to be consistent. Finally, the investigator
presented the final codes to her doctoral committee chair.
Results
Characteristics of the Sample
Research nurses recorded field notes on events that occurred in a sample of 24 women.
The average age of participants was 72 (range from 65 to 80). Most subjects were Caucasian
(79.2%), spoke English (87.5%), and had at least a high school/trade school education (66.7%).
Over half of the participants were married (54%), and 50% lived with at least one other person in
the household. Most women (75%) were not employed. Half of the participants (n=12) reported
an income of $30,000 or below. Disease-specific variables indicated that 70.8% had Stage I
breast cancer. Most received a lumpectomy (70.8%) and radiation therapy (83.3%) and did not
receive chemotherapy (79.2%). The majority (79.2%) were on hormonal therapy at the start of
the study. Table 9 provides a complete summary.
Body of the Findings
Data were summarized according to four main themes. These themes were: 1) continuing
breast health; 2) personal health issues; 3) family illnesses; and 4) potential stressors. In the
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following section, quotes from the field notes that denote the nurse‘s perception will be
italicized, and ―double quotation marks‖ will be used. Instances where the field notes indicated
that the participant stated a particular word or phrase will also be italicized, and ‗singular
quotation marks‘ will be used.
Continuing breast-related health
The field notes featured concerns with continuing breast-related health, which described
the participants‘ experiences with new or ongoing concern related to their breast(s). The field
notes conveyed the participants‘ apprehension regarding mammography, breast symptoms,
breast biopsy or surgery, future tests, waiting for test results, refusing more treatment, and breast
reconstruction. During the study period, seven women underwent mammography. In most
cases, the mammography showed no further evidence of disease. Nine participants experienced
new breast symptoms such as a lump, hematoma, rash, open area or sore, and/or itching.
Symptoms resolved spontaneously in all but two participants, who dealt with ongoing issues
related to their breast. Participants‘ reactions to continuing breast-related health varied. For
example, one woman‘s oncologist discovered a breast lump. When speaking about her
oncologist‘s recommendation to remove the lump, the woman described her reaction as ‗snags
along the way are to be expected.‘ The field note revealed the nurse‘s perception that ―She has a
very positive attitude and states she deals with life as it comes to her.‖ Another woman required
a biopsy when a shadow was detected by mammogram. The research nurse observed that the
participant acknowledged experiencing a week of ―emotional ups and downs and felt better when
the results were negative.‖
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Still another entry describes the anxiety that one woman experienced as she waited for
her first follow-up mammogram and her extreme concern about going through treatment again.
After her interaction with the patient, the nurse noted that ―the participant seems to think about it
[recurrence] all the time.‖
Personal health issues
The field notes also captured concerns with personal health issues, or the participants‘
experiences with health issues unrelated to their breast cancer such as co-morbid illnesses, noncancer related illnesses, and falls. Three women discussed managing co-morbid illnesses such as
diabetes mellitus, irritable bowel syndrome, diabetic neuropathy, pain, and osteoporosis. The
field notes convey that participants were able to manage these illnesses in their lives. For
example, one woman had chronic hip, back and knee pain and used a walker to get around.
Despite these chronic conditions and other cancer-related conditions, such as lymphedema,
which developed during the study period, the research nurse repeatedly recorded her perception
that the participant was able to remain ―optimistic‖ and ―have a positive attitude.‖ Despite both
the chronic and new conditions that the participant encountered, she described herself as ‗in good
spirits‟ and ‗holding her own‟. The field note further reveals the research nurse‘s perception that
this participant ―feels her QoL is excellent and nothing stops her.‖
The field notes also describe nine participants with transient illnesses such as the
common cold, high blood sugar, bronchitis, urinary tract infections, and headaches during the
study period. However, two women experienced potentially serious illnesses. The research
nurses observed that some women lived with serious health symptoms for several weeks before
addressing the symptoms. For example, one participant ignored chest pain for more than a
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month because she was caring for her ill daughter. The field note revealed the research nurse‘s
perception that ―she has few concerns about herself, only for her daughter.‖ In a later entry, the
nurse added her perception that the participant knows ―she has been so focused on her daughter
that she has not been centered on herself.‖
Family health issues
The research nurses‘ field notes also captured family health issues, which described the
participants‘ experiences with ill family members or recently deceased spouses. During the
study period, eight women had either an ill spouse or adult child and three women reported being
a caregiver for ill family members. The field notes convey participants‘ concern over the health
of their family members and how it related to their own QoL. Participants also expressed
concern that their anxiety over the health of their loved ones was reflected in the QoL surveys
that they were asked to complete during the study. For example, one participant whose daughter
was diagnosed with breast cancer expressed anxiety over her daughter‘s diagnosis. The research
nurse observed that the patient believed her ―anxiety related to daughter‟s diagnosis may be
reflected in answers [on quantitative surveys].‖ Another participant had a daughter who was
diagnosed with advanced lung cancer. Throughout the study, the research nurse observed that
this participant continually put aside her own health to care for her daughter. In a field note
entry, the research nurse observed that ―Her daughter continues to do poorly, which is the main
cause of this patient‟s anxiety and low QoL scores.”
Two participants discussed how the death or illness of their spouse affected their current
QoL. One entry describes a woman‘s concern for her ill husband of 35 years. During one of
their interactions, the research nurse observed that the husband has debilitating chronic illnesses
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and “most of patient concerns deal with these issues.‖ In a note for a participant whose husband
recently died, the research nurse stated ―she [the participant] does not feel she has problems that
can be only attributed to her breast cancer.‖
Finally, another entry in the field notes describes how a spouse‘s illness left one woman
unaffected by her diagnosis of breast cancer. During their interaction, the nurse observed that
―When she was diagnosed with breast cancer- it did not have a great impact because she had
experience with [her husbands] illness.‖
Potential stressors
The last theme captured in the field notes was potential stressors. The field notes
conveyed the participants experience and frustration with family issues, housing issues, stressful
living situations, a change in physician, car issues, car crashes, holidays, ―little things‖ and
hurricanes. During the study period, potential stressors were mostly observed by the research
nurses to be short-lived: however, two women dealt with ongoing stressors. For example, one
participant had continuing issues with a tenant who lived in her home. The nurse observed that
the participant did ―Not think [the side effects were] cancer related as much as related to the
stress of having the border. She thinks it will resolve now that he is gone.‖
Another field note describes the ongoing family issues of a participant living with two
grandchildren and four great-grandchildren in a small house without air conditioning in Florida.
The research nurse observed that this participant repeatedly discussed how bothersome the greatgrandchildren were and how her grandchildren ‗irritated‟ her. One entry in the field note
describes the research nurse‘s perception of how the participant felt ―hopeless in her life,‖ but
also noted that the participant states that she was „like that even before her diagnosis.‘ The field
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notes describe the research nurse‘s perception of how this participant was being pressured by her
family to move closer to them, which would ultimately take the participant father away from her
husband who was in a nursing home. Throughout interactions with this participant, the research
nurse observed that this woman seemed ―worn down‖ and ―overwhelmed‖ by life at times.
In addition to the previously mentioned experiences, uncontrollable circumstances were
also observed by the research nurses. During the summer and fall of 2004 when these field notes
were recorded, Florida experienced four major hurricanes. The field notes describe the research
nurse‘s perception of the frustration of three participants who experienced power outages, phone
outages, and damage to their homes. In one field note, the research nurse observed how one
participant ―found the experience overwhelming‖ and was ―saddened by the experience.‖ In
another field note, the research nurse observed that a participant who was without power for a
week found the experience ‗unsettling.‘

Discussion
Content analysis of these field notes captured research nurses perceptions‘ of the
experiences of women, age 65 and older, with early stage breast cancer within the first year posttreatment. These perceptions would not have been captured using standardized measures.
Although the field notes were not originally intended for analysis, the thoughtful perceptions of
the participants‘ comments and behaviors discovered in the data were rich. In summary, these
data were categorized according to four major themes: continuing breast-related health, personal
health issues, family health issues and potential stressors.
Research nurses noted that continuing breast-related health was a stressful experience for
women with breast cancer. They documented a variety of participant responses to continuing
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breast-related health, ranging from little concern over new breast symptoms to a great deal of
fear. Concern over breast symptoms and recurrence have been reported in the literature in
women of all ages with breast cancer.16
Research nurses also documented that personal health issues not related to breast cancer,
such as co-morbid or chronic conditions, were experienced by this sample. Eighty percent of
Americans over the age of 65 have at least one chronic illness,17 so it is surprising that comorbid conditions were noted in only three participants. Everyday illnesses and serious health
symptoms also occurred in the sample. These findings indicate that older women may have
other health concerns besides cancer.
Research nurses observed that family health issues were also a concern for this sample.
Understandably, these women were very concerned when a loved one became ill and discussed
the anxiety family illness caused. The field notes also report that several women were
caregivers. Caregiving itself is stressful,18, 19 which may lead to some of the anxiety women felt
when caring for a loved one.
In addition to capturing patients‘ concern for the health of loved ones, field notes also
noted participants‘ concern that the stress or anxiety caused by their loved one‘s illness would be
reflected in the quantitative surveys that measured their QoL. These concerns indicate that some
subjects seemed to feel that the study was only measuring cancer-related QoL instead of general
QoL. This uncertainty concerning what the QoL instruments were measuring raises questions
about the validity of QoL measurements in older cancer survivors.
When considering family health, nurses also observed that some older women felt that
their QoL issues were related to experiences other than breast cancer. This finding has not been
reported in preceding literature. This observation suggests that breast cancer may not be the

64

biggest or most devastating event these women experience. Nurses observed that the experience
of having breast cancer may be overshadowed by other events such as death or illness of a
spouse or family member.
Finally, nurses observed that the women in this study experienced a number of potential
stressors in their lives. While some of these stressors might be considered minor, significant
consequences could result. For example, several women experienced car troubles, which could
potentially lead to isolation, loss of social support or missing important follow-up appointments.
Other women faced stressors within their own homes and with people living with them. In these
instances, women allowed people to live with them, which caused them stress. This suggests
that some older woman may place themselves in situations where some company or
companionship is better than isolation.
Some of the experiences found in this study have also been noted in the literature. Life
experiences and life stress have been examined in relation to their impact on QoL outcomes and
survival. While the mean age of participants in these studies was below 65 years, older women
did participate. These studies have noted life stressors in women with breast cancer and include:
personal or family illness8, death of a loved one6, 8, 20, financial stressors6, 8, 20, 21, ended
relationships6, conflicts with family6, children leaving home, alcoholic family members,
moving22, and accidents, robberies, and like events6.
Studies that have examined life stress have looked at the effect of stressors prior to
treatment and their impact on QoL outcomes. Baider and colleagues21 compared women with
breast cancer in different cultural settings, one to five years after diagnosis. They found that the
number of stressful life experiences before diagnosis predicted psychological distress after
treatment.21
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Another study by Low and colleagues8 examined life stress, coping strategies, and
adjustment in the year after treatment for breast cancer. This study was longitudinal and followed
558 women over a twelve-month period. The average age of participants was 58.1 years. On
average, women reported 1.34 stressful experiences in the year prior to treatment. Results
showed that women with more life stressors experienced more depression, less vitality, and more
cancer-related distress at baseline however, life stress did not affect psychological adjustment
over time.
Golden-Kreutz and Anderson6 examined the effect of stress on depressive symptoms
after breast cancer. This was a prospective, longitudinal study of women (N=210) with stage II
and III breast cancer. The average age of the participant was 51 years. The majority of subjects
experienced at least one major life event in the twelve months prior to diagnosis. Results
showed that depression after treatment is due to perceptions of global distress, cancer-related
distress, and stressful life events such as financial problems.
In a secondary analysis of the previously mentioned study, Golden-Kreutz and
colleagues7 examined stress at diagnosis in relation to its impact on QoL. Women (N=112) were
assessed at baseline, four and twelve months after diagnosis. Most subjects experienced at least
one life event in the year prior to diagnosis. Results of this study show that life events, cancerrelated stress, and perceived global stress all contribute to declines in physical and psychological
QoL. Life stress was a predictor of QoL at 12 months. According to the authors, these findings
suggest that a diagnosis of cancer may have overshadowed the experience of stressful life events,
delaying their impact on outcomes.
Finally, one study examined the relationship between stressful life events and survival in
women with breast cancer. Maunsell and colleagues22 examined how stressful life events that
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occurred in the five years prior to a diagnosis of breast cancer impacted survival. The Cox
Proportional Hazards model was used for analysis. Participants reported 3.7 stressful experiences
in the five years before diagnosis. The subjects (N=665) were followed for a seven-year period.
Ultimately, stress from life events did not affect survival in women with local or regional breast
cancer.
In summary, breast cancer does not occur in isolation but takes place in women‘s lives at
the same time women experience other events and concerns. In this study, nurses observed that
older women with breast cancer had concerns after their illness, including continuing breastrelated health issues, personal health issues, family illnesses, and potential stressors. Prior
studies examined the impact of life stressors and experiences that occur before the diagnosis of
breast cancer and how they affect QoL after treatment. These studies have shown that these
stressors may negatively impact QoL after treatment. The findings from this study mirror many
of the findings reported in the literature concerning patient experiences and stressors. The use of
field notes to explore nurses‘ perceptions adds to the evidence that older women may experience
events or concerns in their lives after breast cancer that may be related to QoL outcomes.
Limitations
This study has a number of limitations. First, field notes were written by research nurses
who were participant observers during a psychoeducational support intervention clinical trial.
However, at the time of the writing of the field notes, research nurses did not know that their
notes would eventually be used in an analysis. Therefore, research nurses were documenting
their perceptions of their interactions with participants, but they were only documenting what
they felt was important or notable at the time. This led to differences in the quality of and detail
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within the field notes. Despite this limitation, the field notes revealed evidence that older women
experience concerns other than breast cancer after treatment.
Second, researcher bias (influence that may produce a distortion of the results23) may be a
factor in analysis. This investigator was involved in the BCEI as a participant observer who
recorded the field notes. During analysis, the researcher recalled encounters with these women.
For this reason, the researcher avoided reinterpreting the perceptions of other research nurses‘ as
recorded in the field notes, and, instead, conducted the analysis based on the words written in the
notes. This required frequent referral back to the field notes to make sure the results represented
the research nurses‘ impressions at the time of the encounter, not the memories of the researcher.
This form of analysis was essential in order to reduce or prevent misinterpretation of the data
based on memory.
Implications for Research and Practice
There are several implications for research and practice. First, researchers may consider
delving further into the concerns of older women with breast cancer after treatment to achieve a
holistic view of QoL in this population. While this is a study with women with breast cancer,
three of the four themes identified in the field notes were non-cancer related. This fact
demonstrates the complex nature of the lives of older women after treatment for breast cancer. It
is likely that all women who experience cancer continue to experience other events and concerns
in life that are independent of having cancer. Investigating age-related differences in women‘s
lives during and after treatment for cancer may foster the development of specific interventions
to manage to reduce stress in this population.
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Second, the measurement of QoL in older women deserves further investigation. Nurse
observations in this study demonstrated that older women were concerned about stress and
anxiety unrelated to breast cancer, affecting their answers in QoL surveys. Some women in this
study seemed to try to separate their breast cancer from the rest of their lives and were concerned
that stresses from life events were influencing their responses about QoL and breast cancer. This
raises questions regarding the understanding of older women regarding what standardized
measurement tools are trying to capture and how they formulate their answers to the questions
asked in surveys. Understanding the cognitive process of how older women formulate answers
to standardized surveys may improve the reliability and validity of measures.
Clinically, it is important for all nurses to recognize the complexity of older women‘s
lives when a diagnosis of breast cancer is received. For oncology nurses, it is particularly
important to realize that older women often have other age-related concerns, during and after
their breast cancer treatment. Clinically, the awareness that older women may experience issues
and concerns related to continuing breast-related health, personal health issues, family illness and
other potential stressors after treatment may help identify and manage concerns. In addition,
response to these concerns may be individualized. A holistic assessment consistent with geriatric
and health-related concerns is advisable. Awareness of these types of concerns after treatment
for cancer also provides an opportunity for nurses, regardless of their specialty practice to
collaborate in the care of older women to manage cancer and non-cancer related concerns after
treatment that may affect QoL.
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Conclusions
In summary, this study described the research nurses‘ perceptions of their interactions
with older women with breast cancer in the first year of post-treatment survivorship. Content
analysis was used to analyze field notes. Using field notes yielded rich findings concerning the
lives of older women with breast cancer after treatment. Data suggest that older women have
concerns due to continuing breast-related health, personal health issues, family health issues and
other potential stressors, all of which may affect QoL. Research implications indicate
differential measurement of QoL in older women. Clinical implications suggest that an
assessment of older women‘s concerns is warranted.
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CHAPTER 5: CONCLUSION
This dissertation draws several conclusions regarding QoL in women, age 65 and older,
who have completed treatment for breast cancer. First, the State of the Science demonstrates that
fourteen studies focused on women, age 65 and older, after treatment for early stage breast
cancer. Together, these studies provide the basis of knowledge concerning this population.
Current literature suggests that older women with early stage breast cancer: 1) report better QoL
outcomes when they receive conservative treatments; 2) want to be involved in treatment
decisions; 3) experience more symptoms and declines in physical functioning, compared to
younger women; however, they experience similar symptoms and physical functioning compared
to women of a similar age with other chronic illnesses; 4) have fewer psychosocial concerns
compared to younger women; and 5) use faith to cope and find meaning in their illness.
Second, results from the data-based quantitative study, which examined QoL in older
women with early stage breast cancer in the first year of post-treatment survivorship,
demonstrated that baseline overall QoL and QoL within the four domains is good. However, over
time, overall QoL gradually declined. In addition, Physical and Psychological well-being
declined. Social well-being initially improved before returning to baseline. Spiritual well-being
initially declined before returning to baseline.
In this study, there was insufficient power to detect a difference in the effects of the BCEI
Intervention between the two groups. Overall QoL declined in both groups. However, the
intervention attenuated the decline in QoL for the EX Group.
Third, results from the data-based qualitative analysis of field notes, which examined
nurses‘ perceptions of their interactions with women who participated in a psychoeducational
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intervention for women with early stage breast cancer (BCEI), demonstrated that older breast
cancer survivors have concerns both related and unrelated to breast cancer after treatment.
Nurses‘ perceptions were organized into four themes: continuing breast-related health, personal
health issues, family health issues and potential stressors. These concerns may affect overall
QoL.
These findings offer several implications for research. First, researchers may expand on
the current knowledge base regarding QoL in older women after treatment. Areas in need of
further research that have been identified by this dissertation include: the symptoms experienced
by older women after treatment; the extent of the symptom experience; the impact of co-morbid
illnesses on survivorship; and the impact of non-cancer related experiences of older women after
treatment. All of these factors may impact QoL after treatment and merit further study.
Second, while there was insufficient power to detect an intervention effect, the decline in
QoL was less in the EX Group. Future research may focus on other factors that could influence
QoL in older breast cancer survivors. In addition, there is considerable need for research, which
may develop interventions tailored to the specific needs of older breast cancer survivors. This
dissertation serves as a pilot study and can provide data needed to determine power analysis for
future intervention studies for older breast cancer survivors.
Third, the most appropriate way to measure QoL in older breast cancer survivors has yet
to be determined. At this time, it is unclear which measurement tools and what dimensions of
QoL are most appropriate for use in this older population. In addition, this dissertation has raised
questions concerning what is actually being measured in standardized surveys and how older
women formulate their answers to survey questions. The potential to develop instruments
specific to older breast cancer survivors is vast.
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Finally, this dissertation supports the reconceptualization of QoL in older women with
breast cancer. Quality of life in older women after treatment for early stage breast cancer is
influenced by many factors. These include Physical, Psychological, Social, and Spiritual wellbeing as well as factors unrelated to breast cancer such as aging and other experiences after
treatment. Future research may consider the conceptualization of QoL after treatment as holistic
rather than limited to adverse effects directly related to cancer.
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Table 1: Summary of studies focusing on women age 65 and older only with early stage
breast cancer
Author and date

Purpose

Study Population

Instruments and

and Design

Analysis

Major Findings

De Haes et al.

Compare effect of

Population:

Instruments:

(2003)

treatment on QoL in

N=136

Unspecified QoL

mastectomy had

older women

Age 70 or older,

survey covering 9

more arm

within 1 year of

domains

problems.

treatment

Analysis:

Women who

Design: Randomized

Wilcoxon Sign

received

clinical trial

Rank test

conservative

Women with

surgery had better
QoL
Madelblatt et al.

Evaluate long-term

Population:

Instruments: SF

(2003)

impact of primary

N=1812,

12, SF 36

illness affected

treatment on QoL and

Age 67 and older, 3 to

Analysis: Chi

physical outcomes

satisfaction

5 years post treatment,

square

Design: -Randomized

distribution,

problems which

cross-sectional design

t test, logistic

negatively

regression

impacted all other

Having co-morbid

AD led to more arm

outcomes
Women not given
choice regarding
treatment had more
pain, poor mental
health and less
satisfaction
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Author and date

Purpose

Study Population

Instruments and

and Design

Analysis

Major Findings

Mandelblatt et al.

Examine the impact

Population: N=571,

Instruments: SF

(2002)

of axillary dissection

Age 67 and older

12, CARES-SF

reported arm

on QoL

Design: Longitudinal

Analysis:

problems

ANOVA, chi

83% with AD

Women with AD and

square

arm problems

distribution,

report lower

GEE

physical and
mental functioning
Cancer had more of
an impact on life if
arm problems were
reported

Figueiredo et al.

Examine the effects

Population:

Instruments: SF

Physical appearance

(2004)

of treatment

N=563, Age 67 and

36, CARES –SF,

important to older

preferences and

older,

Analysis: Chi

women when

treatment received on

within 2 years of

square

making treatment

mental health and

surgery

distribution,

decisions

body image

Design: Longitudinal

t test, ANOVA,

clinical trial

Pearson and

mastectomy

Spearman rank

reported body

correlation, path

image concerns

analysis, GEE

and worse mental

Women with

health compared to
women who
received
conservative
treatment
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Author and date

Purpose

Study Population

Instruments and

and Design

Analysis

Feher and Maly

Examine spiritual and

Population: N=33,

Instruments:

(1999)

religious coping

new diagnoses

Structured

mechanisms among

Design: Qualitative,

interviews, open

older women with

ended questions

breast cancer

Analysis: Content
anlaysis

Major Findings

Faith assisted with
coping
Faith provided
emotional support
Faith allowed a
social connection
Faith allowed
women to make
meaning in their
lives

Utley (1999)

Discover the meaning

Population:

Instruments: Life

of cancer older, long-

N=8,

history interviews

term breast cancer

Age 65 to 77, 5 to 29

Analysis:

Women experienced

survivors

years post diagnosis

Qualitative

a positive effect

Design: Qualitative

analysis using

from cancer

Meaning of cancer
evolved over time

heuristic approach
Crooks (2001)

Discover new

Population:

Instruments:

understandings of

N=20

Interviews

meaning allowed

having breast cancer

Ages 66-94,

Analysis:

women to live each

for older women

Design: Qualitative

grounded theory

day to the fullest
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Process of finding

Table 2: Summary of studies focusing on women with early stage breast cancer and age
based controls without breast cancer
Author and date

Purpose

Study Population

Instruments and

and Design

Analysis

Major Findings

Heidrich et al.

Examine symptoms,

Population: N=42,

Instruments:

(2006)

symptom belief, and

Age 65 and older,

Heidrich

experienced in both

QoL of older women

Women with and

Symptom Bother

groups of women

with and without

without breast cancer

Scale, SF-36,

breast cancer

Design: Descriptive,

CES-D, OARS

to aging or other

correlational

Analysis:

chronic illness,

Wilcoxon Mann-

rarely to breast

Whitney U test

cancer

and chi square
distribution

Similar symptoms

Symptoms attributed

Not knowing cause
of symptom led to
poorer outcomes

Satariano et al.

Compare

Population: N=900,

Instruments:

(1989)

instrumental

3 age groups: 55-64,

IADL

reported more

functioning of

65-74, 75-84

Analysis: Ridit

problems with

women with breast

Design: Case control,

analysis

functioning than

cancer with age based

longitudinal

controls

Women age 65 to 74

their age based
controls
Women age 75 and
older reported the
fewest functional
problems compared
to their age based
controls
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Author and date

Purpose

Study Population

Instruments and

and Design

Analysis

Major Findings

Kroenke et al.

Explore functioning

Population: N=1,082,

Instruments: SF-

(2004)

before and after

3 age groups: 40 and

36, CARES

cancer in women of

younger, 41-64, 65+,

different ages

women with and

Analysis: Linear

declines in

without breast cancer

regression

functioning when

Older women with
breast cancer
experienced similar

Design: Prospective,

compared to their

longitudinal

non-cancer peers
Functional declines
attributed to aging,
not breast cancer
Youngest women
experienced the
most significant
functional declines
compared to their
non-cancer peers

Heidrich (1996)

Examine influence of

Population: N=188,

Instruments:

age and illness type

women with breast

OARS, Heidrich

arthritis report

on health and

cancer and

Symptom Bother

more symptom

functioning,

osteoarthritis, 2 age

Scale, social

bother and

interpretive

groups: 60-74 and 75+

comparison scale,

problems with

mechanisms and their

Design: 2x2, cross-

social network

ADL‘s than

effect on

sectional

index, CES-D,

women with breast

psychological well-

Rosenberg‘s Self

cancer

being

Esteem Scale,

Older women with

Older women with

Ryff‘s scales

arthritis report their

Analysis:

illness as more

MANCOVA,

severe and chronic

ANCOVA

than older women
with breast cancer
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Table 3: Summary of studies comparing older and younger women with early stage breast
cancer
Author and date

Purpose

Study Population

Instruments and

and Design

Analysis

Major Findings

Fehlauer et al.

Examine functional

Population: N=370, 3

Instruments:

(2005)

status in women of

age groups: younger,

EORTC QLQ-

younger women,

different ages at

than 50, 50-65, 66+

C30, EORTC

older women

diagnosis and effects

Design: Retrospective

QLQ-BR23

reported worse

of adjuvant therapy

Analysis:

physical

on HR-QoL,

ANOVA, post hoc

functioning, more

Scheffe tests

body pain, more

Compared to

arm symptoms, and
less financial
concern
QoL increased over
time for older
women despite
concerns
Cimprich et al.

Examine relationship

Population: N=105, 3

Instruments:

Compared to younger

(2002)

between age and QoL

age groups: 45 and

QoL-CS

women, older women

outcomes in long

younger, 46-65, 66+,

term breast cancer

long-term survivors

Analysis:

survivors

Design: Cross-

ANOVA, multiple

constipation, sleep

sectional

regression

symptoms

reported:
more fatigue, pain,

less distress at
diagnosis , better
outcomes related to
appearance
fewer concerns with
sexuality,
employment,
family distress
Fewer positive
changes and more
uncertainty
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Author and date

Cimprich (1998)

Purpose

Study Population

Instruments and

and Design

Analysis

Determine the effect

Population: N=74,

Instruments:

Compared to younger

of age and extent of

3 age groups: 25-45,

Measures of

women, older women

surgery on cognitive

46-64, 65-74

capacity to direct

reported:

function

attention
Design: Pre and post

Analysis:

test

ANOVA, t tests,

Major Findings

Lower attention
scores at baseline
Experienced

multiple linear

significant losses in

regression

attention
performance and
total attention
scores
Older women who
received
mastectomy
reported greater
loss in attention
than older women
with breast cancer
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Table 4: Demographic characteristics of the quantitative sample (N=50)
Age

Mean: 72.10

Range: 65-83

Time since Diagnosis

6 months or less

18 (36%)

7 months or more

32 (64%)

African American

3 (6%)

Caucasian

41 (82%)

Hispanic

4 (8%)

Native American

2 (4%)

Grade School

2 (4%)

High School

20 (40%)

Trade School

6 (12%)

College

20 (40%)

Graduate School

2 (4%)

Catholic

6 (12%)

Christian

43 (86%)

Jewish

1 (2%)

Married

28 (56%)

Divorced

5 (10%)

Widowed

17 (34%)

Yes

17 (34%)

No

33 (66%)

Full-Time

4 (8%)

Part-Time

6 (12%)

Retired/Homemaker

40 (80%)

Race

Educational Level

Religious Preference

Marital Status

Lives Alone

Employment Status
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Income

Disease Stage

Surgery Type

Chemotherapy

Radiation Therapy

Hormonal Therapy

$30,000 or less

21 (42%)

$30,001 or more

22 (44%)

Did not care to respond

7 (14%)

Stage I

35 (70%)

Stage II

15 (30%)

Lumpectomy

36 (72%)

Mastectomy

12 (24%)

Bilateral mastectomy

2 (4%)

Yes

9 (18%)

No

41 (82%)

Yes

39 (78%)

No

11 (22%)

Yes

42 (84%)

No

8 (16%)
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Table 5: Demographic characteristics of the Wait Control and Experimental Groups
Wait Control Group
(n=26)
72.19 (Range: 65-83)

72.0 (Range: 65-80)

6 months or less

11 (42%)

7 (29%)

7 months or more

15 (58%)

17 (71%)

African American

1 (4%)

2 (8%)

Caucasian

21 (80%)

20 (83%)

Hispanic

2 (8%)

2 (8%)

Native American

2 (8%)

0 (0%)

Grade School

0 (0%)

2 (8%)

High School

9 (35%)

11 (46%)

Trade School

3 (12%)

3 (13%)

College

12 (46%)

8 (33%)

Graduate School

2 (8%)

0 (0%)

Catholic

2 (15%)

2 (8%)

Christian

20 (76%)

22 (92%)

Jewish

1 (4%)

0 (0%)

Married

15 (57%)

13 (54%)

Divorced

3 (12%)

2 (8%)

Widowed

8 (31%)

9 (38%)

Yes

9 (35%)

8 (33%)

No

17 (65%)

16 (67%)

Full-Time

2 (8%)

2 (8%)

Part-Time

1 (4%)

3 (13%)

Retired/Homemaker

23 (88%)

19 (79%)

Age
Time since Diagnosis

Race

Educational Level

Religious Preference

Marital Status

Lives Alone

Employment Status

Experimental Group
(n=24)
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Income

Disease Stage

Surgery Type

Chemotherapy

Radiation Therapy

Hormonal Therapy

$30,000 or less

9 (35%)

12 (50%)

$30,001 or more

13 (50%)

9 (38%)

Did not care to respond

4 (15%)

3 (13%)

Stage I

18 (69%)

17 (71%)

Stage II

8 (31%)

7 (29%)

Lumpectomy

19 (73%)

17 (71%)

Mastectomy

7 (23%)

5 (21%)

Bilateral mastectomy

0 (0%)

2 (8%)

Yes

4 (15%)

5 (21%)

No

22 (85%)

19 (79%)

Yes

19 (73%)

20 (83%)

No

7 (27%)

4 (17%)

Yes

23 (88%)

19 (79%)

No

3 (12%)

5 (21%)
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Table 6: Descriptive summary statistics for Overall QoL and QoL domains

Overall QoL
Physical
Subscale
Psychological
Subscale
Social
Subscale
Spiritual
Subscale

Baseline (N=50)
Mean
S.D
2.38
1.02
1.29
.80

Time 2 (N=49)
Mean
S.D
2.48
1.20
1.52
1.02

Time 3 (N=48)
Mean
S.D
2.58
1.33
1.59
1.06

2.65

1.50

2.74

1.69

2.96

1.83

2.18

1.29

2.11

1.31

2.19

1.43

3.62

1.54

3.82

1.67

3.59

1.68
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Table 7: Between group differences in Overall QoL and subscale scores using independent
t-tests
Baseline
WC
EXP

P
value

Month 3
WC
EXP

P
value

Overall QoL
Mean 2.42
2.45
.900
2.60
2.50
.765
S.D. 1.06
.75
1.28
.90
Physical
Mean 1.41
1.15
.241
1.50
1.55
.870
S.D.
.94
.6
1.11
.94
Psychological
Mean 2.64
2.66
.967
2.79
2.70
.856
S.D. 1.69
1.31
1.94
1.38
Social
Mean 2.14
2.24
.788
2.26
1.96
.432
S.D. 1.40
1.18
1.49
1.06
Spiritual
Mean 3.48
3.76
.529
3.84
3.80
.925
S.D. 1.45
1.65
1.62
1.75
Note: Significance level based on Bonferroni‘s adjustment, p<0.017.
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Month 6
WC
EXP

P
value

2.63
1.44

2.53
.95

.772

1.60
1.17

1.54
.95

.773

3.05
2.08

2.86
1.56

.729

2.32
1.72

2.04
1.07

.504

3.53
1.68

3.66
1.72

.778

Table 8: GEE comparisons between groups: Overall QoL and QoL subscales
Robust Z Score
Overall QoL

-0.516

Physical well-being

1.749

Psychological well-being

-0.601

Social well-being

-1.613

Spiritual well-being

-0.591

Note: Effects of treatment are not considered significant if the absolute Robust Z Score is <2.0
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Table 9: Demographic characteristics of the qualitative sample (N=24)
Age

Mean :72 years

Range: 65 to 80 years

Time since diagnosis

6 months or less

7 (29.2%)

7 to 15 months

17 (70.8%)

Caucasian

19 (79.2%)

Hispanic/Latina

2 (8.3%)

Other

3(12.5%)

High school/Trade school

16 (66.7%)

College

8 (33.3%)

English

21 (87.5%)

Other

3 (12.5%)

Christian

22 (95.8%)

Catholic

2(8.3%)

Married

13 (54.2)

Divorced/Widowed

11(45.8%)

Yes

8 (33.3%)

No

16 (66.7%)

Not working

18(75%)

Full-time

2 (8.3%)

Part-time

4 (16.7%)

$30,000 or less

12 (50.0%)

$30,001 or more

9 (37.5%)

Race

Educational level

Primary language

Religious preference

Marital Status

Lives alone

Employment status

Income
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Disease stage

Surgery type

Chemotherapy

Radiation therapy

Hormonal therapy

Stage I

17 (70.8%)

Stage II

7 (29.2%)

Lumpectomy

17 (70.8%)

Mastectomy

5 (21.8%)

Bilateral mastectomy

2 (8.3%)

Yes

5 (20.8%)

No

19 (79.2%)

Yes

20 (83.3%)

No

4 (16.7%)

Yes

19 (79.2%)

No

5 (20.8%)
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Conceptual Model of Quality of Life in Aging Breast Cancer Survivors
Figure 1: Conceptual Model of Quality of Life in Aging Breast Cancer Survivors
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Figure 2: Plot of means for whole group: Overall QoL
Note: the higher the score, the worse the QoL
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Figure 3: Plot of means for whole group: QoL domains
Note: the higher the score, the worse the QoL
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Figure 4: Plot of means for Overall QoL for WC and EX Groups
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Abstract
Background: There are over 10 million cancer survivors alive today. In 2006,
approximately 1.4 million people will be diagnosed with cancer and 565,000 are
expected to die from their cancer.1 Currently, 57% of all new cancer diagnoses and 71%
of deaths occur in people age 65 and older.2 Little is know about how cancer affects this
elderly population.
Aims: The overall purpose of this research is to examine quality of life in women with
early stage breast cancer who are age 65 or older and are within the first year of cancer
survivorship. Women of all ages diagnosed with breast cancer share common concerns,
but also have unique needs. The specific aims of this dissertation are to: 1) Describe the
overall quality of life of female breast cancer survivors age 65 or older; 2) Describe
quality of life within the domains of physical, psychological, social and spiritual wellbeing in female breast cancer survivors age 65 or older and; 3) Describe additional
current life experiences that may relate to quality of life in older breast cancer survivors.
Research Design and Methods: A descriptive design for analysis using mixed
methods will be used. Data will be obtained from a pre-existing data set, the Breast
Cancer Education Intervention (BCEI) a longitudinal, psychoeducational Quality of Life
(QoL) intervention for 256 breast cancer survivors in the first year of survivorship. This
sample included an experimental (EX) group and a Wait Control (WC) group. QoL was
measured over time. This dissertation will focus on the subset of older women (age 65
and older) surviving with breast cancer. Quantitative analysis of surveys using
parametric and non-parametric statistics and qualitative analysis of field notes and
narrative responses on surveys will occur.
Relevance to Healthcare: The goal of this dissertation research is to add to the body
of knowledge in research concerning older women with breast cancer. Information
concerning the quality of life in older women with breast cancer may help form
guidelines for treatment and follow-up care in this population during cancer
survivorship.
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Quality of Life in Older Breast Cancer Survivors: A
Descriptive Study
Specific Aims
There are over 10 million cancer survivors alive today. In 2006, approximately 1.4
million people will be diagnosed with cancer and 565,000 are expected to die from their
disease.1 Currently, 57% of all new cancer diagnoses and 71% of cancer deaths occur in
people age 65 and older.2 Little is know about how cancer affects this elderly
population.
This dissertation will focus on an understudied population in cancer care: older
women with breast cancer. Older or elderly women will be defined as being 65 years or
older. Approximately 212,920 new cases of invasive breast cancer will be diagnosed in
2006 and 41,430 women will die of this disease1. Within these new cases, it is estimated
that women over that age of 65 will constitute over 88,000 of these new diagnoses and
account for approximately 23,000 of the deaths attributed to breast cancer.3
The overall purpose of this research is to examine quality of life in women with early
stage breast cancer who are age 65 or older and are within the first year of cancer
survivorship. Data will be drawn from an existing cohort of women who participated in
the Breast Cancer Education Intervention (BCEI), a longitudinal, psychoeducational
Quality of Life (QoL) intervention for 256 breast cancer survivors in the first year of
survivorship. This sample included an Experimental (EX) group and a Wait Control
(WC) group. QoL was measured over time.
Aim #1: Describe the overall quality of life of female breast cancer survivors age 65 or
older.
Research Question #1.1: What is the QoL of older breast cancer survivors at
baseline?
Research Question #1.2: How does QoL change over time?
Research Question #1.3: How does QoL compare between groups over time?
Aim #2: Describe quality of life within the domains of physical, psychological, social
and spiritual well-being in female breast cancer survivors age 65 or older.
Research Question 2.1: What is the QoL of older breast cancer survivors within the
domains of physical, psychological, social and spiritual well-being at baseline?
Research Question # 2.2: How does QoL within these domains change over time?
Research Question # 2.3: How does QoL with these domains compare between
groups over time?
Aim #3: Describe additional life experiences that may relate to quality of life in female
breast cancer survivors age 65 and older.
Research Question #3.1: Describe other life experiences of older breast cancer
survivors as described by research nurses.
Research Question #3.2: Describe the types of medication used by older breast
cancer survivors age 65 and older.
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This research is relevant for several reasons. Little is known about older women with
early stage breast cancer, especially during survivorship. These women have been
largely understudied and are apt to be under-diagnosed, under-treated and underappreciated once treatment has ended and survivorship begins. This in turn makes
older women susceptible to late physical and psychosocial effects often encountered in
survivorship. With an increase in the population of older people on the horizon,
guidelines for all aspects of cancer need to be developed in order to properly care for this
population. The dissertation seeks to increase the body of knowledge concerning older
women with early stage breast cancer in order to assist in the development of guidelines
and interventions appropriate for the unique needs of this growing population.

Background and Significance
Today, there are more than 2.3 million women surviving with breast cancer.3
Currently, women have a one in 8 chance of developing breast cancer in their lifetime.
Incidence of breast cancer increases with age. Within the next 10 years of their age, A 20
year old woman has a 1 in 1,985 chance of being diagnosed with breast cancer while a 70
year old woman has a 1 in 24 chance of being diagnosed with breast cancer. This
probability changes depending on the presence of risk factors unique to each woman.3
Fifty percent of women diagnosed with breast cancer are 61 years old or older3.
While there is ample evidence that cancer and its treatment affect quality of life in
breast cancer survivors, the impact of cancer and its treatment on the quality of life in
older women surviving with breast cancer is unclear. Research is often conflicting as
some studies have concluded that quality of life in older women with breast cancer is
poor while others conclude older women surviving with breast cancer suffer little
negative effect from treatment.4-13
The recognition of the need to focus on older populations is not new.14 The burden
of cancer due to aging is now imminent and little is known about cancer in this
population as a whole or within the specific cancers such as breast cancer.2, 15, 16 Further
research is needed across all areas of cancer care and the elderly including screening,
diagnosis, treatment, survivorship and quality of life. Several organizations support this
need for research.
The National Institute of Aging (NIA) has compiled the Action Plan for Aging
Research: Strategic Plan for Fiscal Years 2001-200517 which recognizes the need to
address knowledge deficits regarding the elderly, disease and aging. One of the primary
goals is to improve the health and quality of life in older people. To meet this goal, the
NIA has developed research initiatives for studying diseases such as cancer focusing on
older individuals.
The Institute of Medicine’s (IOM) report From Cancer Patient to Cancer
Survivor: Lost in Transition18 describes the survivorship phase of cancer as neglected in
research. The IOM proposes essential components of survivorship care as: 1)
prevention of new and recurrent cancer as well as late effects; 2) surveillance of new,
recurrent and metastatic cancer as well as side effects; 3) interventions for the effects of
cancer and its treatment; and 4) coordination of care between specialist and primary
care providers to meet all the needs of the cancer survivor. In addition, the IOM report
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suggests developing a “Survivorship Care Plan” to meet the needs of cancer patients
after treatment. This Care Plan would summarize treatment, guide follow-up, suggest
preventive practices for maintaining health, provide information of employment and
health insurance, and detail the availability of psychosocial services within the patient’s
community. An additional recommendation is to encourage health care providers to use
“systematically developed evidence-based clinical practice guidelines” (p5) to help
manage cancer and its effects. Guidelines concerning cancer care in older adults do not
exist at this time.
Quality of life in survivorship has been recognized as an important outcome of
cancer treatment. The National Cancer Institute’s (NCI) Strategic Plan for Leading the
Nation to Eliminate the Suffering and Death Due to Cancer19 includes improving the
quality of care and quality of life in those affected by cancer and encourages the use of
quality of life endpoints in NIH funded clinical trials. To further emphasize the
outcomes of research, the NIH has developed the Outcomes Research Branch to help
define the emerging field of outcomes research. This field looks at relevant endpoints of
treatments and interventions. The endpoints include: survival, health-related quality of
life, healthcare and economic burden.20
This dissertation research involving older breast cancer survivors is significant for
several reasons: First, Americans are aging. In 2000, 14.3% of women in the U.S. were
over the age of 65. By 2050, 22.6% of all women are projected to be over the age of 65.21
Second, incidence of cancer increases with age. People over the age of 65 have nearly 10
times the risk for developing cancer than those younger than 65.22 Due to growth and
aging of our population, the number of cancer cases is expected to double from the
current rate of 1.3 million to 2.6 million by the year 2050.15 Currently, the mean age of
all women diagnosed with breast cancer is 61 while women age 75 to 79 have the highest
incidence rate.3 As more women reach this age group, incidence rates will also increase.
Additionally, many women will approach old age with a personal history of breast
cancer. Risk for recurrence will remain as well as risk for developing a second breast
cancer.23 The cancer burden will substantially increase over the next 30 years.22 Third,
the sheer number of older people who will be diagnosed with cancer will increase the
demand for health care services.23 Healthcare professionals will be unprepared to
appropriately care for these aging women.24, 25 Fourth, co-morbid conditions increase
with age and this will impact care.23 The Centers for Disease Control26 (CDC) estimates
that the average 75 year old has 3 chronic illnesses and uses 5 prescription medications.
It is unclear how these illnesses and medications impact or interact with treatment for
cancer. Fifth, women of different ages have different concerns and needs.27, 28 Due to
the lack of research concerning older women with breast cancer, these needs are largely
unknown.
In summary, little is known about older women with breast cancer. The current
need for research is intensified by the fact that the already large number of older women
surviving with breast cancer will dramatically increase in the near future.

Literature Review

The goal of this literature review is to support the importance of this dissertation
research in adding to the body of knowledge in nursing concerning older women with
breast cancer. This literature review will focus on several areas: 1) aging, 2) breast
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cancer, 3) survivorship, 4) quality of life, and 5) methods of research. All of these topics
will support the need for this research study.

AGING

Changing Demographics
The demographics of America are changing and soon, more elderly people will be
alive and living longer than ever before. According to population projections, there is
about to be a large increase in the number of elderly people in the United States. As of
2003, 35 million
Table 1: Summary Table for Aging Americans29
Americans were over
2000
2030
2050
the age of 65 (men:
Total population
282 million
364 million
420 million
14.4 million, women:
20.6 million)
Number of Americans age 35 million
72 million (20%) 87 million (21%) representing over
12% of the
of 65 or older
(12%)
population in the
Men
14.4 million
United States. By
Women
20.6 million
the year 2030, the
Number of Americans age 3.6 million
9.6 million
18.2 million
number of older
85 or older
Americans will grow
to be 72 million
representing
Number of Centenarians
81,000
800,000
approximately 20%
of the total
population.2, 30 In
the year 2050, it is projected that 87 million people will be over the age of 65,
representing 21% of the nations population.31
The most rapidly growing group are Americans over the age of 85.29, 32 In 1995,
those over the age of 85 were numbered at 3.6 million. This number is expected to
double by 2025 and increase 5 fold by 2050 totaling 18.2 million adults over the age of
85. The numbers of centenarians are also increasing. By 2050, estimates project
800,000 people will be 100 years old or older compared to the 81,000 centenarians
living in the 2000.29 Please refer to Table 1 for a summary.
Life expectancy has also improved over time.30, 31 In 2000, the average life
expectancy was 76.0 years (men: 74.1 years, women: 79.5 years). Currently, the average
65 year old can expect to live 17.9 more years (men: 16.3, women: 19.2), the average 75
year old can expect to live an additional 11.3 years (men: 10.1, women 12.1), and an 85
year old has an additional life span of 6.3 years (men: 5.6, women: 6.7).30 By the year
2050, the average person is expected to have an average life expectancy between 82 and
84 years (see Table 2).30 Both the increase in the number of older people and the
projected longevity of their lives over the next several decades support the importance of
better understanding the needs of older cancer survivors in order to reduce adverse
effects experienced in survivorship.
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Table 2: Life expectancy30
2000
76 years
Men: 74.1 years
Women: 79.5 years
Men: 16.3 years
Women: 19.2 years
Men: 10.1 years
Women: 12.1 years
Men: 5.6 years
Women: 6.7 years

2050
82-84 years
(projected)

Demographic
Differences
between Elderly
Men and
Life expectancy for
Women
65 year old
The elderly
Life expectancy for
are not a
75 year old
homogenous
Life expectancy for
population. Many
85 year old
differences exist
between elderly men and women. Women make up approximately 59% of the
population over the age of 65. Older women are less likely to be married than men (44%
compared to 75%) and more likely to be divorced or widowed. Older women are also
less likely to remarry after a divorce or the death of a spouse. Forty percent of women
over the age of 65 live alone while 41% live with a spouse. At age 85, 60% of women live
alone.
Older Americans represented 3.3% of the overall workforce in 2003 and are
projected to be 5% of the workforce in 2020. Women over the age of 65 continue to
work. Thirty five percent of women age 65 and older remain in the workforce compared
to 59% of men of the same age.32
Poverty rates for adults over the age of 65 has recently declined from 10.2% to
33
9.8%. Older women are more likely to be poor compared to men of the same age.
Elderly women have a 12.2% rate of poverty compared to men at 7.5%. Fewer older
women achieve economic security because they were more likely to either not work
outside the home or work at jobs that do not allow them to collect the maximum benefit
from Social Security (SS). In addition, women are only able to collect 2/3rds of their
husbands benefit if they are widowed.
Social support for older women is also limited. Since older women are likely to live
alone, they must depend on other people for support instead of spouses. The most likely
caregiver or support person for older women is children living nearby. Older women are
also more likely to enter a nursing home than older men.32
As a group, older people spend a considerable amount of money on healthcare. It is
estimated that 12.5% of expenditures are health-related. This is more than double the
amount spent by the average consumer. The majority of these costs are for insurance
(55%), medications (24%), medical care (17%) and medical supplies (4%).34 Almost all
older people not living in an institution receive Medicare (96%) however Medicare only
pays approximately half of medical costs. Over 87% of elderly persons have some type
of supplemental coverage. Individuals living in nursing homes are usually covered by
Medicaid (58%).34
Average life expectancy (at
birth)

Chronic Disease in the Elderly
Many older adults experience healthy aging but most will eventually experience
illness and chronic disease. Illnesses that contribute to morbidity and mortality include
cerebrovascular disease, cancer, chronic lower respiratory diseases,
pneumonia/influenza, diabetes, arthritis, and Alzheimer’s disease. Many older
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Americans chronically suffer from one or more of these illnesses prior to their death.
Chronic co-morbidities often seen in elderly populations include: gastrointestinal
problems35, hypertension, heart conditions, cancer, chronic obstructive pulmonary
disease (COPD), arthritis and diabetes.35, 36 Eighty percent of older Americans over the
age of 65 have at least one chronic illness and 50% have 2 or more chronic conditions.37
The presence of co-morbidities increases with age.36, 38 At the time of diagnosis, it is
likely that cancer is not a person’s first chronic illness.2
Cancer: Cancer is a major consideration in adults. Currently, 57% of all new cancer
diagnoses and 71% of deaths occur in people age 65 and older.2 Cancer is the second
most common cause of death in persons age 65 and older following heart disease.30
Approximately 1.4 million persons will be diagnosed
Table 3: Incidence of cancer in
with cancer in 2006.1 The cancers with the highest
adults over age 652, 38
incidence in men are prostate, lung, colon and bladder
Overall
57%
cancer. In women, breast, lung, colon and uterine
Breast
47.5%
cancer have the highest incidence.1 Overall, 76.9% of
Uterine
55.4%
prostate cancer, 73.9% of colon cancer, 65.8% of lung
Ovarian
45.9%
cancer, 45.9% of ovarian and over 47.5% of breast
Colon
73.9%
cancer diagnoses occur in individuals over age 65. In
Lung
65.8%
addition, 55.4% of women diagnosed with uterine
cancer are age 65 or older (see Table 3).2, 38 Due to advances in cancer treatment, early
detection and screening, cancer is considered a chronic illness contributing to morbidity
and mortality in later life.36 As our population continues to grow, more older Americans
will be diagnosed with cancer and need to be managed within the context of their cancer
diagnosis and other co-morbid illnesses they most likely will be experiencing.36
Comorbidity and Cancer: The presence of co-morbidities affects many aspects of
cancer beginning with screening and diagnosis of cancer. Heflin and colleagues39
found that the relationship between the number of co-morbid conditions and the use of
screening tests varied widely in older populations. Additionally, screening rates
decreased as age increased. Compared to those without a co-morbid condition, women
with hip fractures were less likely to receive mammograms; people with cognitive
impairment were less likely to receive fecal occult blood testing; and those with
hypertension experienced higher rates of clinical breast exams, Pap tests, FOBT and
higher trends toward mammography. Overall, co-morbid conditions were not related to
lower incidence of cancer screening, however age was a determining factor in whether or
not elderly people received screening for cancer. Using age as a determining factor for
screening is worrisome since many elderly are healthy and may be good candidates for
cancer screening tests. Using age as the determining criteria means many older adults
may not receive the benefit of cancer screening when they are otherwise healthy.
Conversely, many fear that older people with multiple co-morbid conditions may
experience harm by participating in cancer screening activities.
Comorbidity has also been associated with later diagnosis of cancer and greater
mortality. Although people with co-morbid illnesses have more exposure to physicians
for the treatment of their illnesses, cancer screening may not be considered as important
as the illnesses already being managed.40 Additionally, the symptoms of cancer may
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not be recognized by patients or practitioners or attributed to pre-existing conditions
leading to missed or delayed cancer diagnosis.41
Treatment of cancer is also affected by the presence of co-morbidities. The National
Comprehensive Cancer Network has published clinical practice guidelines for the
detection and treatment of many common cancers. These guidelines reflect what
experts believe are appropriate practice in the treatment of cancer. However, in the
National Report to the Nation on the Status of Cancer, 1975-2002, Edwards and
colleagues42 recognize age-related disparities for the treatment of cancer. Cancer
patients age 65 and older were treated below guidelines (less than was recommended)
for breast, colorectal, lung, and ovarian cancer. The presence of co-morbid illnesses
influenced treatment decisions.
The impact of co-morbidity on cancer treatment is of great concern to many involved
in the care of older adults.39, 43-48 Many healthcare professionals are concerned that
treatment for cancer may be too dangerous or debilitating depending on the number
and type of co-morbidities a person has when they are diagnosed with cancer. People
with cancer who have either multiple or severe co-morbidities may experience poorer
survival compared to patients with no co-morbidities. The presence of co-morbidities
can also have a negative impact on quality of life in persons diagnosed with cancer.46, 47
People with a history of cancer tend to rate their health lower and their disability higher
than those without a cancer diagnosis. When another co-morbid illness is present, the
chance a person will rate their health as poor increases 5 to 10 times what which would
be expected.49
In the future, it will be necessary to consider these co-morbid illnesses more closely
to reduce morbidity.36, 49 Many researchers and health care professionals that work
with the elderly are concerned with the inevitable increase in cancer diagnosis in the
elderly over the next several decades. They advocate for comprehensive geriatric
assessment of older people diagnosed with cancer to determine the appropriateness of
any given cancer treatment.46 It is agreed that age should not be the sole determining
factor concerning treatment decisions.41, 50 Many older adults may be healthy enough
to undergo standard treatments for cancer. The goal of the geriatric assessment is to
identify medical, functional and psychological problems that may be present in the older
adult diagnosed with cancer and to develop a comprehensive care plan.46 Geriatric
assessment is multidimensional and includes assessing function (activities of daily living
and functional status), co-morbidity (number of illnesses and severity), socioeconomic
issues (living conditions, presence of a caregiver, transportation), geriatric syndromes
(dementia, depression, fall history, osteoporosis), medications (number of prescriptions
and potential drug interactions), and nutritional status.24, 41, 50 Using a geriatric health
assessment may more accurately allow physicians to identify frail patients24 and
estimate risk associated with treatment for cancer and avoid treatments that may lead to
functional disability.46 Balducci and Stanta24 also recommend asking several questions
in addition to the geriatric assessment. These question include: Will the patient die
from the cancer?; Will the patient experience cancer-related morbidity? and; Will the
patient be able to tolerate treatment without life-threatening complications? These
questions and a comprehensive geriatric assessment may help patients, family members
and health care providers determine the best course of action for elderly people with
cancer.
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Aging Summary: The number of older Americans will double by the year 2030.
While some will remain healthy, most will experience co-morbid illness including cancer
at some point in their lifetime. Age coupled with the presence of co-morbid illness
impacts decisions concerning cancer screening and treatment. Comprehensive
assessments of the elderly should be incorporated into decisions related to cancer in this
population. For women, considerations involving breast cancer heighten the need for
such assessment.51

BREAST CANCER
Breast cancer is the most common cancer diagnosed in women.1 Risk factors for
breast cancer are well known and include: age, family history, age at first full-term
pregnancy, length of menstrual history, post menopausal obesity, oral contraceptive and
postmenopausal hormone use, high alcohol intake and low physical activity.3 Currently,
women have a 1 in 8 chance of developing breast cancer in their lifetime. Incidence of
breast cancer increases with age. Fifty percent of women diagnosed with breast cancer
are 61 years old or older3. Women age 75 to 79 years old have the highest incidence rate
(496.6 per 100,000 women) and women age 20-24 have the lowest rate of incidence (1.3
per 100,000 women). Although white women have higher incidence of diagnosis after
the age of 35, African American women have a higher mortality rate from breast cancer
which is consistent across all age groups.3

Incidence and Survival
Incidence is defined by the National Cancer Institute (NCI) as the “number of new cases
of a disease diagnosed
Table 4: Survival Rates for Breast Cancer3
each year.”52 The
Survival at 5 years
incidence of breast
Overall 88%
cancer rose 4% yearly
Local Disease
98%
Age 40 and younger
82%
from 1980 to 1987 most
likely due to increase
Regional Disease
81%
Ages 40-74
89%
screening efforts. Since
Distant Disease
26%
Age 75 and older
88%
1988, rates have
continued to rise but at a much lower rate of 0.3% per year. Recently, women between
the ages of 40 and 49 experienced a slight decline in incidence but women over the age
of 50 continue to experience this slight increase in incidence.
Mortality from breast cancer has been decreasing. A mortality rate is defined by NCI
as “the number of deaths, with cancer as the underlying cause of death, occurring in a
specified population during a year.”53 From 1990 to 2002, mortality rates (the number
of people who died from an illness) decreased 2.3% each year. However, this reduction
in mortality has mostly benefited white women.3 Several factors have been seen to
influence survival at 5 years: age and stage at diagnosis. The overall rate of survival at 5
years is 88% however this survival rate changes according to extent of disease and are as
follows: local (98%), regional (81%) and distant (26%). Age differences also impact 5
year survival rates. Women diagnosed with breast cancer at age 40 or younger have an
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82% survival rate, women ages 40 to 74 have an 89% survival rate and women age 75 or
older have an 88% chance at survival (see Table 4).3
Screening
Screening entails checking for a disease when there are no symptoms.52 Increased
screening for breast cancer has led to tumors being found in early and localized stages.
The American Cancer Society recommends that women age 40 and older receive an
annual mammogram and an annual clinical breast exam. The recommendation for a
monthly breast self exam (BSE) was recently eliminated because it is recognized that
many women find a lump outside of a structured self exam and awareness of changes in
the body is more important than conducting a structured breast exam. However, women
should still be educated about the benefit and technique of the breast self exam so they
can perform one if they are interested in incorporating this into their monthly routine.3
There has been a marked increase in mammography use over the past decade. In
2000, approximately 70% of women reported that they had been recently screened for
breast cancer with mammography. Screening rates varied per ethnic group: White
(72%); Black (68%); Hispanic (63%), Asian/Pacific Islander (57%) and American
Indian/Alaskan Native (52%).54 Annual screening rates also differ according to age.
Women receive mammography and a clinical breast exam (CBE) at the following rates:
age 40 (54.1%), 40-64 (54.9%), and 65+ (52.3%). Rates are lower if women do not have
a regular healthcare provider or are uninsured.3 Sixty four percent of women over the
age of 65 receive screening by mammogram only and do not receive routine CBE.3
Even though older woman are more likely to be diagnosed with breast cancer,
controversy exists concerning the efficacy of screening for breast cancer in older
populations.45, 55-57 This controversy exists because there is little research involving
older women and screening for breast cancer.55 Screening rates have been shown to
decline with age and physicians base their decision to screen women on an assessment
of risk and benefit.57 Additionally, physician recommendation for screening varied
widely according to age. In women between the ages of 50 and 74, providers
recommended mammography at least every other year (51%) and yearly (45%). In
women over age 75, screening was recommended annually for 80% of the women, 5% of
the physicians did not recommend screening and 10% had no policy regarding
screening.56 Physicians reported that issues such as cost, comorbidity, functional status
of the women, lack of guidelines, questionable value of the test and patient resistance as
influencing their decision to recommend screening.56
The National Comprehensive Cancer Network’s (NCCN) Breast Cancer Screening
and Diagnosis Guidelines58 support the ACS recommendations on breast cancer
screening and offers considerations for screening the elderly. As older women are more
apt to develop breast cancer, screening guidelines should apply to all women. However,
if an elderly woman has serious co-morbid conditions that would preclude treatment,
screening for breast cancer should not be used.
McPherson and colleagues45 specifically studied the effect of mammography on
survival in older women with co-morbidity and breast cancer. Results showed a
significant reduction in mortality for all older women, even those who had mild or
moderate co-morbidity. However, for older women with multiple or severe co-morbid
illnesses, survival was not improved. These findings suggest that it may not be effective
110

to screen older women with the presence of severe co-morbidity who may not benefit
from detection of breast cancer and treatment. But treating older women, regardless of
age may be effective if their level of co-morbidity is low.45, 57
Diagnosis
The NCCN has published guidelines concerning the diagnosis of invasive breast
cancer.59 Invasive cancer is defined as cancer that has spread beyond its point of origin
and into neighboring tissues.52 Current guidelines for the diagnosis of invasive breast
cancer includes: diagnostic mammography, pathology review, evaluation of estrogen
(ER) and progesterone (PR) receptor status, Her-2 receptor status and various blood
chemistries.59
Differences have been noted in the use of these guidelines in younger and older
women. Compared to younger women, older women receive fewer diagnoses by
mammogram and needle localization.60 Some older women had no histological
assessment of their disease. Estrogen receptor status was also unknown in 74% of the
population.61
Overall, the presentation and nature of breast cancer at diagnosis in older women is
blurred. While some researchers have reported that older women have more advanced
disease at diagnosis,60, 61 others have found that women over the age of 70 had similar
disease characteristics as younger women, but more favorable histological
characteristics with lower grade disease and less negative ER-receptor status.62 Gennari
and colleagues63 compared the presentation of elderly postmenopausal women with
younger postmenopausal women. Older women had larger tumors and greater lymph
node involvement than younger women. Elderly women also demonstrated more
ER/PR positivity, less tumor vascularization and less Her-2 neu expression than
younger women.
Singh and colleagues64 examined the natural history of breast cancer in women who
did not receive systemic therapy. No difference in tumor size was noted between age
groups; however, women over the age of 70 had less lymph node involvement. It is also
reported that older women have fewer lymph nodes removed. Controversy exists over
the benefit of axillary lymph node dissection in older women with breast cancer. In
early stage disease, there was no significant difference in mortality, recurrence and
survival between older women (mean age 70 years) who had an axillary lymph node
dissection and those who did not. Additionally, no evidence was found to support some
views that breast cancer in the older woman was more indolent than in younger
women.65
Treatment
According to guidelines published by the National Comprehensive Cancer
Network treatment for breast cancer is dependent on tumor size, lymph node
involvement, estrogen receptor (ER), progesterone receptor (PR) and Her-2 status, and
the presence of metastatic disease.59 Women with early stage invasive breast cancer can
opt for total mastectomy or breast conservation therapy which includes lumpectomy
and radiation therapy. The extent of radiation therapy and the receipt of adjuvant
chemotherapy are dependent on axillary nodal involvement, size of the tumor and
ER/PR status. Adjuvant hormonal therapy depends on ER/PR status. In addition,
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women who are Her-2 neu positive should receive trastuzumab. The NCCN guidelines
do not make recommendations regarding chemotherapy in women over the age of 70
stating that data were insufficient to make a determination regarding the safety and
efficacy of chemotherapy in this population. The guidelines state that use of
chemotherapy in older women should be individualized and co-morbid conditions
should be taken into consideration.59 Women with advanced disease also receive a
combination of the treatments already mentioned however, breast conservation therapy
is not recommended.59
Overall, it is agreed that older women have more variable treatment than younger
women and are often under-treated or treated with less than standard treatment for
their disease.60, 61, 66-72 Bouchardy and colleagues61 noted no standardization of
treatment in older women. Women opted for no treatment (12%); Tamoxifen only
(32%); breast conservation surgery and radiation (7%) and mastectomy (14%).
Tamoxifen was given to women regardless of their estrogen receptor status. These
researchers determined that 50% of these women had suboptimal treatment which
contributed to increased mortality related to breast cancer. In this sample, forty seven
percent (47%) of older women (age 80 and older) received standard treatment
compared to 91% of women age 50 to 79 years. In a study to determine concordance
with established guidelines, Giordano and colleagues68 determined that age was
associated with under-treatment. Older women were less likely to receive definitive
surgery, post-lumpectomy radiation, adjuvant chemotherapy and hormonal therapy.
Women age 75 and older were particularly vulnerable to not being treated according to
guidelines.
Surgery: In a study that examined factors associated with surgical options for breast
cancer, Chagpar and colleagues73 found that age was an independent predictor of
surgery type. Women over the age of 55 were more likely to receive mastectomy
compared to breast conservation therapy. If older women received breast conserving
surgery, they were also less likely to receive radiation therapy.60, 63
Chemotherapy: The use of chemotherapy in older women with breast cancer is
inconsistent. Du and colleagues74 noted a decrease in the use of chemotherapy with age.
Women age 65-69 received chemotherapy 54% of the time while women over the age of
85 received chemotherapy 3% of the time.74 In this study, chemotherapy was noted to
significantly reduce mortality in women age 65 to 69, but have little impact in women
over age 70.74 The reason for this difference is unknown.
Muss and colleagues75 demonstrate that there is a survival benefit for older women
who are healthy and receive chemotherapy. Benefit was comparable to that of younger
women. However, overall survival was worse for women over age of 65 due to death
from causes other than breast cancer.
Woodward and colleagues70 also observed that older women were less likely than
younger women to receive chemotherapy as part of their treatment. Women age 50 to
65 were 6 times as likely not to receive chemotherapy and women over the age of 65
were sixty two times as likely not to receive chemotherapy when compared to women
under age 50. They concluded that age bias contributed to the under-treatment of this
patient population.
Older women also receive fewer referrals to medical oncologists. Thwin and
colleagues71 report that 79% of women over the age of 65 were referred to a medical
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oncologist compared to 88% of younger women. Health status evaluated by the surgeon
was associated with referrals. Women perceived to have poor health status received
fewer referrals.
Hormonal therapy: Tamoxifen may be the only consistent treatment given to
women over the age of 65.76 However, older women with co-morbid conditions and
estrogen receptor (ER) negativity were less likely to have discussed this option with
their doctors.77 In one study, women over age 70 were less likely to receive
chemotherapy but more likely to receive hormonal therapy.62 Interestingly, women who
were neutral or negative in their belief that Tamoxifen was beneficial often stopped
taking it before the end of 5 years. Women were at risk for stopping the drug if they held
these beliefs and if they had 4 or more positive lymph nodes.78
Aromatase inhibitors instead of or in combination with Tamoxifen have also been
used as adjunct therapy in older women.79 Mouridsen and Chaudri-Ross80
demonstrated the effectiveness of the aromatase inhibitor letrozole compared to
Tamoxifen. Letrozole was as effective as Tamoxifen in postmenopausal women of all
ages. However, older women (age 70 or older) who took letrozole had more benefit as
time to progression was significantly longer in this group (12.2 months) compared to the
Tamoxifen group (5.8 months). Older women in the letrozole group also experienced
significantly longer survival compared to the Tamoxifen group.
No information was found concerning the use of trastuzumab specifically in older
women. NCCN guidelines do not restrict its use in older women.59
Misperceptions regarding breast cancer in older women: Many of the variances in
diagnosis and treatment can be attributed to misperceptions of health care professionals
and the patients themselves. These include beliefs that: breast cancer in the elderly is
less aggressive; the elderly have limited life expectancy due to other chronic co-morbid
conditions; and breast cancer is not as big of a problem compared to other causes of
mortality.60 Other misperceptions include beliefs that older women accept cancer as a
part of life and expect to experience losses related to cancer, older women would be
better off with surgeries such as mastectomy, and the loss of breast tissue is not
significant to older women.81
Additionally, many health professionals assume older women could not or do not
want to make healthcare decisions.81 Another assumption is that elderly women are frail
and can not handle standard treatments. Contrasting views exist in the literature.
Cameron and Horsburgh28 compared issues faced by younger and older breast cancer
survivors and found that older women were more hesitant and less likely to investigate
changes they found in their breasts. Older women also delayed talking with a doctor
about new or unusual findings in the breast and were less involved than younger women
in making treatment decisions. Older women often did what the doctor told them
needed to be done and did not remember being given choices for treatment. Younger
women were more apt to want to discuss treatment options and participate in decision
making.
Crooks81 found divergent results in her study. Older women stated they were
interested in participating in their healthcare, but communicating with physicians was
often challenging. Women felt that surgeons and oncologists did not have the time to
answer their questions or address their concerns and they did not feel educated enough
about treatment options. Older women did want to be involved in decision making, but
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were often not given the chance. It was noted that choices for treatment decreased as
women aged. The option for mastectomy versus lumpectomy decreased the older the
woman was. Interestingly, women remembered being given information to read to help
make decisions however older women perceived the written material without a verbal
explanation as a lack of interest in them as a person and did not review the materials.
Summary: Older women receive different treatment than younger women and are
often under-treated or treated with less than standard treatment for their breast cancer.
Older women are more likely to receive mastectomy compared to breast conservation
therapy (BCT) however, when they do receive BCT, they are less likely to receive
radiation therapy. Older women are also less likely to receive chemotherapy. Older
women did receive hormonal therapy however; older women with co-morbid conditions
were less likely to have this treatment.
Surveillance
Surveillance and follow-up occurs after treatment for disease in order to monitor
for side effects and recurrent disease. Current surveillance guidelines established by the
NCCN include a history and physical every 4 to 6 months for the first 5 years;
mammogram every 12 months (6 to 12 months post radiation therapy is breast
conservation therapy was used), pelvic exam every 12 months if a uterus is present and
for women on aromatase inhibitors bone health should be monitored.59 No exceptions
were made for older women.
Discussion of surveillance in the literature was limited to follow-up mammography.
In 2001, Lash and Silliman82 investigated the medical surveillance of women over the
age of 55 who had early stage breast cancer. Surveillance at the time of this study
included annual physical exams and mammography. Results showed that older women
(age 75 to 90) were less likely to receive appropriate follow-up and surveillance tests
after treatment than younger women.82 In addition, the farther a woman was from
treatment, the less likely she was to continue with follow-up. Women age 75 to 90 were
more likely to receive less than 4 years of continuous follow-up compared to women age
55 to 64. Doubeni and colleagues83 also report differences in surveillance based on age.
Older women (age 75 +) were less likely to receive annual mammography than younger
women especially if the older women had co-morbid illnesses. Co-morbid illnesses did
not have a significant impact on the use of mammography in younger women.
Breast Cancer Summary: Age related differences related to screening, diagnosis,
treatment and surveillance exist in regards to breast cancer. Older women have a higher
likelihood of being under-screened, improperly diagnosed, and under-treated. Older
women also receive inconsistent follow-up after treatment compared to younger women.
This review of the literature indicates a discrepancy between standardized treatment
and practice in older populations. Reasons for this disconnect have been suggested
however more research is needed with this older population of women. Research based
evidence is clearly more desirable than professional opinion or speculation.51

CANCER SURVIVORSHIP
Anyone living with a history of cancer is a survivor. Today, there are more than 10
million cancer survivors in the United States 1 including 2.3 million women surviving
with breast cancer.3 The National Cancer Institute’s Office of Cancer Survivorship states
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that individuals are considered “a cancer survivor from the time of diagnosis,
throughout the balance of his or her life.” Since family member’s, friends and caregivers
are impacted by cancer and the survivorship experience, they are included in this
definition.84
While survival is often associated with survival rates at 5 years often equating with
cure of disease, it has also come to be known as a continuum in which patients with
cancer experience physical and psychosocial issues after the acute phase of illness.85-91
Physical effects in survivorship are numerous and include: fatigue92, pain, cognitive
chnages,92 lymphedema, sexual effects, pulmonary, neurologic, gastrointestinal,87 and
cardiac effects.87, 93, 94 Psychosocial effects of survivorship include: fear of recurrence,
depression, uncertainty in illness, and finding meaning in illness.90
The survivorship literature shows how cancer survivors go through changes due to
the experience of having cancer and these changes remain with them the rest of their
lives. One of the first people to explore survivorship in cancer was Mullan95 who
describes “seasons in survival.” These seasons are identified as: 1) acute survival, 2)
extended survival and, 3) permanent survival. Each season has its own struggles for the
cancer patient. The acute survival phase is focused on diagnosis and treatment of the
disease. Individuals are confronted with their own mortality and are focused on coping
with and managing the effects from treatments. The extended survival phase begins
after treatment when the cancer patient has less contact with their oncology team.
Patients experience a multitude of physical and psychological effects as they try to
reenter the world and often begin a “watchful waiting” period that is dominated by fear
of recurrence. The permanent phase of survival begins when the cancer patient can
reasonably consider themselves cured or the chance of the disease coming back is
remote. In this phase, the survivor may become comfortable with the changes that have
occurred but may also experience long-term effects.
Dow96 expands on Mullan’s seasons of survival and discusses the adjustments
survivors must make after treatment. The immediate period after treatment is
characterized as one of lessening acute side effects, and it is also a dynamic process
which holds unique challenges for the survivor. After diagnosis and treatment, support
from health care professionals may not be readily available however; this is a time when
survivors may need support most. In addition, returning to “normal” may not be
possible due to all the physical and psychological changes that have occurred. Fear of
recurrence may be extremely prominent for cancer survivors. Lack of education
concerning what signs to look for may be prevalent in this population. Uncertainty is
also an important factor for survivors. On the positive side, cancer patient are often able
to put their experience in perspective and move from surviving to “thriving.” Some
survivors find or renew faith and feel confident about the changes in their life. These
survivors do not define themselves by their cancer, but return to previous roles as wives,
sisters and mothers. Hopefully individuals adjust to the new physical, psychosocial and
spiritual changes that occur in survivorship.
Zebrack89 discusses the potential for cancer survivors to develop a new identity after
the cancer experience. As cancer patients integrate the experience of having cancer into
their self-concept it may renew or change a person’s sense of self. This new sense of self
is challenged in survivorship during times of distress when survivors either meet or fall
short of the expectations they have for themselves and their role in society. Meeting
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expectations leads to better quality of life while falling short of expectations lowers
quality of life. In addition, cancer survivors encounter situations everyday which can be
reminders of their own experience with cancer and can reinforce or upset the new sense
of self.
Little, Paul, Jordens and Sayers97 also believe that surviving cancer changes personal
identity. Identity is defined in their study as the “sense” of being a certain type of
person and includes “future memory” which people construct for themselves as life
proceeds. Cancer has the potential to interrupt this identity and future memories due to
all the changes it brings both physically and psychosocially. Some people are able to
resume lives within the context of their new reconstructed identity others are unable to
construct new identity and meaning into their lives leaving them feeling isolated.
Deimling and colleagues (2006) examined the impact of cancer-related worries and
psychological distress among cancer survivors and found that for many survivors
cancer-related worries persisted for years after treatment. In a sample of older adults
with breast, prostate and colorectal cancers, who were an average of 10 years from
diagnosis, survivors still worried about their cancer returning (32.5%), symptoms that
might indicate recurrence (37.25%), a new type of cancer (30.5%) and future diagnostic
tests that might lead to the diagnosis of another cancer or recurrence (39.5%) well after
the 5 year “cure” date.
Personal accounts from cancer survivors focus on finding a new balance after
treatment. Jenkins98 describes cancer as an event which has a great potential for
learning and growth as well as a time for obstacles. She describes the difficulty of
returning to a “normal” life and the persistence of fear of recurrence.
Other researchers have looked at the meaning of quality of life in survivorship. Dow
and colleagues99 identified themes that depict the meaning of quality of life in the eyes
of cancer survivors. These themes include: finding a balance between independence and
dependence; achieving a sense of wholeness which restores life purpose; search for
meaning; managing physical symptoms; facing losses; controlling life instead of being
controlled by the cancer; contrast between focusing on the now versus the future;
survivorship viewed as a trajectory and dynamic concept; altered meaning of health; and
survivorship as a family experience. These themes demonstrate the complexity of the
cancer survivorship experience and the potential for different issues to be important at
different phases of survivorship.
Summary: Anyone living with a history of cancer is a survivor. Cancer survivors
go through phases of survivorship, experience changes in their self-concept, reconstruct
their identity and experience late physical and psychosocial effects. Survivorship is a
unique and often complex experience in which quality of life is an important aspect. An
aspect of survivorship that is lacking in the literature concerns differences between older
and younger cancer survivors. It is unknown if survivorship issues are the same for
these different populations. Research is needed to investigate survivorship in different
populations.

QUALITY OF LIFE
Quality of life is an important aspect of survivorship and was first discussed in the
literature in 1953. This concept gained rapid popularity in the 1970’s and 1980’s and
now over 92,000 articles in PubMed use “quality of life” as a keyword. Quality of life is
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a term that is used by both patients and health professionals. It is recognized as a
multidimensional concept with perception based on the subjective experiences of the
individual assessing it. 100-104 However, despite its extensive use in research, King and
colleagues.102 suggest that there are “gaps in theory, research and practice” (p.27)
related to quality of life. Lack of a uniform definition of QoL may be the basis for these
issues.
Meeberg105 defines quality of life as a subjective experience that defines a feeling of
overall life satisfaction. The World Health Organization106 defines QoL as “an
individuals perception of their position in life in the context of the culture and value
system in which the live and in relation to their goals, standards, and concerns”.
Ferrans and Powers107 define QoL as “the persons sense of wellbeing that stems from
satisfaction or dissatisfaction with the areas of life that are important to him/her.”
Ferrell and colleagues define quality of life as a personal sense of wellbeing which
encompasses physical, psychological, social and spiritual dimensions.108-110
In many instances the concept of QoL is clarified by researchers through “domains”
or dimensions which are used to measure the concept. Different researchers measure
the concept in different ways. Ferrell and colleagues108-113 use 4 domains to help define
the concept: physical, psychological, social and spiritual well-being. Ferrens114 uses
similar domains of health and functioning, socioeconomic, psychological/spiritual and
family. Other researchers such as Cella and Tulsky101 use the domains of physical
concerns, functional ability, family well-being, emotional well-being, spirituality,
treatment satisfaction, future orientation, sexuality/intimacy, social functioning and
occupational functioning to describe QoL. Aaronson100 uses physical functioning,
disease symptoms and treatment side effects, psychological status, social functioning,
general health perceptions, physical suffering, self-care activities, outlook on life,
meaningful activities and social relationships to describe QoL. Measurement tools exist
that correspond to each of these researchers conceptualization of quality of life.102
These tools enable researchers to look specifically at the QoL of patients on both
individual group levels.103 The different domains examined by researchers demonstrate
the multidimensionality of the concept and the uniqueness of its conceptualization.
King and colleagues102 suggest that the concept of quality of life may be discipline
specific and concept analyses may need to take place in each discipline and then
compared in order to determine how the term is used across disciplines. In addition,
King and colleagues102 suggest that QoL is dynamic and changing. QoL should be
measured on a continuum as QoL at one time point may not predict QoL at subsequent
time points. The evaluation of QoL takes place in social context and is only reflective of
the appraiser’s cognitive view of their life at the time of the survey.104
The conceptual framework for this dissertation is based the Conceptual Model for
Quality of Life in Breast Cancer survivors (QoL-BC) that was developed by Ferrell and
colleagues in 1996. The QoL-BC model was adapted from previous conceptual models
developed by Ferrell and colleagues that had been used in cancer survivors.112 While
examining quality of life in long-term cancer survivors through the use of both
qualitative and quantitative methods, the researchers were able to identify aspects of
cancer that were specific to breast cancer survivors.111 This led to the development of
the Quality of Life-Breast Cancer instrument and the conceptual model for Quality of
Life in Breast Cancer survivors (QoL-BC).
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This conceptual model (QoL-BC) consists of quality of life interacting with and being
influenced by the domains of physical well-being, psychological well-being, social wellbeing and spiritual well-being (See below). Each domain has been defined by the
researchers and describes “concepts” or factors that influence the overall domain. The
definitions for the domains are as follows:
Quality of life: Quality of life is a personal sense of wellbeing which encompasses
physical, psychological, social and spiritual dimensions.108-110
Physical well-being: “The control or relief of symptoms and the maintenance of
function and
independence.”115
Psychological Well Being
Physical Well Being
Concepts within this
Usefulness
Nausea
domain include: nausea,
Happiness/Satisfaction
Constipation
Coping
Appetite
constipation, appetite
Control
Menstrual changes/Fertility
Anxiety/Depression
Sleep
changes, fertility and
Concentration/Memory
Aches/Pains
menstrual changes, sleep,
Pain
Fatigue
Fear of recurrence/tests
pain, and fatigue.
Overall perception of QOL
Psychological wellDistress of Diagnosis and Treatment
being: “Seeking a sense
QOL
of control in the face of
life threatening illness
Social Well Being
Spiritual Well Being
characterized by
Family distress
Hopefulness
Personal relationships
emotional distress,
Life Purpose
Support/Others
Positive/Spiritual Change
altered life priorities, and
Employment
Religious/Spiritual Activity
Home Activities
Uncertainty
fears of the unknown, as
Isolation
well as positive life
Financial Burden
Sexuality
changes”115 Concepts
within this domain
Original Quality of Life Model for Breast Cancer Survivors
include: fear of
recurrence and tests, usefulness, happiness and life satisfaction, coping, being in
control, anxiety, depression, cognitive changes, distress from treatment and an overall
perception of QoL.
Social well-being: “a way to view not only the cancer or its symptoms, but also the
person surrounding the tumor; it is the means by which we recognize people with
cancer, their roles, and relationships.”115 Concepts within this domain include: family
distress, personal relationships, support, employment and financial burden, sexuality,
isolation and activity at home.
Spiritual well-being: “the ability to maintain hope and derive meaning from the
cancer experience that is characterized by uncertainty. Spiritual well-being involves
issues of transcendence and is enhanced by one’s religion and other sources of spiritual
support.”115 Concepts within this domain include having hope, purpose in life,
uncertainty, and religious and spiritual changes/ activity.
The Quality of Life Model for Breast Cancer Survivors is a framework that is applied
to all women with breast cancer. At this time, it is unclear what concepts within each
domain are relevant to older women with breast cancer. This framework will be
modified for this dissertation. Future research may examine how this framework
directly applies to older women with breast cancer.
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Rationale for a Quality of Life Framework
Quality of life is a valid theoretical/conceptual framework for nursing to apply to
many populations including older women with breast cancer because it is a holistic
approach to assessing and evaluating the lives of these women after cancer.
Additionally, a quality of life framework fits this student’s interests and research
questions developed for the dissertation research.
Many of the strengths of a quality of life construct for older women with breast
cancer lie in its uses and are important for many reasons. First, with cancer now being
classified as a chronic illness, focus on outcomes of treatment has changed from
quantity of life to quality of life. Discomfort and disability due to treatments in a life
that may extend many more years is simply unacceptable. Quality of life is a selfreported measure that can compliment the clinically derived mortality rates used to
determine if treatments are appropriate in cancer care. In addition, research involving
quality of life in older women with breast cancer can impact the development of
treatment guidelines for this ever-growing population. Second, older women comprise
the largest group of women with breast cancer. Due to the lack of knowledge previously
mentioned concerning diagnosis and treatment in this population, quality of life in
clinical trials and other research is an important outcome to determine best practice for
these older women. Older women treated for their breast cancer will be surviving with
cancer and are at risk for long-term side effects. It is crucial that quality of life in these
women become a focus so they can live their lives independently and with as few side
effects as possible. Third, quality of life outcomes can provide a patient focused
perspective of QoL after treatment and help guide the development and effectiveness of
interventions designed to improve the lives of older women after treatment for breast
cancer.
The remainder of this literature review will focus on quality of life in cancer
survivorship using the domains established by Ferrell and colleagues.
Quality of Life in Cancer Survivorship
This review of the literature intends to provide the state of the science concerning
issues related to quality of life in older women surviving with early stage breast cancer.
An overview of quality of life issues will be provided and when available, information
specific to women age 65 and older will be discussed.
The literature that discusses quality of life (QoL) in older breast cancer survivors is
far from comprehensive. Many studies that examine QoL report the average age of the
participants as being near 50 years. 108, 111, 112, 116-122 Unfortunately, these data can not be
generalized to an older sample. Some studies have looked at differences between quality
of life in younger and older women and provide information in regards to women in
specific age groups.4, 5, 11, 116, 123-126 Other studies have focused specifically on older
women with breast cancer 6, 9, 127-134. Exclusion or lack of participation of older women
in clinical trials has led to a knowledge deficit in many areas regarding the older women
with breast cancer.
Overall Well-Being: Quality of life is often reported in relation to symptoms
being experienced by survivors compared to controls. For example: women who
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continue to experience symptoms such as fatigue and menopausal symptoms reported
poorer quality of life than non-cancer controls.135
Health-related quality of life (HRQoL) has also been compared to the general
population. Bardwell and colleagues136 noted that breast cancer survivors who averaged
2 years from diagnosis reported high health-related QoL that was comparable to
controls. Poor physical HRQoL was related to poor psychosocial functioning, poor sleep
quality, less physical activity and obesity. Poor mental HRQoL was related to poor sleep
quality, pain, gastrointestinal symptoms and more life events.
Arndt and colleagues137 also compared QoL of breast cancer survivors to controls
at 1 and 3 years post-diagnosis. At 3 years, the overall QoL in breast cancer survivors
was comparable to controls. Women with breast cancer reported slightly worse physical
functioning but larger deficits in role, emotional, social and cognitive functioning.
Symptoms that persisted at 3 years included fatigue, pain, insomnia and shortness of
breath. These symptoms were more severe in younger age groups.
Vinokur and colleagues138 examined physical and psychological functioning and
adjustment in breast cancer survivors. They were surprised to find that women with
early stage disease who had survived over 5 years show positive adjustment to disease.
Compared to controls without a history of breast cancer, they had the same levels of
physical functioning and reported similar psychological and social well-being as the
control group. Interestingly, these survivors rated their breast cancer experience as “a
little” stressful compared to non-cancer controls who rated their most stressful
condition to date as “somewhat” stressful. The researchers speculate that it is the low
severity of disease (early stage) that led to the excellent adjustment.
Additionally, how women with breast cancer perceive the side effect burden
affects quality of life. Longman, Braden and Mishel139 looked at psychological
adjustment, side effect burden and quality of life in breast cancer survivors over time.
The study demonstrated that negative feelings such as depression and anxiety persist
and are burdensome for survivors. This negatively impacts quality of life. This finding
was consistent at all time points in the study.
Vacek and colleagues12 also looked at factors that influenced quality of life in breast
cancer survivors. This study compared women treated for breast cancer with a group
that had benign breast biopsies. This study was conducted over time to ascertain trends.
Using the Quality of Well-Being Instrument, quality of life declined over time for the
breast cancer survivors. Presence of co-morbidity was related to significantly lower QoL
scores. Survivors who were married showed a slower decline in quality of life. Older
survivors had a more rapid decline in their quality of life scores.
On the contrary, Kenefick9 reported that older women have better global quality of
life scores than younger women and experience less symptom distress. Quality of life in
older women has been shown to improve over time as well.5, 9
Overcash140 conducted interviews with older women with breast cancer which
resulted in descriptive qualitative data reflecting quality of life in these women. Eight
major themes emerged: importance of God, importance of a positive attitude; no
alteration in lifestyle; physician trust; caregiver to others; need to protect family;
importance of health and importance of family. Additionally, many of the women who
participated in the study had active lives despite diagnosis and treatment. Overall,
women were able to maintain their activity level in spite of breast cancer and being ill at
120

times. This study emphasized that preconceived notions of older women being ill and
dependent are exaggerated as older women are able to keep up with their active lifestyle
despite having cancer.
Summary: Women of all ages diagnosed with breast cancer share common concerns
but also have unique needs. Due to the heterogeneity of women, age related differences
related to breast cancer occur from diagnosis into survivorship. Overall, QoL seems
positive. Sammarco141 states that every woman will adapt to breast cancer and make
choices based on their own personal history, psychosocial stage and current concerns
based on their stage in life. Survivors who are able to adjust to having cancer often have
comparable QoL to non-cancer peers. As a group, older women adjust well to breast
cancer and often report better QoL scores than younger women. However, those with
co-morbid illnesses may report lower QoL. Older women remain active after diagnosis
despite treatment and side effects and long-term effects.
Physical Well-being: Any cancer survivor may experience a wide range of
symptoms and side effects after diagnosis and treatment. Physical well-being is defined
as “the control or relief of symptoms and the maintenance of function and
independence.”115
Fatigue: Fatigue is one of the most frequently reported symptoms.4, 6, 9, 13, 109, 111, 120,
142-146 Fatigue has been noted to be a problem for breast cancer survivors both
immediately after treatment145 and over time.9, 111, 146, 147 Ferrell and colleagues111 studied
a group of cancer survivors an average of 6.6 years after diagnosis and noted that fatigue
was the top physical issue for these survivors. Servaes and colleagues146 also noted longterm fatigue in breast cancer survivors. In a sample of women who completed
treatment an average of 29 months previously, 38% stated they were severely fatigued.
Compared to survivors that did not have severe fatigue, these patients reported worse
physiological well-being, more functional impairment, more sleep concerns, lower
physical activity, poorer social support and social functioning. No association was made
between prior treatment received and current level of fatigue.
Fan and colleagues135 also noted fatigue in long term breast cancer survivors
compared to controls. Hormonal therapy had a small effect on fatigue levels. Women
taking hormonal therapy tended to be more fatigued at 2 years but this effect was not
statistically significant. In addition, an association was found between fatigue and the
severity of menopausal symptoms.
Fatigue has been shown to decrease over time. Fatigue has been reported as most
severe during treatment but decreases one year after treatment.147 Fatigue affects
overall quality of life and domains of quality of life. Using the Medical Outcomes Study
Short Form General Health Survey, Byar and colleagues147 noted that fatigue affected
the physical, social, bodily pain, mental, vitality and general health domains.
While looking at patterns of symptom distress in older women (mean age of 68
years) after surgical treatment for breast cancer, Kenefick9 noted fatigue to be a
persistent problem and the number one distressing symptom at each time point in the
study. Fatigue distress was measured after discharge and at 3 and 6 months. Fatigue
related distress did improve over time most notably from discharge to 6 months.
Fatigue was also repeatedly correlated with concentration over time.
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Pain: Pain is one of the most frequently reported symptoms. 5, 6, 9, 10, 13, 121, 133, 143 Pain
in breast cancer survivors can be due to surgery,148-150 lymphedema151 or co-morbid
conditions such as arthritis8, 133
Post-mastectomy pain (PMP) can be experienced by women with breast cancer well
into survivorship. MacDonald and colleagues150 examined women with chronic PMP
approximately 9 years after their surgery. Over half of their sample reported the
persistence of PMP. Younger women were particularly at risk. Women who
experienced PMP reported functional limitations and difficulty with activities of daily
living as well as lower quality of life scores. Pain can also be present in women who
receive lumpectomy and breast conservation therapy and in women who elect breast
reconstruction.148
In comparative studies, it has been noted that both younger and older women
experience pain124, but older women experience more pain.4, 5
Lymphedema: Lymphedema (LE) and arm symptoms are frequently reported side
effects of breast cancer treatment5, 10, 142, 143, 151-155 Women with any type of lymph node
removal are at risk for LE however, those who receive axillary lymph node dissection
experience more symptoms of LE than women with sentinel lymph node biopsies.
Symptoms may include: numbness and tingling, firmness or tightness in the arm and
larger arm size.155 Women with LE report frustration, anxiety, depression, changes in
role functioning, pain, disability and poor social support.156
Ridner153 found that women with lymphedema consistently scored lower on multiple
QoL instruments compared to women without LE. Symptoms associated with LE in this
group included: altered limb sensation, decreased physical activity, presence of fatigue,
psychological distress and loss of confidence in the body. Additionally, women’s
perception of limb size, not objective or measured limb size, influenced the experience
of having LE.
Armer and Fu151 have studied the occurrence of lymphedema (LE) in older breast
cancer survivors. Incidence of LE for older women was lower (31%) when compared to
incidence in younger women (41%). The difference in incidence may be due to less
extensive surgery in older women. Women with and without documented diagnoses of
lymphedema reported experiencing symptoms such as numbness, tenderness and
aching in the affected arm. Older women had a tendency to report these symptoms less
than younger women. With the projected number of older women that will be
diagnosed with breast cancer over the next several decades there is a risk for both
under-diagnosis and under-treatment of lymphedema in this growing population.152
Menopausal Symptoms: Symptoms of menopause have been reported as a concern
of women treated for breast cancer.135, 157-160 Fan and colleagues135 report that women
who received chemotherapy (n=104) experienced more menopausal symptoms than the
non-treated control group. In this sample, the use of hormonal therapy did not impact
menopausal symptoms. However, more women were treated for hot flashes as time
progressed.
Carpenter and Andrykowski158 also examined the presence and severity of
menopausal symptoms in breast cancer survivors and its impact on quality of life. The
most commonly reported and most severe symptoms were: joint pain, fatigue, trouble
sleeping and hot flashes/night sweats. Other symptoms reported were vaginal dryness
and painful sexual intercourse. The total number of symptoms was related to years in
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post-menopause. Women who experienced fewer years of menopause reported more
symptoms. Sixty percent of this sample reported 6 or more symptoms of menopause.
Additionally, the more symptoms a women experienced and higher the severity of
symptoms, the lower women rated their physical and emotional QoL.
The presence of menopausal symptoms in breast cancer survivors has been
compared to non-cancer controls and found to be similar in both groups.159, 160 Schultz
and colleagues160 concluded that breast cancer and menopause were 2 separate issues
and the menopausal symptoms women experienced may not have been breast cancer
related.
Hot flashes have also been noted in older breast cancer survivors.6 In a sample
consisting of women over the age of 65 with a history of breast cancer, hot flashes were
repeatedly named as one of the top ten symptoms experienced up to a year after
diagnosis. Out of 246 women, 3.3% ranked hot flashes as a concern.6
Weight gain: Weight gain and weight changes have been linked to developing breast
cancer161, 162 and to higher rates of recurrence and mortality in breast cancer.163, 164 Risk
factors of weight gain in breast cancer survivors include time since diagnosis, receipt of
adjuvant chemotherapy and high body mass index at time of diagnosis. Additionally,
women who did not exercise gained more weight.165
Weight gain has been a reported concern of breast cancer survivors.93, 162-169 Weight
gain can begin during chemotherapy167 and continue into survivorship as women take
endocrine therapy.93, 168, 170 McInnes and Knobf169 analyzed weight gain and QoL in
women who received adjuvant chemotherapy for early stage breast cancer. In their
sample, 78% had gained weight (average 9 lbs.) one year after treatment. Women
maintained this weight gain at 3 years. Greater weight gain was seen in pre-menopausal
women. Women who took Tamoxifen gained more weight than women who did not, but
this result was not statistically significant. Although, weight gain did not affect overall
QoL, women were distressed by the gain.
Weight gain has been noted as a problem in older breast cancer survivors. Heidrich
and colleagues8 reported that weight gain was one of the 10 most distressing symptoms
for older women after breast cancer however, none of the women in this sample
attributed their weight gain as being cancer related. Instead weight gain was attributed
to chronic illness or the aging process.
Insomnia: Insomnia and sleep disturbances have been examined in breast cancer
survivors. Disturbances in sleep often begin in treatment and persist into
survivorship.147, 171 Savard and colleagues171 conducted a randomized clinical trail to
evaluate the effectiveness of Cognitive Behavioral Therapy for insomnia in women with
breast cancer. Women who received the intervention reported better sleep than
controls. In addition, treated women also reported using less sleep medication, had
decreased anxiety and depression and better global QoL than the control group.
Women who report sleep disturbances also report more symptom distress. Pain,
fatigue, bowel problems, and lack of concentration were associated with insomnia.9
Older women were noted to experience sleep changes however the literature does not go
into great detail concerning this issue. 4, 6, 9, 172
Physical Functioning: Physical functioning in breast cancer survivors is usually
comparative and results vary widely. Schroevers and colleagues126 found that women of
any age with cancer experience difficulty with physical functioning. However, at 8 years
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after diagnosis, older cancer survivors were more likely to have more physical symptoms
and limitations than younger women. In addition, younger survivors were more likely
to appreciate themselves and believe that life was more fulfilling compared to older
survivors.126
In a study looking at physical functioning in older cancer survivors, Cimprich and
colleagues4 noted that older women report lower physical functioning compared to
middle aged women and men of different ages. Older women reported more problems
with fatigue, pain, constipation and sleep changes while younger women have more
problems with menstrual and fertility issues. The number of co-morbid illnesses also
correlated to lower physical functioning.
In a different study, Satariano and colleagues11 compared the functional status of
women with breast cancer (ages 55 to 84) to controls without breast cancer using the
Instrumental Activities of Daily Living (IADL) survey. The IADL evaluates
transportation, housekeeping, meal preparation and grocery shopping. Results showed
that women with cancer, ages 55 to 74, had the most problems with functioning
compared to controls within that age group. The oldest women in their sample (age 75
and older) reported the fewest functional problems compared to similar aged controls.
Breast cancer in the oldest age group was not associated with poorer functioning.
Interestingly, physical impairments and deficits in functioning were not always
perceived by older breast cancer survivors as being attributable to having breast cancer.
Aging and chronic illness were often reported as the cause of current symptoms.8
In a study that looked at quality of life in long-term breast cancer survivors, women
who were older at diagnosis reported worse physical functioning and more pain
compared to younger women at both 7 and 12 years from treatment. Older women also
noted more arm symptoms than younger women. However, global quality of life
increased for older women at 12 years.5
Wenzel and colleagues117 reported that older women reported more health problems
that were unrelated to their cancer and higher quality of life than younger women.
Summary: Physical problems are common in breast cancer survivors. Women
experience fatigue, pain, LE, insomnia, weight gain, menopausal symptoms and
decreases with physical functioning. Older women report that fatigue persists over time,
have more pain than younger women, fewer menopausal symptoms and more issues
with physical functioning. Age and chronic illness seem to be negatively associated with
physical functioning however the data on physical functioning has shown conflicting
results and may be sample specific.
Psychological Well-being: Psychological well-being is defined as “seeking a
sense of control in the face of life threatening illness characterized by emotional distress,
altered life priorities, and fears of the unknown, as well as positive life changes”115
Fear of Recurrence: Fear of recurrence is extremely common among breast cancer
survivors.10, 110, 111, 133, 143, 173, 174 In a study focusing on breast cancer and psychosocial
well-being in early stage breast cancer survivors, Spencer and colleagues174 report that
fear of recurrence is the number one concern of survivors. Ferrell and colleagues110
report that even though women fear recurrence, they are able to balance hope with these
fears. Women were hopeful that new treatments would be available if their cancer
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returned. Other fears such as fear of more treatment and instances of poor health have
also been described by survivors.175
While women with breast cancer share concerns with fear of recurrence,10, 143 older
women seem to have less fear.10 Older survivors may experience these fears many years
after diagnosis. Gil and colleagues 133 studied older women 5 to 11 years after treatment
and found that on average, older women have 1.8 experiences per month that trigger
feelings of uncertainty and fears of recurrence. The most common trigger was hearing
of some one else being diagnosed with cancer. Other triggers included: new aches and
pains or physical symptoms, information from the media and environmental factors
that remind the survivor of their experience. Uncertainty regarding breast cancer lasts
well into survivorship.
Cognitive changes: Cognitive changes have been reported as a problem for breast
cancer survivors4, 123, 135, 172 Cimprich and Ronis172 compared attention and symptom
distress in women with and without breast cancer. When comparing attention in these
groups at baseline, the breast cancer group had lower attentions scores than the control
group. At 3 months, the breast cancer group had gradually improved their attention
scores. However, loss of concentration was still a distressful symptom for breast cancer
survivors even though their overall attention scores had improved.172
Cognitive changes (loss of concentration) also occur in older breast cancer
survivors.123, 172 Cimprich123 stated that the normal processes of aging results in the
lowered ability of women to focus and concentrate. As a result, older women are more
at risk for attention fatigue after treatment for breast cancer. In this study, older women
had lower attention scores and lower attention performance over time compared to
younger women, Older women who received mastectomy were most affected by these
cognitive changes.
Depression: Depression impacts women with cancer in several ways. Badger and
colleagues176 specifically looked at the effect of depression burden and psychological
adjustment and quality of life in women with breast cancer over time. Women who
reported a higher level of depression burden at baseline experienced poor psychological
adjustment than women with low levels of depression burden. In addition, women with
high levels of depression reported lower overall quality of life. Women with high levels
of depression benefited from an intervention and were able to report improved quality
of life compared to women who did not receive an intervention.
Goodwin and colleagues166 looked at the effects of depression on diagnosis,
treatment and survival of older women with breast cancer. Results of their study
showed that women who had a diagnosis of depression prior to the diagnosis with breast
cancer were less likely to receive definitive treatment and had poorer survival rates. The
reasons for the poorer survival rates are unknown but may be due to adherence to
appropriate screenings and medical recommendations.
Effect of Symptom Distress: When studying the psychological well being of older
women with chronic illnesses (breast cancer or osteoarthritis) Heidrich7 found that
women with arthritis reported more symptoms and functional health problems than did
women with breast cancer. Women with arthritis also viewed their chronic illness as
more severe, less controllable and more chronic than women with breast cancer.
Women with arthritis were more bothered by symptoms and portrayed their physical
health more negatively than women with breast cancer. Women also compared
125

themselves with other women they knew and were able to make upward and downward
comparisons. These comparisons influenced psychological well-being.
When comparing older women with and without breast cancer Heidrich and
colleagues8 noted that both groups of women reported multiple symptoms but had low
levels of symptom distress. In addition, women with breast cancer rarely associated
their symptoms with breast cancer but instead attributed symptoms to aging and other
chronic illnesses. Women often rated the cause of their symptoms as unknown and this
correlated with poorer social functioning and mental health, less energy, lower
perception of purpose in life, and higher levels of depression and anxiety negatively
impacting quality of life.
Summary: Women with breast cancer often continue to fear recurrence, have
cognitive changes, depression and symptom distress. Older women seem to fear
recurrence less than younger women. Older women experience more cognitive changes
possibly due to the changes of aging. Depression has been linked to lower QoL in
women with breast cancer and with poorer survival rates in older women. Compared to
controls, older women with breast cancer seem to have better QoL than some women
with other chronic illnesses such as osteoporosis and often fail to associate “symptoms”
with their breast cancer, instead attributing symptoms to age and other chronic
illnesses.
Social Well-being: Social well-being is defined as “a way to view not only the
cancer or its symptoms, but also the person surrounding the tumor; it is the means by
which we recognize people with cancer, their roles, and relationships.”115
Thewes and colleagues143 compared the psychosocial needs of older and younger
breast cancer survivors and found that younger women had more unique needs.
Younger women were more concerned with their careers and had a greater number of
concerns about relationships, sex and fertility. Younger women were more likely to
want and seek out additional support from professionals than older women. Older
women discussed not wanting information about their treatment as a way lessening
anxiety. Finally, younger women spoke about feeling very isolated as a young woman
with breast cancer due to its rarity in women their age.
Body Image: The effects of breast cancer on body image have been reported in the
literature. Ganz and colleagues124 found that women who received breast conservation
treatment had significantly fewer problems with their body image compared to women
who received mastectomy or reconstruction. Pinto and Trunzo122 looked at body esteem
among breast cancer survivors. Women who exercised reported better body esteem and
better mood states (less confusion, fatigue, and depression and higher vigor) than
survivors who did not exercise.
Although King and colleagues10 reported that older women have better body image
than younger women, older women are still concerned about body image. Figueiredo
and colleagues128 found that body image was important for 31% of their sample (mean
age 74 years) when making treatment decisions. At 2 years after treatment, older
women who had breast conservation surgery had better body image than women who
received mastectomy. Additionally, women who wanted breast conservation treatment
and received mastectomy had the poorest body image. Other studies have also shown
that body image for the older woman improves over time.5
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Employment: Concerns regarding work and employment are most likely
experienced by younger breast cancer survivors due to their age. Maunsell and
colleagues177 used qualitative methods to explore work problems after breast cancer in a
small sample (n=13) of survivors. Several concerns emerged from the interviews.
Women worried about returning to work. Some feared not being able to perform the
tasks they did prior to treatment and others worried that the changes in their physical
appearance would cause co-workers to look closely at their bodies. Some women
experienced changes in their job that they did not ask for. Women were demoted, given
modified tasks or lost their jobs. Others felt their relationship with their boss and coworkers changed. Many women felt they had a decreased ability to do their jobs and
cited fatigue and arm problems as the cause. Work also became less of a priority after
treatment and returning to work. Bloom and colleagues178 also found that continuing to
work created conflicts for women. Due to fatigue, some women were too tired to work
during treatment. Some women found they had unsympathetic employers. Other
women quit their jobs and made a career change.
In other studies, women used the return to work to gain a sense of normalcy and to
relieve financial burdens incurred due to the breast cancer diagnosis.109
Generally, it has been shown that older women have less concern over employment,
work, and financial issues compared to younger women. 5, 27
Sexuality and Sexual Functioning: Ganz and colleagues124 examined sexual
functioning in breast cancer survivors. The majority of the sample was sexually active at
the time of their participation in the study (60%). The women at greatest risk for sexual
dysfunction were post-menopausal women under the age of 50 and those who received
chemotherapy. Tamoxifen was not noted to significantly contribute to sexual
dysfunction in breast cancer survivors over the age of 50.
Speer and colleagues130 also looked at sexual functioning in long-term (mean: 4.4
years) breast cancer survivors. Sexual functioning was not linked to type of treatment or
hormone levels but, sexual functioning was significantly poorer in survivors compared
to controls. Survivors who were depressed had lower levels of sexual desire and
survivors who had relationship distress reported poor arousal, lubrication, orgasm and
sexual satisfaction. In addition, survivors with poor body image also had low levels of
sexual satisfaction.
Information concerning the impact of breast cancer on sexuality in older women is
uncertain. Wyatt and Friedman13 report that sexual concerns were the highest reported
quality of life concern among midlife and older women. Cimprich and colleagues4
report that although breast cancer impacts sexuality, that impact is low in older women.
Spencer and colleagues174 also report that older women had less concern over sexual
issues and partner related concerns than younger women.
Relationships, Support and Social Functioning: The impact of breast cancer on
relationships has been reported. Holmberg and colleagues119 explored the impact of
breast cancer on relationships and found breast cancer caused both physical and
psychological changes in women impacted their relationships. Women felt shame,
undignified and embarrassed by the changes in their bodies and had difficulty looking at
themselves. Psychologically, they did not feel adequate in their role as woman or
partner. Women looked at themselves differently after breast cancer. Women also
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reported fatigue, vaginal dryness, loss of libido, and depression which they attributed to
their decrease in desire and sexual response.
Partners of the women with breast cancer expressed less concern over their partner’s
appearance but more concern over their partner’s survival. Partners also expressed
concern over reconstructive surgery fearing that it was an unnecessary operation or that
it might cause their wife more pain and discomfort.
Women without partners reported negative comments about their physical
appearance from prior partners and feared these responses from future partners. Unpartnered women also found that breast cancer did not strengthen their relationships
but may have hastened the demise of troubled relationships. Partnered women believed
cancer strengthened their relationships with their spouses.
The changes in how women viewed themselves affected their sexual relationships as
well as other relationships. Friendships sometimes changed as women found close
friends becoming more distant however, women were able to draw support from other
friends and new relationships. Variable responses from employers and co-workers were
discussed. Most women were supported, however some lost their jobs due to cancer
related side effects and time needed off from work.
Ganz and colleagues124 found that younger women encountered more difficulty in
relationships than older women. In addition, younger un-partnered women were very
concerned about dating issues such as telling a date about their cancer or beginning a
sexual relationship. 119, 124
It has been reported that older women have better social functioning compared to
younger women.10 134 Partners and adult children were found to be important sources of
support for women. Families that were able to adjust to the breast cancer predicted
better mental health (less depression and anxiety) for the cancer survivor.179 Older
women with limited social support were less satisfied with their lives180 Sammarco134
reported that older women who have better social support also rate their overall quality
of life as better. Social support was correlated with less disease related uncertainty.
Social support was also seen to lessen as women got older.
Summary: Women with breast cancer experience similar issues and concerns related
to body image, employment, sexuality, relationships and support. Older women seem as
concerned with body image and sexuality as younger women, but less concerned with
employment issues. Physical and psychological issues do impact relationships and
younger women who do not have partners experience anxiety over future relationships.
Older women report equal if not better support than younger women and this support
correlates to overall quality of life.
Spiritual Well-being: Spiritual well-being is defined as “the ability to maintain
hope and derive meaning from the cancer experience that is characterized by
uncertainty. Spiritual well-being involves issues of transcendence and is enhanced by
one’s religion and other sources of spiritual support.”115
Religion and spiritual beliefs: When exploring the impact of breast cancer on
spiritual well-being, Ferrell and colleagues110 found using formal religious practices and
having spiritual beliefs helped support women in survivorship. Women in their study
were concerned with uncertainty and hope and discussed how cancer altered their
priorities and life meaning.110 Cotton and colleagues181 also noted that having an active
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religious life was significantly associated with spiritual well-being. However, this study
noted no significant difference in QoL between women who did and did not actively
practice religion.
Women also discussed having a relationship with God and being able to rely on God
for support and guidance. The presence of God was felt by many women in their lives
and this made women feel supported. Women used activities such as prayer, either
their own prayers or prayers from others to help them cope with their illness.182
Spiritual well-being has also been examined in relation to symptom distress.
Manning-Walsh120 looked at psychospiritual well-being and symptom distress in cancer
survivors. Although symptom distress was reported as low by this sample, there was an
inverse relationship between symptom distress and psychological, spiritual, and
psychospiritual well-being. In addition, younger women had significantly lower
psychospiritual well-being compared to older women.
Manning-Walsh183 also examined spiritual struggle and its relation to quality of life.
Women who had greater spiritual struggles reported lower quality of life and lower life
satisfaction.
Fehring and colleagues184 examined spiritual well-being, religiosity, hope, depression
and mood states in older people with cancer. Being highly religious was found to be
positively related to hope, mood and spiritual well-being and negatively related to
depression and negative mood states. Older cancer survivors used religion and spiritual
beliefs to cope and keep life in perspective.
Feher and Maly127 also found that religion and spirituality helped older women to
cope. Women felt that their religious and spiritual faith helped give them the emotional
support they needed in order to cope with the breast cancer and make meaning in their
illness. Their faith gave them a sense of companionship and being taken care of. Faith
gave older women emotional support, helped them control fears, take comfort and have
a sense of well-being. Older women also used their connections to the church to keep a
social connection with others. Being associated with a church or religious community
allowed women to keep in touch with others through volunteer work and their
relationship with the leader of their church. Women also liked being prayed for by
others. Women felt protected, loved and unafraid due to the presence of God in their
lives.
Meaning: Meaning has been examined in several ways: meaning in life and meaning
in illness. Gall and Cornblat182 examined meaning in breast cancer survivors and found
that many women believed their cancer was serving a Divine purpose. Albaugh185 also
found that some women viewed breast cancer as a wake up call so they could find out
what was really important in their lives. Others thought God was asking something of
them. Some believed cancer was just a part of life and did not know why they got the
cancer, but life had meaning despite this. Meraviglia186 noted that meaning in life for
breast cancer survivors was positively related to psychological well-being and negatively
related to symptoms and physical well-being.
Utley131 looked at meaning in illness in older long-term breast cancer survivors.
Women were found to go through 3 distinct phases of meaning. The first phase viewed
cancer as sickness and then death. In this phase women talked about expecting to feel
sick if they had cancer and how their expectation did not correlate with how they really
felt. The second phase viewed cancer as an obstacle and something they had to get over.
129

In this phase they realized cancer was something they could live with. In the third
phase, cancer was viewed as transforming. Women realized that their lives had changes
and could see how cancer benefited them and their lives.
Through grounded theory, Crooks81 developed the theoretical model of Living Day
by Day in which older women went through several phases before coming to terms with
and finding meaning in their disease. Initially, women “faced the music” by finding out
about their diagnosis and taking action against it (treatment). “Getting back to normal”
after treatment was a considerable task for older women. In this phase, women
acknowledged the physical changes they experienced such as pain or the loss of a breast
and strategized to assimilate these changes into their lives. In addition, older women
were able to realize that having cancer changed how other people viewed them as
individuals. This caused older women to protect family members by downplaying their
own fears and concerns and sharing information about themselves with others in similar
situations or with those who were perceived as caring about their situation. “Getting
perspective” is the third phase in which older women sought perspective on both their
disease and life expectancy. Women made decisions for themselves based on their
analysis or perspective. Older women compared themselves to other women in similar
situations and with different illnesses to determine if their problems were more or less
significant compared to other women. Older women used this strategy to affirm that
their previous decisions were correct and to determine how much effort should be given
to concerns about the diagnosis and fears of recurrence. Finally, “being different than
before” was acknowledged by older women. Women became aware of the isolation or
aloneness caused by the diagnosis and the need for time to make sense of the changes
that have occurred. Older women also examined their belief systems and the important
things in life were stressed. Ultimately, this process of finding meaning in illness and
the outcomes and changes it caused allowed women to reach a different level of living in
which each day was lived to its fullest possible potential.
Summary: Women who are religious use their faith as a source of support during all
phases of cancer survivorship. Higher faith often correlated with lower distress.
Additionally, women often found meaning in their having breast cancer which led to a
purpose in life. Older women seemed to go through “stages” in order to find meaning in
illness and could often see the benefit cancer had brought to their lives.

RESEARCH METHODS

This section of the literature review discusses the methods to be used in this
dissertation research. This dissertation will be conducted using secondary analysis and
mixed methods.
Secondary Analysis: Conducting original research from existing data is
recognized as an important and legitimate method for conducting scientific inquiry.187189 Searches in national databases such as PubMed and CINHAL using the keywords
“secondary analysis” reveal over 6,000 research studies in several disciplines conducted
using secondary analysis. Recognizing the utility of sharing research data, the National
Institutes of Health (NIH) has implemented a policy concerning data sharing.190 The
purpose of data sharing is to help expedite “translation of research results into
knowledge, products, and procedures to improve human health.”
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Using pre-existing data is a rigorous undertaking that requires astute research
planning and data analysis.187 Pre-existing data can be used to answer questions other
than those of the original study. Answering questions developed during an original
study or that focus on a subset of a population are also appropriate uses.191 Existing
data can be combined with other data sets to more thoroughly investigate a problem.189,
192, 193 Using pre-existing databases is also a means to answer policy questions and
influence policy decisions concerning healthcare.192 Some researchers advocate pairing
data mining with secondary analysis in order to make new discoveries in patterns,
correlations and trends.192
Secondary analysis can be conducted from both quantitative and qualitative data.191,
194-196 Advantages to conducting research using existing data are numerous. A primary
advantage is resource savings. Conducting research using independent data collection
may not be feasible due to limitations in funding and resources.189 Using an existing
data set requires less research funding due to lower staff needs and less time needed to
conduct original research.189, 191 Research using pre-existing data eliminates the need for
a researcher to affiliate with a large organization in order to receive the support needed
to collect data from an adequate sample. Using a pre-existing data set eliminates data
collection problems and can be used with a variety of research designs.189, 196
Additionally, quality issues and threats to reliability and validity in large well-known
data sets are usually known by the primary researchers and documented. The length of
time it takes to report results is also shortened.192
Limitations of secondary analysis also exist. The researcher needs to remember
that the original data were collected for different purposes. The existing data set must
“fit” with the current research problem.187, 191 Methodological issues will exist if the
secondary study or studies that are being combined are not theoretically or conceptually
congruent with each other or the primary study.193 There may also be restraints on the
amount of creativity a secondary analysis may provide due to limited available
variables.189 Additionally, the quality of the data may be unknown.189 Missing data and
other inaccuracies may affect the outcome of further analysis.189, 191 It is important to
know how the data were collected and what limitations are present within the database
so the researcher can determine if the database is appropriate to use for their own
research purposes.192 Additionally, a historical bias may exist in the data. Outdated data
or changes in treatment patterns can impact the results of a secondary analysis and
threaten internal validity.191, 192 193
Other threats to reliability and validity involve the sample. In large data sets, the
sample may not be random.192 In addition, the desired population may be
underrepresented in the existing data set189 or fundamentally different when looking to
combine studies.193 Several issues regarding analysis are also discussed in the literature.
Samples in the larger databases may be weighted leading to inaccurate conclusions.
Researchers may need to seek advice concerning analytical approaches to evaluate their
research questions.188 Other disadvantages include the time frame to gaining access to
existing data, lack of existing data in a particular area of interest and a reluctance of
researchers to share their hard-earned data.189 Finally, not understanding the nuances
of the data being used in analysis can also be considered a weakness in secondary
analysis.51
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Summary: Secondary analysis is a rigorous undertaking that uses pre-existing data
sets in order to answer new research questions. Although limitations exist, this
student’s familiarity with the pre-existing data set is an advantage for the dissertation
research. In addition, the current research questions and conceptual framework fit well
with data collected in the parent study, the BCEI.
Mixed Methods: Mixed method design includes both quantitative and qualitative
methods in the research design and in data analysis.197-199 Using mixed methods can be
used to answer different types of research questions in one study.197 It can also be used
for a variety of research goals that include: developing instruments, explicating and
validating constructs, generating hypothesis, illustrating, clarifying or amplifying
analysis, understanding causal relationships and building, testing and refining theory.199
Triangulation has also been associated with mixed methods however, Williamson200
discusses triangulation as not being exclusive to mixing qualitative and quantitative
methods, but with combining 2 of “something” such as 2 different studies using the
same method or using 2 different researchers to collect and interpret data. For this
reason, the use of the word “triangulation” will be specifically avoided to limit confusion.
Much of the discussion concerning the use of mixed methods centers around the
possible incompatibility of paradigms each method is based in (see Table 5).201-205
However, since the paradigm debate is not the purpose of this literature review, the
controversy will be noted, but not discussed in detail. Recognizing this debate,
Giddings201 asserts that there is no need for methods (or researchers) to compete, but
researchers need to integrate and carry out multi-methodological studies that meet their
needs. Freshwater206 also supports mixed methods and states the goal is to find the best
approach to answer the research question.
Table 5: Differences between Quantitative and Qualitative Design207
Assumption
Ontologic (What is the
nature of reality?)
Epistemologic (How is
the researcher related to
subjects?)
Axiologic (What is the
role of values in inquiry?)
Methodologic (How is
the knowledge
obtained?)

Quantitative (Positivist)
Reality exists. Real world is driven by
natural causes
The researcher is independent from those
being researched

Qualitative (Naturalistic)
Reality is subjective and constructed by
individuals
The researcher interacts with research
subjects. Interactive process

Objectivity is the goal. Values and biases
are controlled
-Deductive
-Emphasizes discrete concepts

Subjectivity is desired. Values come into
play
-Inductive
-Emphasizes the entirety of a
phenomenon

-Results verify researchers “hunches”
-Fixed, tightly controlled design
-Emphasizes statistical analysis
-Aims to generalize findings
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-Results are grounded in subjects
experiences
-Flexible and context driven design
-Emphasizes narrative information
-Aims to find patterns in the data

Polit and Beck199 support the use of mixing methods for several reasons. First: the
mixed method approach is complementary in research because integrating multiple
methods can overcome weaknesses of using a single research design. Second: mixed
methods may enhance theoretical insights given that qualitative and quantitative
methods reflect different ways of viewing the world. Third: mixed methods may provide
an incremental approach in the research process in which
feedback loops are used to create a body of evidence. Fourth: mixed methods may
enhance validity of study findings. Cross validation can occur by using qualitative
methods to confirm quantitative results. Fifth: if results are incongruent, new research
ideas and questions can emerge.
Considerations for using mixed methods include: paradigm incompatibility, cost,
researcher training, analytical challenges and publication biases.199 As discussed,
researchers need to be aware of the paradigmatic differences between qualitative and
quantitative research. High cost and limited funding may prohibit the use of mixed
methods. Funding agencies may need to be educated on the benefits of this type of
research.199 Finally, the researcher or research team should have expertise in both
methods in order to be successful and be able to combine the data from both
methods.197, 199
Creswell and colleagues198, 208 acknowledge that using mixed methods is a rigorous
undertaking and several methodological decisions need to be made. Collecting the data
is only the first step in using mixed methods. Researchers need to state a logical reason
for wanting to use multiple methods. In addition, researchers need to determine when
to use these methods in their study: concurrently or sequentially. In a sequential
approach, one method acts a basis for the next method of data collection or analysis. In
a concurrent approach, all data are collected at the same time and combined for results.
When to integrate the data also needs to be decided.
The use of mixed methods has already contributed to nursing research. Ferrell and
colleagues108-113, 121, 209 combined both quantitative and qualitative methods throughout
the development of a series of Quality of Life Conceptual Models and empiric
measurement tools to examine quality of life in numerous groups of cancer survivors.
Cancer patients were asked about their experiences which led to the development of
conceptual frameworks and quality of life measurement tools. Subsequently,
quantitative data was used to develop cancer specific conceptual models such as the
Quality of Life- Breast Cancer conceptual model. Their work continually validated and
refined the content domains of both the models and empirical measurement tools.
Rees and Bath210 also have used mixed methods to examine information sources for
partners of women with breast cancer. Subjects were interviewed; data was transcribed
and interpreted by the researchers. Subsequently, subjects were given surveys to
complete; this quantitative data was then analyzed. Their qualitative findings were
supported by the quantitative data. According to the researchers, the use of mixed
methods created a “fuller picture” of the research topic than either method would have
achieved on their own. This study listed financial constraints as one of the limitations
which prohibited the use of more than one researcher in the data analysis phase.
Schulmeister and colleagues211 also used mixed methods to examine quality of life in
patients receiving autologous stem cell transplant in an outpatient facility. Telephone
interviews were conducted and patients were asked to complete a QoL survey. Results
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showed that QoL initially decreased in these patients but rebounded to at least pretreatment levels at 6 months. The researchers state that their use of mixed methods
gave them a greater understanding of the patient’s treatment experience which could
lead to appropriate individualized nursing interventions.
According to Zebrack,104 in order to capture the true essence of QoL in an individual,
using standardized quantitative instruments may not be enough. Methods that capture
the subjective experience are also needed. Powel and Clark212 also advocate for methods
that enable patient experiences to be captured more thoroughly. Allowing open ended
questions allows patients to tell their story and presents a more complete picture of the
experience for researchers.
This dissertation will use mixed methods in order to capture issues that could not be
captured on quantitative surveys. It is expect that older women surviving with breast
cancer also have other experiences that occur during this period of their lives that may
affect their quality of life. Qualitative analysis of field notes will aim to identify these
experiences.
Summary: Using mixed methods in research provides several advantages. Using
both quantitative and qualitative methods may give a fuller picture of quality of life in
older woman surviving with breast cancer.
Literature Review Summary: This review of literature supports the urgency for
research involving older women with cancer as our population ages and the number of
breast cancer diagnoses in women is expected to dramatically increase. It shows that
women with breast cancer are a heterogeneous group and women of different ages have
unique needs and concerns after being diagnosed with breast cancer that continue into
survivorship and affect quality of life. These differences are demonstrated in the often
sparse or conflicting information related to older women surviving with breast cancer
and the quality of their lives found in the literature. This literature review also supports
using secondary analysis for this dissertation and the benefit of using mixed methods in
the research design. Older women with breast cancer are not necessarily a more
important group than others. However, the paucity of research and empirically-based
understanding of how to best meet the needs of this group make the topic and
population a very important foci of study.51

Preliminary Studies
None

Dissertation Research Design and Methods

The overall purpose of this research is to examine quality of life in early stage breast
cancer survivors, age 65 and older, who are within the first year of survivorship. This
student’s dissertation research will use a descriptive design for analysis using mixed
methods. Data will be drawn from a pre-existing data set, the Breast Cancer Education
Intervention (BCEI) and will focus on the subset of older women (age 65 and older)
surviving with breast cancer. Please see the letter of permission from the BCEI Principal
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Investigator (Appendix A). The quantitative analysis of surveys and qualitative analysis
of field notes will be used to answer the research questions. Assumptions that will be
the basis for this study stem from the literature review and include:
1. Risk for breast cancer increases with age
2. Older women may develop co-morbid illnesses as they age and cancer may not
be their first illness
3. Survivorship begins once a woman is diagnosed with cancer, however many
people view “survivorship” as beginning after treatment
4. The path from cancer screening to survivorship is variable in older women and
this can impact quality of life in survivorship
5. Survivorship is a complex time in which women with cancer may experience
physical and psychosocial late effects from illness
6. Women of different ages may have unique needs- older women are no
exception
7. Changes in well-being may constantly fluctuate depending on a woman’s
current situation or experiences and this influences quality of life
8. Older breast cancer survivors eventually adapt to having had breast cancer
9. Quality of life related to having breast cancer influences quality of life of the
aging woman which continues in survivorship
The Parent Study- The Breast Cancer Education Intervention (BCEI): The
parent study conducted by Dr. Karen Dow and colleagues established the effectiveness
of the Breast Cancer Education Intervention (BCEI) in improving the QoL in early stage
breast cancer survivors.213 This study used a randomized, two-group, longitudinal
experimental design. A total of 261 subjects enrolled and 256 completed the study.
Subject Enrollment: Subjects were recruited through several means. Most subjects were
referred from local cancer centers and community oncology offices. A small number of
subjects were self-referred to the study. A total of 261 women were enrolled into the
study. Four women in the experimental group withdrew from the study during the
study intervention, one subject in the waiting control group died prior to receiving the
intervention due to causes unrelated to the study. Inclusion/Exclusion criteria:
Eligibility was based on the following criteria: female age 21 or older; histologically
confirmed early stage breast cancer (Stage 0-II) with no evidence of a second primary
cancer or metastatic and recurrent disease; completion of treatment for their early stage
breast cancer with the exception of hormonal treatments such as Tamoxifen or Arimidex
and anti-HER2 therapy; live within 50 miles of their referring cancer center and be
willing and able to participate in the BCEI. Intervention description: Experimental
subjects (EX) received 3 face to face Education and Support sessions, reinforcing
written and audio materials followed by both telephone and face to face follow-up
support sessions. The Waiting Control (WC) group received 4 attention control
telephone calls, 1 to 3 face to face Education and Support Sessions, reinforcing written
and audio materials and 1 face to face follow-up support session. The domains of
interest for this study included overall quality of life, physical, psychological, social and
spiritual well-being, mood and pain. Sample characteristics: The mean age was 54.4
years (sd 11.58). Eighty two percent of the subjects were Caucasian, 8.8% African135

American/Black, 5.7% were Hispanic and 3.5 % were Asian, Middle Eastern or Native
American. English was the primary language (94.6%) followed by Spanish (3.8%). The
majority of subjects were either married or living with a partner (68.2%). Sixty two
percent were employed either full or part-time and 55% had an annual income of
$50,000 or more. 47.5% were college educated. 60.5% of subjects received a
lumpectomy, 69.3% received radiation therapy, 54% received combination
chemotherapy, and 75.5% were on hormonal therapy. No significant differences were
noted between groups except the WC group had statistically higher college education
(p<.05) compared to the EX group.
Dissertation Aims and Research Questions
Aim #1: Describe the overall quality of life of female breast cancer survivors age 65 or
older.
Research Question #1.1: What is the QoL of older breast cancer survivors at
baseline?
Research Question #1.2: How does QoL change over time?
Research Question #1.3: How does QoL compare between groups over time?
Aim #2: Describe quality of life within the domains of physical, psychological, social
and spiritual well-being in female breast cancer survivors age 65 or older.
Research Question 2.1: What is the QoL of older breast cancer survivors within the
domains of physical, psychological, social and spiritual well-being at baseline?
Research Question # 2.2: How does QoL within these domains change over time?
Research Question # 2.3: How does QoL with these domains compare between
groups over time?
Aim #3: Describe additional life experiences that may relate to quality of life in female
breast cancer survivors age 65 and older.
Research Question #3.1: Describe other life experiences of older breast cancer
survivors as described by research nurses.
Research Question #3.2: Describe the types of medication used by older breast
cancer survivors age 65 and older.
Conceptual Model and Framework
Conceptual models form a context for most studies, including those directed
toward nursing.214 According to Polit and Beck214, conceptual models are more loosely
constructed than theories but provide a “perspective regarding interrelated
phenomenon” (p.116) A conceptual model presents a “broad understanding of the
phenomenon of interest and reflects the assumptions and philosophic views of the
model’s designer (p.116). Conceptual models are often accompanied by a visual
framework to illustrate the conceptual linkages. Fawcett215 states that the distinction
between a theory and a conceptual model is the level of abstraction. Conceptual models
are more abstract than a theory. Conceptual models also provide general guidelines for
researchers to follow. A model specifies a phenomenon by “identifying relevant
concepts and by describing the connections among them” (p.88). In addition,
conceptual models can evolve either intuitively or deductively.
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The Conceptual Model of Quality of Life in Aging Breast Cancer Survivors (see
below) is intuitively developed and based on the experience of the investigator and the
Quality of Life Model in Breast Cancer Survivors developed by Ferrell and colleagues.
The new model maintains that quality
of life is a personal sense of wellbeing which encompasses physical, psychological, social
and spiritual dimensions.108-110 The literature review for this dissertation and the
investigator’s own clinical and research experiences form the basis for the assumptions
for this conceptual model.

Older
Woman

Agi

ng

Breast
Cancer

Physical
Well being

QoL in
survivorship

Psych.
Social
Well being Well being
Spiritual
Well being

Conceptual Model of Quality of Life in Aging Breast Cancer Survivors
When an older woman is diagnosed with breast cancer several things influence how
they will perceive their quality of life in survivorship. This includes both aging and the
domains of physical, psychological, social and spiritual well being. Changes in the
domains of well being may occur and continue to influence quality of life in
survivorship.
The assumptions for this model include:
1. Quality of life is multi-dimensional, subjective and dynamic
2. The domains of quality of life are interactive with each other and one concept
within a domain often influences another domain
3. Aging influences perception of quality of life in survivorship
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4. Perception of physical, psychological, social and spiritual well-being influences
QoL in survivorship
Although Ferrell and colleagues have defined and described the domains of physical,
psychological, social and spiritual well-being in their conceptual model, this new model
of Quality of Life in Aging Breast Cancer Survivors does not include the concepts within
each domain. For example, the physical domain includes concepts of fertility and
menstrual issues which may not affect older women with breast cancer. It is unclear if
the concepts within the domains of well-being set forth by Ferrell and colleagues apply
to an older population of women surviving with breast cancer.
Sample Size
This dissertation
Table 6: Effect Sizes for Overall QoL, Physical, Psychological, Social, and
research will be
Spiritual well-being213
conducted using a pre3rd Month-baseline
6th Month-baseline
existing data set to study
WC
EX
Effect
WC
EX
Effect
Size
Size
a specific population of
Overall
QoL
0.313
0.209
older women surviving
mean
0.042
-0.309
-0.162
-0.405
with breast cancer. The
s.d.
0.752
0.834
0.765
0.879
original BCEI obtained a
sample of 261 women who were randomly selected to be in an Experimental (EX) group
or a Wait Control (WC) group. Randomization was paired and 129 women were placed
in the EX group and 132 in the WC group. For example, when one woman was placed in
the EX group- her “pair” was automatically assigned to the WC group. The groups are
not exactly equal because women were randomized primarily due to age and race and
sampling was not purposeful in order to achieve the same number of women for age or
racial groups. Women over the age of 65 were included in the randomization process
and will become the sample of “older women” for this dissertation resulting in a
convenience sample of 50 older women consisting of 24 EX subjects and 26 Wait
Control subjects. None of the women lived in a nursing home, all were community
dwelling.
Effect size was calculated during data analysis of the BCEI and indicated a small
effect at both 3 and 6 months of the study (See Table 6).213
Data Collection Procedures
This dissertation will use the data set of the BCEI experimental research study.
The Principal Investigator (PI) for the BCEI was contacted about sharing the data
collected during the BCEI. After discussion concerning the importance/relevance of
studying the sub-population of older women- women age 65 and older (n=50) with
breast cancer, the PI consented to share the de-identified data pertaining to women age
65 and older with this doctoral student. This student was involved in the BCEI as the
Project Director and has first hand knowledge concerning data collection, entry and
cleaning.
Data was collected during face to face and telephone interviews using a paper and
pencil format. Subjects recorded their own answers on the surveys. Research Nurses
and an Administrative Assistant double checked all forms for missing data prior to data
entry. If missing items were identified, the subject was immediately contacted for the
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information. All raw collected data was kept in a locked file cabinet in the UCF BCEI
research office.
Data was entered into SPSS v11 and v12 by graduate research assistants as the data
became available. Several of the surveys (Demographics, POMS, BPI, QoL-BC) were
double-checked for accuracy by another research assistant who did not do the original
entry. Initial data check included checking 25% of the data. This number was adjusted
based on the findings. If an unacceptable number of errors were found, an additional
percentage of the sample was checked for errors. If the error rate was acceptable, fewer
subjects were double-checked. Initially a data accuracy threshold was set at 95%
however, due to the volume of data points per patient this could have resulted in
accepting an unacceptable high number of actual errors. The criterion for accuracy was
subsequently changed to 99%.216
Due to the complexity and clinical interpretation needed for some forms such as the
BCEI Finances Form, a Research Nurse completed 100% data-checks on this dataset
and completed the primary data entry for questions which involved qualitative answers
concerning current medications and out of pocket costs for those medications. Another
RN subsequently double-checked this data as well. Overall, data was found to be over
0.99% accurate.
Data cleaning took place once all data was collected and entered. Initially, the data
files were constructed by a designee of the study statistician. These files were not
descriptively labeled and were recoded during the initial data cleaning stage so variables
represented the questions being asked of the subjects. Data consists mostly of discrete,
categorical and dichotomous variables. Descriptive frequencies were run on all data
files to find missing data, outliers and problematic data. Only .02% of the data was
missing. Outliers and extreme values exist on some surveys which asked for qualitative
data such as current medications and cost of the medications. Extreme cost-related
values were noted on the BCEI Finances Form however this data is not needed for this
dissertation. Nonsensical data was noted and corrected by referencing the original raw
data.
Data files were labeled according to the data collection instruments used. Large data
sets were separated into subscales so each subscale has its own data file. For example,
The Quality of Life- Breast Cancer instrument was divided into 4 files according to the
subscales of physical, psychological, social and spiritual well-being. 10 quantitative files
will be used and are listed as follows: Demographics (1), POMS (1), BPI (1), QOL-BR
(4), and BCEI Finances Form (3).
Field notes written by the research nurses will also be used in data analysis but were
not part of the initial data cleaning process.
Data Collection Instruments (see Appendix B)
BCEI Demographics Tool: Demographic information is important to describe the
sample. Information concerning age, religion, marital status, income, occupation, and
treatment variables were collected.
The BCEI Demographic Tool has 17 items that include both closed (n=14) and open
(n=3) ended questions. Several closed ended questions also include an opportunity for
an “other” answer in which subjects could state an answer if none of the given answers
were acceptable. This was included in items asking about ethnicity, primary language,
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religious affiliation, specific chemotherapy, hormonal and fatigue related drugs. Open
ended questions were for age, occupation and describing other cancers the subject may
have had in the past.
Profile of Mood States-Short Form: The Profile of Mood States- Short Form
(POMS-SF) was used in the BCEI to measure mood disturbance. The POMS- SF
contains 37 items and asks subjects to rate how certain descriptive words such as
“fatigued”, “hopeless”, and “furious” describe them at the present time. Subjects were
asked to think about the past week (present time) and state if the given descriptive
words describes them on a scale of “0- not at all” to “4- extremely well”.
Both the original Profile of Mood States (POMS) and the POMS-SF have been used
in cancer patients. Normative data for both forms has been reported.217-222 The POMS
was developed by McNair and colleagues220 to identify and measure transient and
fluctuating mood states. The POMS has been translated into several languages and is
used in multiple populations. There are six factorially-derived mood states. These
include: tension-anxiety; depression-dejection; anger-hostility; vigor-activity; fatigueinertia; and confusion-bewilderment. Normative data for the original POMS was based
on 235 normal college students and 1000 outpatient psychiatric patients.220 No further
information is available. Internal consistencies for this scale range from .84 to .95
among the 6 factors. Test-retest reliability ranged from .65 to .74 among the 6 factors.
Concurrent validity was supported by comparisons with normative samples for the
MMPI-2 and the Hopkins Symptom Distress Scale.
Cassileth and colleagues218 used family members of cancer patients as the normative
sample in their study. Although total scores for the POMS can range from -32 to +200,
scores can be reported as mean scores. Higher scores mean greater disturbance in
mood. In these samples, mean scores for patients were 20.1 and mean scores for family
members was 14.5. The researcher’s state that this contrasts sharply with the norms
reported by McNair in the POMS manual in which mean scores of college students were
43.3 and mean scores for psychiatric patients was 77.5. These researchers believe it is
important to evaluate cancer patients against more normative norms such as general
populations instead of extreme populations.
A short form (POMS-SF) was developed by Shacham221 and norm referenced in
cancer patients with pain. The short form contains 37 items. Each of the original
subscales was shortened by 2 to 7 items and internal consistency was retained.
Cronbach’s alphas ranged from 0.80 to 0.91 for the subscales on the new short form.
The short form also had high correlation to the original form (all reliability coefficients
above r=.95).
Baker and colleagues217 also psychometrically evaluated the POMS-SF in 428 cancer
patients waiting for bone marrow transplantation. Reliability analysis showed
Cronbach’s alpha of .78 to .91 among the 6 subscales.217 This compared favorably to the
Cronbach’s alpha’s reported by Shacham (.80 to .91 among the 6 subscales). Convergent
and discriminate validity was also shown through patterns of correlations between the
subscales and other well known measures such as the CES-D. Confirmatory factor
analysis supported the 6 factors for the POMS items. 217 These researchers concluded
the POMS-SF developed by Shacham was an acceptable alternative to the original 65
item form.
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DiLorenzo and colleagues219 compared the POMS and the POMS-SF in a sample of
breast cancer patient undergoing chemotherapy compared to a group of healthy women.
Again, the POMS-SF highly correlated to the full-length POMS (range: r= .93 to .99). In
addition internal consistency was similar to the full-length POMS for both the breast
cancer and healthy groups. Cronbach’s alpha’s ranged from .73 to .97 in the healthy
group and from .62 to .93 in the breast cancer group.
Finally, the POMS-SF was used in the BCEI and the Cronbach’s alpha ranged
between 0.95 and 0.99 for this scale213 (see Table 7).
The POMS is a very easy form to complete. One limitation is that subjects may not
be familiar with all the descriptive words they are asked to describe themselves with.
Words such as “peeved” and “weary” may be difficult to score if subjects do not know
how to define these words in order to determine if they describe how they are feeling.223
BCEI Brief Pain Inventory: Pain was measured in the BCEI using a modified
version of the Brief Pain Inventory (BPI). The BPI is a well established pain measure
(originally known as the Wisconsin Brief Pain Questionnaire) that evaluates the
intensity of pain and how it interferes in the life of the person experiencing it. Pain
relief is also addressed. The patient is asked to think about the last 24 hours when
answering the questions. The 14 items used in the BCEI asks subjects if they are
currently having pain related to their cancer (yes/no), the intensity of the pain (0-10
scale), treatments/medications they currently take for their pain and how pain
interfered with everyday activities such as walking, enjoyment of life, and everyday
activities (0-no interference, 10-extreme interference). Demographic questions and
diagrams for describing pain were eliminated in the modified version. Questions that
asked patients to “check” adjectives to describe their pain and reasons for pain were also
eliminated
The original BPI was specifically designed for use in people with cancer and other
diseases. The original survey has 23 items.224 Reliability was assessed using test-retest
with 2 samples. Reliability was higher when the interval between completing the
surveys was short (range of r= 0.59 to 0.93). Validity was supported by correlating the
amount of medications taken to higher pain ratings.225
The BPI has been used to address pain specifically in breast cancer survivors after
surgery226 and in other patients with cancer pain.227-229 Tittle and colleagues229
validated the BPI for use with surgical patients with cancer. In a mixed sample of
surgical and medical patients (n-388), the BPI correlated with the Visual Analogue Scale
for both populations (range r=0.71 to 0.73). Alpha coefficients for reliability were high
for both groups (r= 0.95 for medical group and r= 0.97 for the surgical group.229
The BPI has good test-retest reliability over short intervals.224 Cleeland states that
using the BPI may reduce response bias,224 however, bias may occur in samples of older
women because older women may not want to “complain” about their pain for fear of
being prescribed pain medication.
The Cronbach’s alpha for subjects using this form in the BCEI was -0.85 to 0.95213
(see Table 7).
A limitation to using the modified BPI with an older sample of women with breast
cancer is that the questionnaire is specific to cancer pain and does not allow the woman
to identify the source of pain. Many older women may experience pain for reasons other
than cancer. This could not be captured on the modified BPI.223
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Quality of Life- Breast Cancer: The Quality of Life Instrument- Breast Cancer
(QoL-BC) version is a 50 item scale that specifically measures quality of life in women
with breast cancer based on a conceptual model of quality of life in breast cancer
survivors using the domains of physical, psychological, social and spiritual well-being.108
It was adapted from the Quality of Life-Cancer Survivors (QoL-CS) scale. Subjects are
asked to use a scale from 0 to 10 to describe current problems and levels of distress
within the domains of quality of life. For example: “To what extent is fatigue a problem
for you?” 0=no problem, 10= severe problem, and “How much anxiety do you have?”
0= none at all, 10= a great deal. Questions also address having hope and perception of
positive changes due to cancer. Patient were asked to think about the last week or so
(the present time) before answering.
Reliability was established on the original QoL-CS using test-retest and internal
consistency measures. Test-retest reliability was r=0.89. Overall reliability was
established with a Cronbach’s alpha of 0.93. Alpha coefficients for the subscales were
acceptable at: physical well-being 0.77, psychological well-being 0.89, Social well-being
0.81 and spiritual well-being 0.71.108
Reliability for the QoL-BC scale was established in the BCEI. Cronbach’s alpha’s
were 0.99 for overall QoL, 0.99 for physical subscale, 0.93 to 0.99 for psychological
subscale, 0.71 to 0.99 for social subscale and 0.70 to 0.99 for the spiritual subscale213
(see Table 7).
Content validity was supported by using expert nurses and quality of life
researchers to review the tool. Pearson’s correlations were also used to gauge the tool
compared to the already established FACT-G tool. Correlation was high in the subscales
for physical, psychological and social well being.108
One limitation to this form is that although it has been successfully used in
populations that include older women, it is uncertain to what extent the components of
each domain (physical, psychological, social and spiritual) represent concerns of older
(over age 65) women with breast cancer. Domains such as physical functioning are not
represented in this measurement and issues such as fertility and menstrual changes may
not apply.
Another limitation to the tool is that some questions ask about change, but do not
ask if the item has changed for the better or worse. For example, one question asks
“How much has your spiritual life changes as a result of your diagnosis?” and asks the
subject to rate from 0= no change to 10= a great deal. Another questions asks “Has your
illness or treatment caused changes in your self concept (the way you see yourself)?” but
again does not allow the subject to state if these changes were positive or negative.223
BCEI Finances Form: A Finances Form, based on a measurement by Given, Given
and Stommel,230 focuses on the financial burden of the woman with cancer and her
family due to cancer related expenses. Forty four questions ask subjects to report
information on insurance, time off from work, out of pocket costs for breast cancer
related expenses are collected and actions such as selling a house or filing for
bankruptcy they have had to do in order to cover breast cancer related expenses.
Information concerning out of pocket costs for prescription and over the counter
medications is also collected. Subjects are asked first to answer questions based on their
expenses since diagnosis, but in M3 and M6, they are asked only to report new expenses
and experiences.
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In the 1994 study by Given, Given and Stommel230, family and patient out of pocket
costs are evaluated for women with breast cancer. Either patients or caregivers of
deceased patients were interviewed. Patients and family members were asked to report
expenses that were non-reimbursable for the 3 months prior to the interview. In
addition, family labor costs based on the number of hours caregivers spent giving care
were calculated. Researchers then estimated the cost of care.
No evidence of psychometric evaluation, reliability or validity can be found in the
literature. This information seems to have been garnered from interviews and an
original survey instrument for reporting finances does not seem to exist. The reliability
measures for the BCEI Finances Form ranged from Cronbach’s alpha .45 to .86213 (see
Table 7).
Table 7: Reliability Measurement for BCEI tools213
Variables
Measurement Tool

Limitations to this tool
used in the BCEI exist.
This tool requires recall of
Overall Quality of Life
QoL-BC total score
dollar amounts for specific
Physical Well-being
QoL-BC Physical
items which may be
subscale score
difficult to remember. In
Psychological Well-being QoL-BC Psych subscale .93-.99
the parent study, many
Social Well-Being
QoL-BC Social subscale
.71-.99
women had difficulty
items
estimating the amount of
Spiritual Well-Being
QoL-BC Spiritual subscale .70-.99
money spent per month on
breast cancer related costs.
Reasons for poor recall
Psychological distress
POMS
.95-.99
included buying
Pain
BPI
.-85-.91
medications in bulk or
infrequently, using credit
Finances/
Work, Finances,
.45-.86
cards, ordering by mail or
Medications
Insurance Tool
having husbands who
tended the finances. In future studies, this information could be captured differently. If
determining financial burden and not actual out of pocket costs is the goal, the form can
be simplified to replace the reporting of out of pocket costs for each breast cancer
related item with subjective questions regarding the subjects perception of overall
financial burden. An estimation of out of pocket costs can also be garnered by asking for
a “ballpark” figure as opposed to exact amounts.223
Cronbach’s
Alpha
.93
.99

Data Management and Integrity
Once this study gains IRB approval, this doctoral student will obtain de-identified
data from the Principal Investigator. De-identified data is data that is anonymous and
does not contain information that can identify a subject. This is important to maintain
the privacy of the subjects in the BCEI. This de-identified data will include SPSS files
for the Demographic, POMS-SF, BPI, QoL-BC and BCEI Finances Form surveys and
field notes in the form of Word documents/files. A copy of the SPSS data files will be
downloaded onto single read-only CDs so data can not be overwritten. Data will then be
transferred and stored on the student’s home computer and the “master copy” will be
placed in a fire-proof safe in the student’s home. Data analysis will take place only on
143

the student’s computer. A back-up copy of the working SPSS files will be placed on a
portable “jump” drive and stored in the fire-proof safe. Password protected files will
also be used.
Field notes in the form of Word documents will also be copied and placed on readonly CD’s. These files will be downloaded onto the student’s home computer for
analysis in Ethnograph- a qualitative software program. Back-up copies of the working
files will also be kept on a portable jump drive and stored in a fire-proof safe.
Files will be backed-up each time a new file is created or a current file altered.

Data Analysis Plan
The overall purpose of this research is to examine quality of life in a group of early
stage breast cancer survivors, age 65 and older, who have recently completed treatment
for their cancer. This student’s dissertation research will use a descriptive design for
analysis using mixed methods. Data will be drawn from a pre-existing data set, the
Breast Cancer Education Intervention (BCEI) and will focus on the subset of older
women (age 65 and older) with early stage breast cancer. Quantitative analysis of
surveys and qualitative descriptive and content analysis of field notes will be used to
answer the research questions. The main research variables are listed in Table 8.
Table 8: Main Research Variables and Data Source
Pre-analysis data screening:
Main Research Variables
Data Source
Data will be screening to assess
Overall
QoL
QoL- BC
accuracy, missing data, outliers,
Physical Well-being
QoL- BC subscale
and assumptions of fit
Fatigue
POMS subscale
(normality, linearity and
Pain
BPI
homoscedasticity).
Psychological Well-being
QoL- BC subscale
Data accuracy, missing
Psychological Distress
POMS subscale
data and outliers: Data will be
Social Well-being
QoL- BC subscale
examined using descriptive
Spiritual Well-being
QoL- BC subscale
statistics. Frequencies will be run Current Life Experiences
Field Notes
on all
variables to evaluate
Medications
BCEI Finance Form
completeness of the data. The
original BCEI reported a missing data rate of 0.2%, so missing data is not expected to be
an issue. Outliers are also not expected to be an issue since the surveys used had very
few open ended questions or those questions that contained open ended answers such
as financial data are not included in the research questions and will not be considered
for data analysis.
Assumptions of fit: Data will be explored to consider normality, linearity and
homoscedasticity. Descriptive statistics will be run. Normality will be examined using
histograms, normality plots and the Kolmogorov-Smirnov test. Homoscedasticity
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(homogeneity of variance) will be evaluated when comparing groups using Levene’s test
for equal variances.
Reliability analysis: Reliability of the measures used in this sample of older women
with breast cancer will be evaluated using Cronbach’s alpha. Cronbach’s alpha is a
measure of internal consistency and indicates if an instrument is measuring one or more
traits. The range for this measure is between .00 and 1.00 with higher scores indicating
higher internal consistency.231 SPSS software will be used to calculate Cronbach’s
alpha. Each instrument will be assessed as a whole for internal consistency.
Additionally, tools such as the QoL-BC tool will be assessed for consistency within each
subscale.
Power Analysis: The power of a statistical test indicated the “probability that it will
yield statistically significant results (p.1).232 Power analysis is a method to reduce the
risk and estimate the occurrence of Type II errors (accepting a false null hypothesis).
The 4 components of power analysis are: 1) significance criterion (α); 2) the sample size;
effect size (γ) and power (1-β).233 For this dissertation, several of these components are
known. The significance criteria which signifies the probability of rejecting a true null
hypothesis (Type I error) is set at α = 0.05. This means that in a sample of 100, the null
hypothesis would be rejected 5 times when it is true. The sample size is N=50, with
Ex= 24 and WC = 26. Although an effect size can not be calculated for this dissertation
at this time, the effect size for the BCEI was .313 at 3 months. It is expected that the
effect size for the sample of older women used in this dissertation study will be different
from that found in the BCEI. Since a premise of this study is that women of different
ages have unique needs, the probable difference in effect size may be due to the overall
samples used in each study. The BCEI had a large sample consisting of 261 women ages
28 to 83. This dissertation will focus on a specific subset of women (N=50) ages 65 to
83. The effect size is likely to change based on the overall differences inherent to each
sample which may include perception of quality of life and report of symptoms. Older
women (age 65 and older) are likely to be different from younger women or a sample of
women who average age is approximately 54 years old. Once an effect size for the
dissertation study can be calculated, a power analysis will be conducted during the data
analysis phase of the proposed research.
Data analysis of specific research questions: Analysis of the research questions
will be conducted using parametric and non-parametric statistics (See Table 9).
Demographics: Demographics contain nominal data and will be evaluated using
descriptive statistics and frequencies for the overall sample and the 2 groups (EX and
WC). Comparisons between the EX group and WC group will be done using Chi Square
test.
Research Questions: The measurement tools contain both ordinal and interval data.
Aim #1: Describe the overall quality of life of female breast cancer survivors age 65 or
older.
Research Question #1.1: What is the QoL of older breast cancer survivors at
baseline?
Research Question #1.2: How does QoL change over time?
Research Question #1.3: How does QoL compare between groups over time?
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1.1

1.2

1.3

The goal of this research question is to describe how older women with breast
cancer report their quality of life after being treated for early stage breast cancer.
The global measure of QoL contained in the QOL-BC tool will be averaged (mean
score) at M1 to determine overall QoL for the sample. Score range will also be
determined.
This research question will describe how overall QoL changes over time. The
entire sample will be examined as a group and QoL scores at M3 and M6 will be
compared to baseline. Paired t- tests will be used to compare baseline QoL
scores to QoL scores at M3 and M6. If needed, non-parametric statistics may be
used such as the Wilcoxon signed-rank test.
This research question will describe how overall QoL compares between a group
who received an intervention (EX) and a group who did not (WC). Repeated
Measure Analysis of Variance (RM-ANOVA) will be used to determine group
differences over time (M3 and M6). If needed, non-parametric tests such as the
Kruskal-Wallis test will be used.

Aim #2: Describe quality of life within the domains of physical, psychological, social
and spiritual well-being in female breast cancer survivors age 65 or older.
Research Question 2.1: What is the QoL of older breast cancer survivors within the
domains of physical, psychological, social and spiritual well-being at baseline?
Research Question # 2.2: How does QoL within these domains change over time?
Research Question # 2.3: How does QoL within these domains compare between
groups over time?
2.1

2.2

2.3

The goal of this research question is to determine how older women with breast
cancer report their QoL within the domains of the quality of life at M1. Scores for
each item in each subscale in the QoL-BC will be calculated as an average (mean
score). The scores within each subscale will then be added to make a total
subscale score. Ranges will also be computed. In addition, within each subscale,
items will be ranked according to level of concern (high to low concern).
This research question will describe changes in the subscale scores within the
entire sample over time. Subscale scores within the entire sample at M3 and M6
will be compared to baseline subscale scores. Paired t-tests will be used. If
needed, non-parametric statistics such as the Wilcoxon signed-rank test will be
used.
This research question will describe how changes in subscale scores compare
between 2 groups (EX vs. WC) over time (M3 and M6). RM-ANOVA will be used
to determine group differences over time. If needed, non-parametric tests such as
the Kruskal-Wallis test will be used.

Aim #3: Describe additional life experiences that may relate to quality of life in female
breast cancer survivors age 65 and older.
Research Question #3.1: Describe other life experiences of older breast cancer
survivors as described by research nurses.
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Research Question #3.2: Describe the types of medication used by older breast
cancer survivors age 65 and older.
3.1

3.2

The goal of this research question is to describe other life experiences of older
breast cancer survivors as they related to quality of life. Data will be obtained
from field notes documented by research nurses throughout the duration of the
study.
The goal of this research question to describe the types of medication used by
older breast cancer survivors age 65 and older. Data will be obtained from the
BCEI Finances Form. Frequencies will be used to describe this data.

Qualitative Data Analysis Procedure: The goals of the research questions
presented in Aim #3 are largely descriptive. As posed, the questions do not lend
themselves to one of the well-known methods of qualitative analysis such as
phenomenology, grounded theory or ethnography. During this analysis there will be no
attempt to determine the lived experience of older women with breast cancer, provide a
holistic view of that population’s culture or determine the social processes within a
social setting. Instead, this dissertation will use qualitative description234, 235 and
qualitative content analysis is used to discover themes in the research nurses field
notes.236, 237 Qualitative description is used when straight description of a phenomenon
is desired.235 One characteristic of using qualitative description is that it is a lowinference procedure meaning the “facts” are presented in everyday language as opposed
to other methods such as phenomenology, ethnography or grounded theory that present
or interpret events in other terms.235
Process for content analysis of field notes: Qualitative content analysis of field notes
will be based on a systematic process set forth by Schilling238 in which there are 5 levels
of analysis that include turning transcripts into raw data, condensing records,
developing a preliminary category system, formally defining the categories and
analyzing and interpreting data. Due to the nature of the field notes as being a second
hand account (nurse observations) of patient experiences, the steps will be modified.
The following describes the process for analyzing the field notes for this dissertation:
1) Field notes will be entered into Ethnograph and used as raw qualitative data.
2) Data will be read thoroughly prior to coding. Since the field notes are not a
traditional narrative (in the subjects own words) and are expected to be brief, data will
not be further reduced.
3) Themes or events will be generated from the data and codes will be applied that
describe the theme using language closely reflecting the language used by the nurses in
the field notes. For example, if the nurse observed and noted that the patient was
concerned with an ill family member, recently experienced the death of their spouse, or
was worried over a follow-up appointment, the codes used to describe the experience
will specifically state the event i.e., “concerned with husband’s illness”, “spouse recently
died”, or “worried about follow-up mammogram.” Codes and themes will reflect the
actual event or experience noted by the research nurse in the field note.
4) Categories will be developed and defined and the previously used codes will be
placed in these categories. For example, a several subjects may be worried about the
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health of family members; hence, the overall category may be “worried about the health
of family member.”
5) These themes and categories will be used describe other life experiences that may
relate to quality of life in older breast cancer survivors.
Consistent with basic content analysis, reliability will be verified by either a fellow
doctoral student who is naive to the data or a member of the dissertation committee.
The procedure for reliability is to 1) review 5 field notes, 2) compare the themes and
codes identified by the doctoral researcher with the actual field notes.
TABLE 9: Summary of Data Analysis Plan
Research
Goals
Questions
1.1
Within group- Overall QoL score
1.2
Within group changes- Overall QoL score
1.3
2.1
2.2

Between group changes- Overall QoL score
Within group- QoL subscale score
Within group- Item scores within subscales
Within group changes- QoL subscale scores

2.3
3.1
3.2

Between group changes- QoL subscale scores
Within group- Current life experiences
Within group- Medications

Analysis Method
Means
Paired T-tests/ Wilcoxon signed
rank test
RM-ANOVA/ Kruskal-Wallis test
Means
Means
Paired T-tests/ Wilcoxon signed
rank test
RM-ANOVA/ Kruskal-Wallis test
Qualitative Content Analysis
Means

Study Limitations
Several limitations exist for this dissertation research.
Secondary Analysis: The primary limitation of this dissertation is that the data set
was originally intended for different research questions. However, a strength of this
dissertation research is that the data set “fits” the current set of research questions and
the overall conceptual framework used in the BCEI is suitable for examining quality of
life in older breast cancer survivors.
Additionally, using a preexisting data set may cause a researcher to question the
integrity and quality of the data. Fortunately, this student is very familiar with data set
and was involved in data management and cleaning procedures. The student is
confident that the data set is sound and few instances of missing data exist.
Sample Size: This dissertation will be using a subset of a larger population of early
stage breast cancer survivors. The sample of women age 65 and older is small. Data
from 50 older women will be analyzed and statistical significance is not guaranteed.
However, both parametric and non-parametric statistical procedures are available and
worked into the data analysis plan to provide the most rigorous data analysis possible
with the limited sample size.
Reliability of Measurements: While the tools used in the original study (BCEI) have
been used in populations with breast cancer, their reliability specifically in older women
has not been reported. For example, the Quality of Life- Breast Cancer instrument has
not been used specifically in a population of older women and it is uncertain if the items
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contained within each domain is relevant to a population of older women surviving with
breast cancer.
In addition, the content of the field notes taken by the Research Nurses during the
BCEI is unknown. These notes have not been examined prior to this study. These notes
were originally written to document face to face visits and telephone calls between
nurses and subjects. Notes were also used to document specific issues subjects were
encountering and interventions suggested by the Research Nurses during the course of
the study. The contents of these notes may vary in quality and usability.
Generalizability: The results of this research will not generalizable outside of the
setting in which it was collected. However, it is hoped that this research will foster new
research questions concerning older women with breast cancer and lead to intervention
testing in future research endeavors.
Summary of Research Design and Methods
The overall purpose of this research is to examine quality of life in women with early
stage breast cancer who are age 65 and older and are within the first year of
survivorship. This student’s dissertation research will use a descriptive design for
analysis using mixed methods. Parametric and non-parametric statistical tests will
examine QoL in this sample of older women surviving with breast cancer. Thematic
analysis of field notes will investigate additional life experiences experienced by older
breast cancer survivors.
Timetable- (See Table 10)
TABLE 10: Projected Timetable for Dissertation Completion
August 2006
Prepare research protocol
Sept 2006
Defend Dissertation Proposal
October 2006
Submit to UCF IRB
November 2006
Begin data analysis
December 2006
Complete data analysis
January 2007
Begin writing of results, findings, conclusions
Elicit dates for dissertation defense from committee
Request Dissertation Defense date no later than March 2nd
February 2007
Continue writing of results, findings, conclusions
Begin development of papers for publication
March 2007
Complete dissertation within parameters of UCF Dissertation
guidelines
Write abstracts of 3 papers for publication and submit to
journal editors
Complete writing of results, findings, conclusion
April 2007
Defend Dissertation no later than April 6
Complete changes and modifications requested by
Dissertation Committee
Submit hard copies to dissertation committee
Complete all final reports required by SON and UCF
May 2007
Graduation
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Human Subjects Research

Protection of Human Subjects
Approval for this dissertation research will be obtained from the University of
Central Florida Institutional Review Board (IRB) prior to the start of any research
activities.
Potential risks
No risk to the subject can be predicted at this time. This dissertation research will
use de-identified quantitative and qualitative data.
Protection against risks
Not Applicable
Importance of knowledge to be gained
This dissertation research is important because little is known about quality of life in
older breast cancer survivors. Although the sample for this study is small, it may help
clarify some of the ambiguity concerning older women with breast cancer found in the
literature. The results of this research are expected to contribute to the limited
knowledge concerning older breast cancer survivors to gain a better understanding of
this population and their concerns and needs after being treated for early stage breast
cancer.
Inclusion of Women and Minorities
Women are the focus of this research and minority women are included. The parent
study achieved an 18% minority participation rate. The sample of older women will also
be examined for minority participation.
Inclusion of Children
No children under the age of 21 were included in the original BCEI.
Data Safety and Monitoring Plan
According to the NIH Policy for Data and Safety Monitoring240 a data safety and
monitoring plan is needed for clinical trials (intervention studies) to ensure the safety of
research participants as well as the integrity and validity of data in clinical trials
supported by the NIH. The data and monitoring safety board functions separately from
the Institutional Review Board. This dissertation will not employ a DSMB because of
the inherent low risk to subjects involved in an analysis of pre-existing de-identified
data. There will be no recruitment of subjects, no opportunity for significant adverse
events involving subjects and no patient contact. In the event that an adverse event
(AE) that had not been previously discovered in the BCEI is found, the Principal
Investigator of the BCEI will be notified so the AE can be reported to the UCF IRB.
Vertebrate Animals
Not Applicable
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11. Loerzel. V.W. (2003). Late physical effects of treatment. In Karen H. Dow (Ed.), Contemporary
issues in breast cancer, 2nd Ed. (pp. 263-280). Boston, Massachusetts. Jones and Bartlett
Publishers.
12. Loerzel. V.W. (2003). Support and survivorship issues. In Karen H. Dow (Ed.), Contemporary
issues in breast cancer, 2nd Ed. (pp. 313-322). Boston, Massachusetts. Jones and Bartlett
Publishers.
ACCEPTED FOR PUBLICATION
13. Meneses, K., McNees, P., Loerzel, V.W., Su, X, Hassey, L. Transition from treatment to
survivorship: Effects of a psychological intervention on quality of life in breast cancer survivors.
Oncology Nursing Forum, Accepted for publication.

PEER REVIEWED PUBLISHED ABSTRACTS:
14. Powel, L., Dow, K.H., McNees, P., & Loerzel, V.W. (2007). Early use of qualitative techniques
to improve intervention integrity. Oncology Nursing Forum, 34(1), 246.
15. Loerzel, V.W., Dow, K.H., & McNees, P. (2007). Data Integrity: The value of clinical context in
data preparation and entry. Oncology Nursing Forum, 34(1), 245.
16. Dow, K.H., McNees, P., & Loerzel, V.W. (2006) Effectiveness of psychoeducational
interventions for breast cancer survivors: An interim analysis. Conference Proceedings, American
Psychosocial Oncology Society 3rd Annual Conference.
17. McNees, P., Dow, K.H., Spellman, S., Lerz, R., McNees, C., & Loerzel, V.W. (2006). Fertility
and cancer project: Psychoeducational and psychosocial research in an electronic environment.
Conference Proceedings, American Psychosocial Oncology Society 3rd Annual Conference.
18. Loerzel, V.W., Dow, K.H., & McNees, P. (2006). Why women with breast cancer use or don‘t
use lymphedema prevention and management strategies. Conference Proceedings, American
Psychosocial Oncology Society 3rd Annual Conference.
19. Dow, K.H., McNees, P., Loerzel, V.W., & Zhang, Y. (2006). Tailored breast cancer education
intervention (BCEI) for breast cancer survivors: An interim analysis. 20th Annual Conference
Proceedings, Southern Nursing Research Society.
20. Loerzel, V.W., Dow, K.H., & McNees, P. (2006). Tools for managing patient recruitment:
Evolving strategies in longitudinal research. 20th Annual Conference Proceedings, Southern
Nursing Research Society.
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21. Dow, K.H., McNees, P., & Loerzel, V.W. (2006). CuSum technique: A tool to evaluate change
in referral and enrollment. 20th Annual Conference Proceedings, Southern Nursing Research
Society.
22. McNees, P., Dow, K.H., Ramaswamysanthanam, R., Subramanian, G., & Loerzel, V.W. (2006).
Tools and processes for improving research data integrity. 20th Annual Conference Proceedings,
Southern Nursing Research Society.
23. Dow, K.H, McNees, P., & Loerzel, V.W. (2005). The internet as a comprehensive environment
for quality of life research: Challenges, strategies and tactics. Quality of Life Research, 14(9),
1990.
24. McNees, P., Dow, K., & Loerzel, V.W. (2005). Live Item index technique (LIITE) in
longitudinal quality of life clinical trials. Quality of Life Research, 14(9), 2017.
25. Loerzel, V.W., Dow, K.H., & McNees, P. (2005) Incidental findings related to lymphedema
incidence and prevention in quality of life research. Quality of Life Research, 14(9), 2039.
26. Dow, K.H., Loerzel, V.W., Zhang, Y., & McNees, P. (2005). A targeted breast cancer education
intervention (BCEI) for breast cancer survivors: An interim analysis. Proceedings of the 30 th
Annual Congress of the Oncology Nursing Society, Orlando, FL.
27. McNees, P., Dow, K.H., Ramaswamysanthanam, S., Subramanian, G., & Loerzel, V.W. (2005).
Improving data integrity: Applying novel tools in a longitudinal breast cancer clinical trial.
Proceedings of the 30th Annual Congress of the Oncology Nursing Society, Orlando, FL.
28. Loerzel, V.W., Dow, K.H., & Subramanian, G. (2005). Lymphedema: Incidental findings from
the BCEI. Proceedings of the 30th Annual Congress of the Oncology Nursing Society, Orlando,
FL.
29. Loerzel, V.W. (2005). Hardiness: A concept analysis. Proceedings of the 19th Annual
Conference of the Southern Nursing Research Society. Atlanta, GA.
30. Dow, K.H., & Loerzel, V.W. (2005). Lymphedema incidence in early stage breast cancer
survivors: Secondary analysis of the BCEI. Proceedings of the 19th Annual Conference of the
Southern Nursing Research Society. Atlanta, GA.
31. Dow, K.H., McNees, P., & Loerzel, V.W. (2005). Novel application of CuSum technique to
evaluate changes in recruitment strategies on referral and enrollment: Implications for prospective
recruitment management. Proceedings of the 8th National Conference on Cancer Nursing
Research, Fort Lauderdale, FL.
32. Dow. K.H., Loerzel, V.W., Roberts, S., Denton, S., & Nunes, J. (2004). Changing recruitment
strategies in longitudinal research. Proceedings of the 18th Annual Conference of the Southern
Nursing Research Society. Louisville KY.
33. Dow. K.H., Loerzel, V.W., Roberts, S., Denton, S., & Nunes, J. (2004). Using collaboration and
innovation to improve subject recruitment and retention in a longitudinal intervention research
study. Proceedings of the 29th Annual Congress of the Oncology Nursing Society. Anaheim,
CA.

PATIENT EDUCATION:
34. Loerzel, V.W. Primary author or editor of patient education materials developed at M. D.
Anderson Cancer Center Orlando.
2002:
―Cisplatin‖ (Chemotherapy)
―Carboplatin‖ (Chemotherapy)
2001:
―What you should know about implanted ports‖
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―Antioxidants and vitamin supplements‖
―Managing diarrhea‖ (Editor)
―Anemia‖
―Alopecia‖
―Managing nausea and vomiting during cancer treatment‖
―Dry mouth‖ (Editor)
―Managing a sore mouth and throat‖ (Editor)
―Doxorubicin‖ (Chemotherapy)
―Etoposide‖ (Chemotherapy)
2000:
―Constipation‖
―Lymphedema‖ (Editor)
―Arm exercises: To minimize the risk of lymphedema‖ (Editor)
―Leg exercises: To minimize the risk of lymphedema‖ (Editor)
―Neutropenia precautions‖ (Editor)
―Cancer information websites: A guide for patients and their families‖ (Editor)
1998:
―An introduction to your blood counts‖
―Fatigue during cancer treatment‖

VII.

PRESENTATIONS

REFEREED NATIONAL/INTERNATIONAL:
Feb 2007

Oct 2006

Feb 2006

Oct 2005

Poster Presentation. Loerzel, V.W., Dow, K.H., & McNees, P. (2007). Data
Integrity: The value of clinical context in data preparation and entry. Ninth
National Conference on Cancer Nursing Research, Hollywood, CA
Symposium. Loerzel V.W., Dow K. H., & McNees P. Tools for managing patient
recruitment: Evolving strategies in longitudinal research. 2006 National Congress of
the State of the Science in Nursing Research, Washington, D.C.
Poster Presentation. Loerzel V.W., Dow K. H., & McNees, P. Why women with
breast cancer use or don‘t use lymphedema prevention and management strategies.
American Psychosocial Oncology Society 3rd Annual Conference, Amelia Island.
Poster Presentation. Loerzel, V.W., Dow, K.H., & McNees, P. Incidental finding
related to lymphedema incidence and prevention in quality of life research. 12th
Annual Conference of the International Society for Quality of Life. San Francisco,
CA.

May 2005

Poster Presentation. Loerzel, V.W., & Dow. K.H. Lymphedema incidence in early
stage breast cancer survivors: Secondary analysis from the BCEI. Oncology
Nursing Society 30th Annual Congress. Orlando, Fl.

Nov 1998

Symposium Presentation. Murphy, M., DeJesus, Y., Newman, J., & Wochna, V.
From the comprehensive cancer center to the community: Building the bridges of
the future. Oncology Nursing Society Fall Institute. Dallas, TX.

179

REFEREED REGIONAL/STATE/LOCAL:
Feb 2007

Mar 2006

Feb 2006

Feb 2006

Mar 2005
Mar 2005
Feb 2005

Feb 2005
Mar 2004

Symposium, Loerzel, V.W., Dow, K.H., & McNees, P. (2007). Data Integrity: The
value of clinical context in data preparation and entry. 21st Annual Conference,
Southern Nursing Research Society, Galveston, TX.
Poster Presentation Loerzel, V.W. Theoretical perspectives of quality of life in
breast cancer survivors. 2006 Graduate Research Forum. University of Central
Florida, Orlando, FL.
Doctoral Session Poster Presentation Loerzel, V.W. Theoretical perspectives of
quality of life in breast cancer survivors. 20th Annual conference, Southern Nursing
Research Society, Memphis, TN.
Symposium. Loerzel V.W., Dow K. H., & McNees P. Tools for managing patient
recruitment: Evolving strategies in longitudinal research. 20th Annual conference,
Southern Nursing Research Society, Memphis, TN.
Poster Presentation. Loerzel, V.W. ―Hardiness: A concept analysis.‖ 13th Annual
Research Day. Sigma Theta Tau International Theta Epsilon Chapter, Orlando, FL.
Poster Presentation. Loerzel, V.W. ―Hardiness: A concept analysis.‖ 2005
Graduate Research Forum. University of Central Florida, Orlando, FL.
Poster Presentation. Loerzel, V.W., & Dow, K.H. ―Lymphedema incidence in early
stage breast cancer survivors: Secondary analysis from the BCEI.‖ Southern
Nursing Research Society 19th Annual Meeting. Atlanta, GA.
Doctoral Session Poster Presentation. Loerzel, V.W. ―Hardiness: A concept
analysis.‖ Southern Nursing Research Society Annual Meeting. Atlanta, GA.
Paper Presentation. Dow, K. H., & Loerzel, V.W. Changing recruitment strategies
in longitudinal research. 12th Annual Research Day: Spinning the Web: Nursing
Theory, Research and Practice. Sigma Theta Tau International, Theta Epsilon
chapter. Orlando, FL.

INVITED (NON-REFEREED) REGIONAL/STATE/LOCAL PAPERS:
Nov 2006

Dec 2005

Oct 2005

1999-2002
Spring 2001

2000-2002
2001-2002

Invited Speaker, Loerzel, V.W. ―Quality of life in older breast cancer survivors: A
review of the literature.‖ Sigma Theta Tau, Theta Epsilon Chapter, Fall General
Meeting, Orlando, FL.
Invited Speaker, Dow, K.H. & Loerzel, V.W. ―Quality of life interventions for
breast cancer survivors: A collaborative effort. M. D. Anderson Cancer Center
Orlando, Oncology Grand Rounds, Orlando, FL.
Poster Presentation, Loerzel, V.W. & Dow, K.H. ―Lymphedema incidence in early
stage breast cancer survivors: Secondary analysis from the BCEI.‖ Research
Renewal and Roses, UCF SON Alumni Conference, Orlando, FL.
Invited Speaker, ―Principles of patient and family education.‖ Orlando Regional
Healthcare System, Oncology/Chemotherapy Symposium. Orlando, FL
Invited Speaker, ―Current treatment options‖ First Connection Peer Volunteer
Training. Central Florida Chapter of the Leukemia and Lymphoma Society,
Orlando, FL.
Invited Speaker, ―Immediate side effects of chemotherapy.‖ Orlando Regional
Healthcare, Chemotherapy Verification Program. Orlando, FL.
Invited Speaker, ―Oncologic emergencies.‖ Orlando Regional Healthcare System.
Orlando FL.
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1998-2001
Spring 2002
May1999
Apr 1999
1998-1999
Apr 1998
March 1998

Feb 1998
Jan 1998
Nov 1997
July 1996

Invited Speaker, ―Learning about cancer: pathophysiology and diagnosis.‖ I Can
Cope. American Cancer Society, Orlando, FL.
Invited Speaker, ―Blood cell transplantation.‖ The University of Central Florida.
Medical Technologist Conference, Orlando, FL.
Invited Speaker, ―Cancer surgery: An overview.‖ Orlando Regional Healthcare
System. Oncology/Chemotherapy Symposium. Orlando, FL.
Invited Speaker, ―General cancer update.‖ Orlando Regional Healthcare System,
55+ program, St. Cloud Hospital. St. Cloud, FL.
Community Presentation, ―Cancer prevention and early detection: A focus on breast
self exam.‖ Orlando Regional Healthcare System. Orlando, FL.
Invited Speaker, ―Cancer screening and early detection.‖ Orlando Regional
Healthcare System, 55+ program, Orlando. FL.
Invited Speaker, ―Immediate side effects of chemotherapy.‖ Chemotherapy
Symposium: Beyond the Basics. Orlando Regional Healthcare System and M. D.
Anderson Cancer Center Orlando. Orlando, FL.
Invited Speaker, ―Understanding cancer treatments.‖ I Can Cope. M. D. Anderson
Cancer Center Orlando and the American Cancer Society. Orlando, FL.
Invited Speaker. ―Blood cell transplantation.‖ VNA Home Healthcare. Orlando,
FL.
Invited Speaker. ―Blood cell transplantation.‖ Oncology Nursing Grand Rounds, M.
D. Anderson Cancer Center Orlando. Orlando, FL.
Invited Speaker, ―Oncologic emergencies.‖ Oncology Nursing Review. Sponsored
by the Cleveland Chapter of the Oncology Nursing Society and Cleveland State
University. Cleveland, OH.

ACEDEMIC LECTURES AND TEACHING EXPERIENCE:

Spring 2007

Courses: University of Central Florida, School of Nursing
Adjunct Instructor, Nursing Research/Critical Inquiry (NUR-3165 0W61)

Fall 2006

Adjunct Instructor, Principles of Oncology Nursing (NUR-3795 0W91)
Adjunct Instructor, Health Assessment Lab (NUR-3065L-0018)
Adjunct Instructor, Health Assessment Lab (NUR-3065L-0019)

Sum 2006

Adjunct Instructor, Principles of Oncology Nursing, (NUR-3795 0W91).

Fall 2005

Adjunct Instructor, Principles of Oncology Nursing, (NUR-3795 0W91).

Spring 2005

Adjunct Instructor, Principles of Oncology Nursing, (NUR-3795 0W91).

Sum 2003

Adjunct Instructor, Health Assessment Lab (NUR-3065L)

Fall 2006

Lectures: University of Central Florida, School of Nursing
Invited Speaker, ―Acute care issues in oncology nursing‖ Lecture for
undergraduate students of acute nursing.
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Spring 2006

Invited Speaker, ―Acute care issues in oncology nursing‖ Lecture for
undergraduate students of acute nursing.

Spring 2005

Invited Speaker, ―Acute care issues in oncology nursing‖ Lecture for
undergraduate students of acute nursing.

Nov 2004

Invited Speaker, ―Acute care issues in oncology nursing‖ Lecture for
undergraduate students of acute nursing.

2002-2003

Invited Speaker, ―Breast health assessment‖ Lecture for undergraduate students of
nursing health assessment.

VIII.

PROFESSIONAL ACTIVITIES & COMMUNITY SERVICE

PROFESSIONAL ORGANIZATIONS/ MEMBERSHIP
Year
1994 – Present
1994-1996
1997 – Present
1993 – Present
2002 – Present
2002 – Present
1993,
2004 – Present
2006 -- Present

Organization
Oncology Nursing Society
Cleveland Chapter, Oncology Nursing Society
Central Florida Chapter, Oncology Nursing Society
Sigma Theta Tau International
Theta Epsilon Chapter
Southern Nursing Research Society
American Nurses Association and Florida Nurses Association
Doctoral Student Nursing Organization

PROFESSIONAL SERVICE ACTIVITIES
Oncology Nursing Society

2003 - 2007
2004 - 2007
2002

National Service
Oncology Nursing Certification Corporation
Member, OCN® Test Development Committee
ONCC Item Writing Mentor
ONCC Item Writing Workshop Participant

2007
2006

Local/Regional Service
Oncology Nursing Society
Past-President, Central Florida Chapter
President, Central Florida Chapter
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2005
2005
2004
2003
2001-2002
1999-2000
1996
1995-1996

President-Elect, Central Florida Chapter
Member- ONS Congress local Planning Committee
Director at Large, Central Florida Chapter
Nominating Committee Co-chair, Central Florida Chapter
Newsletter Chair, Central Florida Chapter
Nominating Committee Chair, Central Florida Chapter
Secretary, Cleveland Chapter
Member, Community Outreach, Cleveland Chapter

EDITORIAL REVIEW:
2006- Present
2004-2006

Review Board Member, Cancer Nursing (International peer reviewed journal)
Review Board Member, Clinical Journal of Oncology Nursing. (National peer
reviewed journal).

COMMUNITY AND INSTITUTIONAL SERVICE:
2006-2007
Community

2005-2006
University
School of Nursing
Community

2004-2005
School of Nursing
Community

2003-2004
University

School of Nursing

Member, Patient Services Committee, The Leukemia & Lymphoma Society,
Orlando

Member, Planning Committee, 3rd Annual Breast Cancer Update
Elected Student Representative, Doctoral Committee
Member, Patient Services Committee, The Leukemia & Lymphoma Society,
Orlando.
Member, Institutional Review Board, M .D. Anderson Cancer Center Orlando.

Elected Student Representative, Doctoral Committee
Invited Speaker, ―Breast cancer education intervention study: Quality of life in
breast cancer survivors.‖ Summer Undergraduate Research Academy 2004.
Invited Speaker, ―Breast Cancer Awareness.‖ 4th Annual Breast Health Awareness
Day, Sponsored by: Colonial Medical Supplies, Orlando, FL.
Member, Patient Services Committee, The Leukemia & Lymphoma Society,
Orlando.
Member, Institutional Review Board, M .D. Anderson Cancer Center Orlando.

Invited Speaker, ―Women‘s health/breast cancer.‖ Open forum on breast cancer for
students, faculty and staff, Bluestocking Luncheon Series. The University of Central
Florida Women‘s Studies Program
Elected Student Representative, Doctoral Committee
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Community

2002-2003
Community

Invited Speaker, ―Collaborative partnerships: University and community cancer
program relationships to strengthen recruitment and retention of research subjects‖
The University of Central Florida, School of Nursing, Professional Development
Series.
Invited Speaker, ―Cancer prevention and early detection‖ University High School
Student Health Awareness Series. Orlando, FL. Quarterly- January, April, June,
November.
Member, Patient Services Committee, The Leukemia & Lymphoma Society,
Orlando.
Member, Institutional Review Board, M .D. Anderson Cancer Center Orlando.

Invited Speaker, ―Cancer prevention and early detection‖ University High School
Student Health Awareness Series. Orlando, FL. Quarterly- January, April, June,
November.
Member, Patient Services Committee, The Leukemia & Lymphoma Society,
Orlando.
Member, Institutional Review Board, M .D. Anderson Cancer Center Orlando.

Orlando Regional Healthcare System/ M. D. Anderson Cancer Center Orlando
Year
1998-2002
1999-2002
2001-2002
1999-2002
2001-2002
2000-2002
2000-2001
2000-2001

1997-2002

1998-2002
2001-2002
1998-2001
2000
1999-2000
1999-2002

Committee
Chair and Co-chair, Oncology Nursing Practice Council- MDACCO
Coordinator, Oncology Nursing Grand Rounds
Member, Institutional Review Board- MDACCO
Member, Process Improvement Committee
Member, Radiation Oncology Conference Planning Committee
Co-coordinator, JCAHO Record Audits
Coordinator, Patient Education Process Improvement Committee
Member, M. D. Anderson Cancer Center Orlando Education Council
Service
Coordinator, Blood and Marrow Transplant Patient Coordinator and liaison to The
University of Texas, M. D. Anderson Cancer Center, Blood and Marrow Transplant
Center
Coordinator, Oncology Patient Education
Co-auditor, Concordance Study, M. D. Anderson Cancer Center Orlando and The
University of Texas, M. D. Anderson Cancer Center
Coordinator, Wait-Time Study, M. D. Anderson Cancer Center Orlando
Co-Chair, Danskin Triathlon- ―Team Survivor‖ Orlando, FL.
Co-Chair, National Cancer Survivor Day at M. D. Anderson Cancer Center Orlando.
Member, Patient Services Committee, The Leukemia & Lymphoma Society, Orlando.
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